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Abstract 
Blood-Brain Barrier (BBB) breakdown occurs in ageing and neurodegenerative 
disorders and affects several brain regions including cortex and hippocampus. During 
ageing, structural and functional changes affecting the main BBB components (brain 
endothelial cells (BECs), pericytes and astrocytes), appear to be associated with altered 
expression of genes and microRNAs (miRNAs) potentially related to development, 
protein synthesis or longevity pathways. However, little is known about the age-related 
BBB dysfunction in females. In this study, we aimed to assess the relation between 
ultrastructural and transcriptional changes in the ageing female BBB. A combination of 
transmission electron microscopy (TEM) and 3D reconstruction was used to study 
microvessel ultrastructure in 6- and 24-month-old female C57BL/6J mice. According to 
our results, the ageing female BBB shows a significant increase in basement membrane 
(BM) thickness, volume and number of BEC pseudopods, pericyte mitochondrial volume, 
pericyte – BEC contact and tight junction (TJ) tortuosity. Also, cortical capillaries 
appeared to be prominently more affected during ageing than hippocampal capillaries. 
These results suggest a higher impact of ageing on the cortical BBB in females, promoting 
changes that lead to a pro-inflammatory state, among other processes. In addition, 
sequencing results showed that the majority of upregulated genes in the ageing female 
BBB were involved in inflammation and immune response pathways, whereas the 
downregulated genes were mostly related to metabolism and signalling pathways. 
Amongst the age-deregulated mRNAs and miRNAs, miR-144-3p (upregulated) and 
Dnmt3a (downregulated) were selected for functional analysis in a human BEC line 
(hCMEC/D3), where their inverse correlation was confirmed. However, DNMT3A, not 
miR-144-3p, was shown to influence BEC function when deregulated, thereby promoting 
higher leukocyte adhesion and mRNA levels of adhesion molecules (ICAM-1, VCAM-1) 
and the chemokine CCL5. Age-induced increase of miR-144-3p appears to modulate 
DNMT3A expression, but DNMT3A might be independently contributing more to 
switching BECs into a pro-inflammatory state. 
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1. General introduction 
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Chapter 1. General introduction 
1.1 The Blood-Brain barrier  
The first studies pointing to the existence of a barrier between the brain and the 
circulatory system were performed in the late XIX century and early XX century. Paul Ehrlich 
in 1885 and Edwin Goldmann in 1909, carried out a series of experiments that consisted in 
administration of vital dyes capable of staining living cells and tissues (i.e. trypan blue) into 
rats. Administrations were followed by examination of the dye distribution throughout the 
animal’s body. When the dye was infused into the systemic blood circulation, Ehrlich observed 
that the brain remained unstained (Ehrlich 1885). Whereas when Goldmann performed the 
injection of the dye directly into the cerebrospinal fluid, it resulted in staining of the brain only 
(Goldmann 1909). There appeared to exist a barrier between the brain and the blood that would 
prevent the passage of the dye from the cerebral vessels into the brain. However, the term 
‘blood-brain barrier (BBB)’ was not introduced until 1921 by Lina Stern and Raymond Gautier, 
who also performed detailed penetration studies with a wide range of molecules from blood 
into the brain (Stern and Gautier 1921). Additional experiments showing that intravenous 
administration of cholic acids and sodium ferrocyanide had no effects in the central nervous 
system (CNS), whereas intracerebral administration did, provided further evidence that brain 
capillaries modulate and regulate the passage of molecules from the blood stream into the brain 
and vice versa (Lewandowsky 1900).  
Later studies (1960s) using electron microscopy techniques and horseradish peroxidase 
showed how this protein diffuses relatively fast across capillaries into peripheral tissues, 
whereas it would remain confined within the lumen of capillaries in the brain parenchyma for 
a longer period of time (Brightman et al. 1970). From these experiments it was concluded that 
the lack of permeability to peroxidase by brain and spinal cord microvessels was due to two 
main features present in the capillary brain endothelial cells (BEC): 1) the absence of channels 
for intracellular transport and 2) a low trafficking rate of pinocytotic vesicles. This assumption 
is complemented by the fact that inter-cellular tight junction (TJ) proteins are highly expressed 
in the brain endothelium, compared to peripheral endothelial cells, thereby providing the actual 
physical barrier properties of the whole anatomical structure. From this and later studies, it has 
been demonstrated that the BBB is localised at the level of the BECs (Kniesel and Wolburg 
2000; Wolburg and Lippoldt 2002).  
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1.1.1 Vascularisation of the CNS 
The CNS is highly vascularised, and as any other organ in the body its vascular network 
can be classified depending on the size and cell composition of the blood vessels. Following 
mainly the size criterion, cerebral vasculature is divided in macrocirculation and 
microcirculation. The main function of macrocirculation vessels is promoting the arrival and 
exit of blood into and out of the brain, whereas the microcirculation plays a role in regulating 
the blood flow and facilitating exchange of oxygen and nutrients (Kulik et al. 2008). 
1.1.1.1 Macrovascular network in the CNS 
Macrocirculation is comprised by cerebral blood vessels of higher size, which include 
the internal vertebral arteries that originate in the neck and fuse within the skull into the basilar 
artery. These arteries join at the base of the brain to form the circle of Willis, and from there 
arterial blood is carried by pial vessels, which are followed by penetrating arteries that finally 
reach the brain parenchyma (Zirak et al. 2010). The final aim of macrocirculation arteries is to 
perfuse the brain with oxygenated blood. Following gas exchange, deoxygenated blood is 
removed from the brain via cerebral veins that ultimately drain it into the transverse and 
sigmoid cranial sinuses (Hendrikse et al. 2005; Kılıç and Akakın 2007).  
1.1.1.2 Microvascular network in the CNS 
CNS microcirculation is comprised by smaller penetrating vessels. The microvascular 
network exists between the cerebral arterial and venous systems and includes arterioles, 
capillaries and venules, which are also known by the general term of microvessels. Arterioles 
(50 to 100 µm of diameter) arise from the larger penetrating arteries and are followed by pre-
capillary arterioles (20 to 50 µm). Venules and post-capillary venules show a diameter similar 
to arterioles and pre-capillary arterioles and participate in the removal of deoxygenated blood 
(Macdonald, Murugesan, and Pachter 2010), these vessels present loose organization of cell to 
cell junctions, being the segment of the microvascular network where leukocyte extravasation 
preferentially occurs (Ge, Song, and Pachter 2005). Brain capillaries (less than 10 µm of 
diameter), are the site of gas exchange in-between arteriolar and venular systems, have the 
largest surface area of all CNS vessels, and are the ones in which the barrier characteristics, 
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including TJs, are highly prominent (Itoh and Suzuki 2012). As stated above, the BBB is 
located at the level of the BECs. With respect to its location within the neurovascular tree, the 
higher expression of a BBB is generally considered to exist at the level of microvessels, and 
that is the reason why most of the studies focus on them. However, bigger vessels such as 
cerebral arteries and veins also show barrier characteristics (Butt, Jones, and Abbott 1990; Ge 
et al. 2005; Mayhan and Heistad 1986). 
1.1.1.3 Microvessel heterogeneity 
Several studies have described segmental differences along the brain microvasculature. 
BECs have been shown to present gradual phenotypical and transcriptional changes depending 
on the level of the vascular hierarchy they are at, a phenomenon known as zonation 
(Vanlandewijck et al. 2018). Indeed, these differences at the level of BECs appear to be 
associated as well with structural, biochemical and functional changes among segments of the 
microvasculature. Zonation-specific differences include organization of TJs, rate of 
transcytosis, expression of enzymes such as Na+/K+ ATPase, expression of transporters such 
as P-glycoprotein (Pgp) and presence of mural cells (i.e. smooth muscle cells, pericytes). These 
parameters differ between arterioles, capillaries or venules, thus can also be used for 
classification (Table 1) (Saubaméa et al. 2012).  
Table 1. Structural and functional differences between arterioles, capillaries and venules.  
Presence of perivascular cells is indicated by Yes, No or Yes/No. Presence of BBB features is indicated by 
Yes/No/? (not specifically described). Relative expression of transporters, enzymes and transporters is indicated 
by +, ++ or +++, from lowest to highest expression; -, for absence; +/-, when available publications do not agree; 
?, when not specifically described for a certain type of microvessels.  
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1.1.2 Components of the BBB 
As discussed above, the unique expression of TJ proteins by BECs confers the barrier 
properties and selectivity of the BBB itself. The BBB is essential for the separation between 
brain parenchyma and circulatory system. Therefore, it contributes to the proper functionality 
and tight homeostasis regulation of the CNS (Popescu et al., 2009). 
Although extremely important, BBB properties are not only due to the BECs. Blood 
vessels include BECs, mural cells (pericytes specifically) that sit on the basal surface of the 
endothelial monolayer and are embedded in a basement membrane (BM), sheathed by the 
astrocytic end-feet (Figure 1). These cellular and acellular components play a role in inducing 
and maintaining the BBB properties. In addition, microglia, neurons and oligodendrocytes have 
also been shown to contribute to this barrier (Banerjee and Bhat 2007; Seo et al. 2014). Thus, 
the group of cells that form the vessel, including the TJ-expressing BECs, is known as the 
neurovascular unit (NVU) (Daneman and Prat 2014). Although NVU refers to the different 
interacting cell types, and the BBB to the actual barrier at the endothelial level, both terms are 
usually exchangeable in literature.  
Arterioles Capillaries Venules References
Cells
Smooth muscle cells Yes No Yes/No Bechman et al., 2006; Vanlandewijck et al., 2018
Pericytes Yes/No Yes Yes Dalkara et al., 2011; Vanlandewijck et al., 2018
Perivascular macrophages Yes Yes Yes Bechman et al., 2006; Vanlandewijck et al., 2018
BBB features 
Tight Junctions (TJs) Continuous TJs/? Highly expressed TJs Loosely organized TJs Dahl, 1973; Simionescu et al., 1976; Ge et al., 2005
Permeability for BBB markers ? No Yes Mayhan et al., 1985; Bechman et al., 2006
Astrocytic end-foot shealth No Yes No Bechman et al., 2006; Ge et al., 2005
Transporters/Enzymes/Receptors
P-glycoprotein ? +++ ? Virgintino et al., 2002; Golden & Pardridge, 2000
Na+/K+ - ATPase +++ + + Ge et al., 2005
Transferrin receptor (TFRC) - +++ +/- Kalaria et al., 1992; Vanlandewijck et al., 2018
Alkaline phosphatase +++ +++ + Ge et al., 2005
Mg2+ - ATPase +++ + + Ge et al., 2005
5' -nucleotidase +++ + + Ge et al., 2005
γ-Glutamyl Transpeptidase (GGTP) ? +++ ? Wolff et al., 1992; Hanigan & Frierson, 1996
Bidirectional horsedish peroxidase transp. +++ + + Ge et al., 2005; Sheikov et al., 2006
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Figure 1. Main components of the BBB at capillary level.  
Brain endothelial cells (BECs) are distributed in continuous layers forming the blood vessels walls. They establish 
tight junctions (TJs) with neighbouring BECs to limit paracellular transport across the endothelium. Pericytes 
surround the BECs, sharing a common basement membrane (BM) with them. Astrocytic end-feet ensheath the 
microvessel and connect vascular and neural components. (Diagram by Eduardo Frías Anaya). 
1.1.2.1 Brain endothelial cells (BECs) 
Blood vessels in the brain are formed by a continuous layer of BECs which are 
considered the first physical barrier in order to maintain brain homeostasis. This specialty is 
due to unique properties different from all other endothelial cells in the body (Sá-Pereira, 
Brites, and Brito 2012).  
Unlike endothelial cells from peripheral circulation, BECs are non-fenestrated, present 
low pinocytotic activity, their surface is negatively charge, thereby limiting solute exchange 
between brain and blood, and their number and volume of mitochondria is also higher, 
providing energy for selective enzymes and active transport of certain solutes (Cardoso, Brites, 
and Brito 2010). Mainly due to the expression of highly organized TJ proteins, BECs also 
exhibit limited paracellular (i.e. between cells) flux of hydrophilic molecules across the 
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endothelium and have a high electrical resistance (average 3000 Ω∙cm2, in vivo conditions) 
(Ballabh, Braun, and Nedergaard 2004; Bradbury 1993).  
1.1.2.2 Pericytes 
Pericytes are located adjacent to endothelial cells on the abluminal (brain-facing) side 
of capillaries, precapillary arterioles, postcapillary venules and collecting venules. Pericytes 
are embedded within the endothelial-astrocyte BM and are able to send cellular projections that 
cover substantial parts of the vascular circumference (Balabanov and Dore-Duffy 1998). 
Pericyte recruitment onto vessels during development depends on the relationship between 
platelet-derived growth factor-β (PDGFβ), secreted by endothelial cells and its receptor 
PDGFRβ, which is expressed in pericytes (Armulik, Abramsson, and Betsholtz 2005; 
Hellström et al. 1999). The close relationship between BECs and pericytes is further 
demonstrated in areas where the BM is absent and via the formation of ‘peg-and-socket’ 
contacts that consist of membrane invaginations from both cell types and contain junctional 
contacts such as TJs, but also GAP and adherens junctions (Gerhardt and Betsholtz 2003). This 
way, pericytes are thought to facilitate and integrate cell communication in the BBB (Dalkara, 
Gursoy-Ozdemir, and Yemisci 2011). CNS pericytes are also important for control of the 
growth and migration of BECs in de novo formation of microvessels as well as for maintaining 
the integrity of brain capillaries through signalling pathways (e.g. Notch pathway) (Stratman 
and Davis 2012; Wang et al. 2013). They also regulate TJ formation and paracellular 
permeability of the BBB via expression of growth factors. Indeed, transforming growth factor 
β (TGF-β) released by pericytes was shown to increase barrier tightness in mouse primary 
BECs (Dohgu et al. 2005), while pericyte-derived secretion of angiopoietin-1 has been reported 
to induce expression of TJ proteins (e.g. occludin) in cultured rat BECs (Hori et al. 2004). 
Similarly, it has been reported how interactions between pericytes and astrocytes promote 
polarization of astrocytic end-feet and consequently the ensheathment of blood capillaries, 
contributing to BBB stability (S. Liu et al. 2012). Additionally, several studies have reported 
the expression of pericytic contractile proteins, which suggests that pericyte contribute to 
controlling capillary diameter and modulating cerebral blood flow at the level of capillaries, in 
response to changes in neuronal activity (Cai et al. 2018; Hall et al. 2014; Peppiatt et al. 2006). 
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1.1.2.3 Basement membrane (BM) 
The endothelial BM, or basal lamina, within which pericytes are embedded, is located 
on the abluminal side of the blood vessel and separates pericytes from BECs and astrocytic 
end-feet (Yurchenco and Patton 2009). BECs, pericytes and astrocytes all contribute to the 
formation and maintenance of the BM (Abbott, Revest, and Romero 1992). Capillaries contain 
an endothelial BM and an astrocytic BM that are in close contacts and often appear as one. 
This non-cellular component is a 30 to 40 nm thick layer comprised mainly of collagen type 
IV (important for the integrity of small vessels), laminins (mediate attachment between BM 
and cells), heparin sulphate proteoglycans like perlecan (provides a negative charge) and 
glycoproteins such as fibronectin (Sá-Pereira et al. 2012). 
The extracellular matrix (ECM) of the BM contains proteins that provide an anchor for 
the endothelium via interaction of laminins and integrin receptors located in the endothelial 
cells, as well as proteins that regulate expression of TJ proteins, which suggests contribution 
to barrier properties (Engelhardt 2011). Accordingly, disruption of the ECM has been 
associated with increased BBB permeability (Hawkins and Davis 2005). Also, the interaction 
between BM and astrocytes has been proved to promote the specific localisation of several 
membrane proteins (e.g. dystrobrevins and dystroglycans) in the astrocytic end-feet anchored 
to the BM, thereby contributing in turn to the contact and communication between astrocytes 
and brain endothelium (Abbott, Rönnbäck, and Hansson 2006). 
1.1.2.4 Astrocytes 
As a component of the BBB, astrocytes have been shown to play an important role in 
the induction and maintenance of the barrier properties in the BECs, including overexpression 
of proteins forming TJ complexes (Bauer and Bauer 2000). Astrocytes send specialized 
processes, known as end-feet, to closely ensheath the brain capillaries on their outer surface, 
ultimately covering the BM, BECs and pericytes (Newman 1986). Astrocytic end-feet promote 
the interaction between the vascular and the neural components, and express specific 
membrane transporters such as Aquaporin 4 (AQ4, water channel) or the potassium channel 
Kir4.1, while also release factors that regulate the expression of several proteins and barrier 
properties in the BEC, including TGF-β, sonic hedgehog (Shh), bovine fibroblast growth factor 
(bFGF) or angopoietin-1 among others (Obermeier, Daneman, and Ransohoff 2013). These 
astrocyte-derived factors have been shown to modulate expression levels of TJ proteins or 
1. General introduction 
 
8 
 
transport systems in the endothelium, thereby contributing to BBB stability (Haseloff et al. 
2005; Wolburg et al. 1994). 
1.1.2.5 Smooth muscle cells (SMCs) 
SMCs are present as mural cells on the abluminal side of endothelial cells in arteries, 
veins and pre-/post-capillary vessels (Bechmann, Galea, and Perry 2006), whereas capillaries 
lack the continuous layer of SMCs (Peppiatt et al. 2006). Some of the proteins and markers that 
define the SMCs include smooth muscle actin α- (SMA-α), SM-myosin or desmin (Hirschi, 
Rohovsky, and D’Amore 1998). SMCs contribute to the maintenance and regulation of blood 
pressure and flow via their contractile ability (Hughes and Chan-Ling 2004). Interestingly, 
SMCs are developmentally related to other type of mural cells, pericytes, which also appear to 
play a role in contraction and blood flow at the capillary level (Rhodin 1968). Also, as described 
above for pericytes, SMCs are recruited by endothelial and have been shown to participate in 
vasculature development and contribute to vessel function during the life of the individual 
including vascular stabilization, matrix formation, and BBB properties (Korn, Christ, and Kurz 
2002).  
1.1.2.6 Perivascular microglia 
Microglial cells are originally derived from leptomeningeal mesenchymal cells that 
differentiate into microglia when entering the brain (Bechmann et al. 2006). Alternatively, 
circulating monocytes also provide an important source of perivascular microglia when 
infiltrating the brain (Bechmann et al. 2005). Perivascular microglia are therefore macrophages 
in close contact with brain blood vessels and have been reported to express markers involved 
in antigen recognition and presentation (Fabriek et al. 2005). These observations suggest that 
microglial cells participate in regulating perivascular inflammation in the brain, which together 
to their strategic position in the BBB allows them to contribute to the control of immune 
responses in the CNS (Correale and Villa 2009). In addition, perivascular microglia have been 
shown to participate in phagocytosis of BECs or subcellular endothelial-derived particles in 
situations of brain injury or ischemia (Jolivel et al. 2015).  
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1.1.3 Structural and molecular organization of junctional complexes in brain 
microvasculature 
It has already been established that the barrier properties of the BBB are conferred by 
the expression of and interaction between junctional proteins. These junctional complexes 
include mainly TJs, adherens junctions (AJs) and GAP junctions (GJs). TJs in the brain 
endothelium are more complex and its protein constituents are highly expressed when 
compared to the rest of the body, contributing to the barrier phenotype (Ge et al. 2005). TJs are 
located at the limit between the apical and basolateral domains of the BEC surface, forming 
continuous belts of intermingled proteins (Figure 2). Three types of transmembrane proteins 
have been described to participate in the formation of TJs, including claudins, occludin and 
junctional adhesion molecules (JAMs) (Bechmann et al. 2006). In addition, adaptor and 
scaffolding proteins present in the cytoplasm such as zonula occludens 1, 2 (ZO-1, -2), 
junction-associated-coiled-coil protein (JACOP, also known as para-cingulin) and cingulin, 
allow interactions between TJs and the actin cytoskeleton interactions, as well as signal 
transduction (Balda and Matter 2009; Brightman and Reese 1969). TJs interact with AJs, which 
also contribute to cell-cell contact between BECs. AJs comprise vascular endothelial cadherin 
(VE-cadherin) and platelet endothelial cell adhesion molecules 1 (PECAM-1, or CD31), they 
are linked to the cytoskeleton via interaction with catenins (Daneman and Prat 2014). Apart 
from all this intricate structure of junctional protein complexes, BECs also connect to each 
other through GJs, formed mainly by connexin channels that promote direct intercellular 
communication. Ultimately, BECs are anchored to the underlying BM via integrins and 
dystroglycans, which interact with ECM proteins (Zhao et al. 2015). 
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Figure 2. Molecular organization of TJs at the BBB.  
TJs are mainly comprised by claudins, occludin and JAMs. Occludin and claudins share a common structure and 
are essential for BEC inter-membrane contacts between BECs as well as TJ establishment and regulation. JAMs 
are members of the immunoglobulin superfamily and participate in TJ stability and leukocyte adhesion and 
migration across the BBB. Additionally, TJs are intertwined with AJs, which are mainly comprised by PECAM-
1/CD31 and VE-cadherin. PECAM-1 controls the location of VE-cadherin and is involved in vascular integrity, 
whereas VE-cadherin is involved in the formation and strength of junctional contacts. BECs also express GJs 
comprised by connexins that mediate direct communication between neighbouring cells. These membrane 
proteins interact with cytoplasmic adaptor proteins, including ZO-1, -2 and -3 which are essential for the assembly 
and scaffolding of TJs and connect the junctional protein to the cytoskeleton via cingulin or JACOP proteins. 
Catenins also participate in the stabilisation and anchoring of AJ proteins. In addition, integrins and dystroglycan 
anchor BECs to the extracellular matrix if the BM (Diagram by Eduardo Frías Anaya).  
 
1.1.3.1 Occludin 
Occludin is a 60-65 kDa protein that is highly expressed in endothelial cells of the CNS 
and was the first integral transmembrane protein identified as part of the TJs in BECs; occludin 
is found in cell contact sites at the basolateral surface of the cell, where it establishes 
homophilic interactions with other occludins in neighbouring BECs and also with claudins, as 
a way of promoting TJ maintenance (Kniesel and Wolburg 2000). Occludin structure includes 
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a terminal domain that links to the actin cytoskeleton via scaffolding proteins such as ZO-1 and 
ZO-2 by binding to PDZ domain, which stabilizes its localisation in the plasma membrane 
(Feldman, Mullin, and Ryan 2005). Although several studies suggest occludin is not essential 
for the formation of TJs (Furuse et al. 1998), reduced expression of occludin is associated to 
BBB dysfunction (Brown et al. 1999). Interestingly, some studies have shown occludin 
phosphorylation to be a key regulator in TJ permeability (Hirase et al. 2001), especially in size-
selection diffusion in the case of epithelial cells (Balda et al. 1996, 2000).  
 
1.1.3.2 Claudins 
Claudins are integral membrane proteins of 20-27 kDa that have similar membrane 
topography to occludin but not sequence homology, and are involved in TJ formation in various 
tissues (Morita et al. 1999). Most claudins present tissue specific expression, brain tissue 
expresses mostly claudin -5, but also claudin-1, -3 and -12 (Cldn-5, -1, -3, -12) (Liebner, 
Fischmann, et al. 2000; Liebner, Kniesel, et al. 2000). Due to its higher levels in the brain 
endothelium, claudin-5 has been suggested to be the major constitutive claudin at the BBB 
(Ohtsuki et al. 2007). Nevertheless, other studies have shown how the BBB remains 
ultrastructurally normal in claudin-5 knock-out mice, followed by an increase in claudin-1 
(Berndt et al. 2019). These observations suggest a far more relevant role for other claudins 
apart from claudin-5 than originally thought. Claudins establish homophilic and heterophilic 
interactions with other claudins in adjacent BECs in order to promote TJ sealing (Furuse, 
Sasaki, and Tsukita 1999). Additionally, claudin carboxyl-terminal domains bind to 
cytoplasmic ZO proteins in a similar way to occludin (Itoh et al. 1999). 
 
1.1.3.3 JAMs 
JAMs are 40 KDa glycoproteins, members of the immunoglobulin superfamily whose 
structure includes a short intracellular carboxyl-terminal domain by which they interact with 
ZO-1 via a PDZ domain (Martìn-Padura et al. 1998; Wolburg and Lippoldt 2002). 
Extracellularly, these adhesion proteins establish homophilic or heterophilic interactions with 
adjacent cells contributing to TJ structure and have also been reported to participate in 
modulating leukocyte transendothelial migration (Del Maschio et al. 1999; Ostermann et al. 
2002). 
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1.1.3.4 PECAM-1/CD31 and VE-cadherin 
PECAM-1 is a 130 kDa transmembrane glycoprotein member of the immunoglobulin 
superfamily, highly expressed on the basolateral surface of endothelial cells (Newman et al. 
1990). PECAM-1 extracellular domain mediates homophilic interactions with adjacent cells 
and by interaction with leukocytes it plays a role in their transendothelial migration (Liao et al. 
1995; Muller et al. 1993; Sun et al. 1996). On the other hand, PECAM-1 cytoplasmic domain 
phosphorylation mediates regulation of signalling complex assembly and interaction with the 
cytoskeleton (Ilan et al. 2000). Regarding its role in adherens junctions, PECAM-1 controls the 
subcellular location of VE-cadherin and β-catenin, which contributes to maintaining barrier 
integrity and permeability (Park et al. 2010; Wimmer et al. 2019). Also, PECAM-1 is involved 
in vascular integrity, acting as an important vascular mechanosensor in angiogenesis and vessel 
remodelling (Chen and Tzima 2009; Osawa et al. 2002). 
Cadherins are cell adhesion molecules involved in the establishment and maintenance 
of junctional contacts (Suzuki, Sano, and Tanihara 1991). There are several cadherins 
expressed by endothelial cells but the only specific one is VE-cadherin, a 140 kDa 
transmembrane protein located in the basolateral cell surface (Gotsch et al. 1997; Pulous et al. 
2019). VE-cadherin extracellular domain mediates homophilic Ca2+-dependent interactions 
with neighbouring endothelial cells contributing to barrier properties (Ali et al. 1997). 
Furthermore, the cytoplasmic tail contains catenin-binding sites (for p120, α-catenin, β- and γ-
catenin) that mediate VE-cadherin connection to the actin cytoskeleton (Noren et al. 2000). 
Interestingly, VE-cadherin and catenins together are suggested to function as an early- 
recognition mechanism between BECs, being involved in the formation of intercellular 
junctions (Vincent et al. 2004; Vorbrodt and Dobrogowska 2004).  
 
1.1.3.5 Tight and adherens junction-associated submembranous proteins 
Junctional proteins form intracellular connections with cytoplasmic ZO-1, -2 and -3, 
members of the membrane-associated guanylate kinase-like proteins (MAGUK) family. These 
proteins play a role in the assembly and scaffolding of TJs, connecting them via cingulin to the 
actin cytoskeleton and also working as support for signal transduction proteins (Huber, 
Egleton, and Davis 2001). ZO proteins show structural homology, and all contain PDZ 
1. General introduction 
 
13 
 
domains, specific for the interaction with cytoskeleton and TJ proteins (Itoh et al. 1999). 
Indeed, ZO proteins interaction with claudins promotes formation of functional TJ strands 
(Umeda et al. 2006). Moreover, these proteins participate in transduction of several signals, 
thereby influencing cellular processes such as establishment of cell polarity, adhesion 
complexes or cell survival (González-Mariscal, Betanzos, and Ávila-Flores 2000). 
Interestingly, ZO-1 has also been reported to modulate VE-cadherin role in cell tension and 
cytoskeleton organization, and also has been linked to barrier formation (Tornavaca et al. 
2015). In fact, lack or decreased expression of ZO proteins leads to mislocalisation of 
junctional adhesion complexes, higher barrier permeability and BBB disruption (Shimojima et 
al. 2008).  
The catenins are cytoplasmic anchor proteins of the Armadillo family that mediate the 
linkage of cadherins to the cytoskeleton (Ozawa and Kemler 1992). BECs mostly express α-
catenin, β-catenin, γ-catenin (plakoglobin) and p120, which share multiple repeats of the 
Armadillo sequence (Peifer et al. 1992). These proteins bind to VE-cadherin through its 
cytoplasmic tail and to α-catenin, which interacts with actin-binding proteins such as α-actinin, 
ZO-1 and others (Itoh et al. 1997; Knudsen et al. 1995; Rimm et al. 1995). VE-cadherin 
interaction with catenins modulate junctional stabilisation and anchoring and barrier 
permeability (Dejana, Orsenigo, and Lampugnani 2008; Liebner, Gerhardt, and Wolburg 
2000). In addition, catenins are also crucially involved in cell signal transduction including 
Wnt canonical signalling pathway, a role that has been shown to be fundamental in CNS 
vascularization and BBB formation and maturation (Tran et al. 2016). 
 
1.1.4 Functions of the BBB 
In the CNS, neurons communicate via chemical and electrical signals, therefore a 
regulated microenvironment and a properly maintained homeostasis are required for a reliable 
neural function. The presence of the BBB allows the brain to tightly regulate the entry of 
selected cells, proteins and molecules from the circulation and maintain CNS homeostasis 
(Aschner and Aschner 1990; Gee and Keller 2005).  
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1.1.4.1 Physical barrier and selective transport systems 
Pathways across the BBB are either transcellular (across the cell body, controlled by 
specific transporters) or, more limited, paracellular (in-between BECs, depending on TJs). 
Indeed, the presence of junctional protein complexes, as well as a lack of fenestrations in the 
brain microvessel endothelium reduces the paracellular passage of ions and other small 
hydrophilic molecules between cells, therefore inducing an actual physical barrier that 
separates the CNS from the circulatory system and promoting mostly transcellular mechanisms 
(Abbott 2013; Haseloff et al. 2015). BECs are permeable to small lipophilic molecules and 
gases such as O2, CO2 and ethanol (Friis, Paulson, and Hertz 1980; Paulson 2002). Smaller 
molecules may cross the BBB by receptor-mediated transcytosis or endocytosis, although 98% 
of all small molecules do not freely move across the barrier (Mikitsh and Chacko 2014; 
Pardridge 1995). Large molecules such as proteins and certain peptides including glucose, 
amino acids and nucleosides, get into the brain by regulated and selective transport systems 
(Boado et al. 1999; Kalaria et al. 1988). Accordingly, the BBB also regulates both recruitment 
and entry of immune cells that participate in the surveillance of the normal CNS immune 
environment (Loeffler et al. 2011). Additionally, the BBB promotes the removal of waste 
products and other solutes out of the brain, using efflux pumps to regulate the passage 
(Hagenbuch, Gao, and Meier 2002; Ito et al. 2013).  
Differential expression of specific solute carriers and enzymes determines cellular 
polarity in the BECs, with membrane proteins and transporters being asymmetrically 
distributed on the luminal (blood-facing) and abluminal sides (Betz, Firth, and Goldstein 1980). 
Therefore, transporters present in the BBB include transporter system of monocarboxylic acids, 
amino acid transporters such as L1 transporter or γ-glutamyl transpeptidase, GLUT-1 glucose 
carrier or transferrin receptor (Ge et al. 2005; Janzer 1993). Specific ion channels and 
transporters expressed at the BBB also help to maintain physiological and metabolic conditions 
of the brain. For instance, the Na+/ K+ – ATPase actively transports Na+ and K+ across the 
BBB, while Mg2+ is also actively transported by ATPase-related enzymes (Harik 1986; Serlin 
et al. 2015). On the other hand, the BBB also expresses several pumps aimed to actively protect 
the brain environment. For example, ATP-binding cassete (ABC) transporters located on the 
plasma membrane of BECs act as efflux pumps that protect the CNS from the entry of 
neurotoxicants, but also limit the access of therapeutic compounds into the parenchyma (Miller 
2010). Amongst these ABC transporters, Pgp is highly expressed in the luminal surface of the 
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brain capillary endothelium and interacts with a large number of drugs, contributing to their 
active exclusion from the BECs back into the blood stream (Potschka and Löscher 2001; 
Vogelgesang et al. 2012). 
1.1.4.2 CNS immune surveillance 
The brain has traditionally been considered immune privileged in healthy conditions 
due to the lack of classical lymphatic systems, low levels of major histocompatibility complex 
molecules and the unique presence of the BBB (Kleine and Benes 2006). However, despite the 
strict separation between the circulatory system and the CNS, it has been shown that both the 
brain and the spinal cord are under continuous immune surveillance to detect and eliminate 
potential threats. The primary immune agents, are microglia and circulatory immune cells (i.e. 
lymphocytes) from the blood that also contribute to this defence and the maintenance of brain 
homeostasis in absence of inflammation (Ousman and Kubes 2012). For instance, blood-borne 
macrophages located at the perivascular spaces of the brain vasculature have also been reported 
to contribute to CNS immune surveillance (Bechmann et al. 2001). 
 
1.1.5 Interactions between cells and ECM at the BBB 
The integrity of the barrier properties of the brain endothelium also depends on the 
interactions with the ECM and the BM, since adhesion to the ECM is required for an 
appropriate stabilization of the whole BBB structure, with the BM also acting as a key outer 
barrier to the mature BBB (Menezes et al. 2014; Reed et al. 2019). Integrins and dystroglycans 
are two main adhesion proteins involved in the cell/ECM interactions at the BBB. Integrins are 
transmembrane glycoprotein non-covalently-linked αβ heterodimers that bind specific ECM 
ligands, activate different signal transduction mechanisms, and are normally expressed in all 
cell types that comprise the BBB. Their activation affects processes such as survival, 
proliferation, differentiation and migration (Hynes 1992). Interestingly, these effects are 
mediated by signalling pathways, including focal adhesion kinase/c-Jun N-terminal kinase 
(FAK/JNK), Ras/ERK (MAP kinase) or small GTPases like Rho, which may end up activating 
growth factors (Giancotti and Ruoslahti 1999; Miranti and Brugge 2002). Dystroglycan, is a 
non-integrin single αβ heterodimeric (α, extracellular; β, intracellular) transmembrane receptor, 
involved in the linkage of cytoskeleton with the ECM, and is mainly expressed in perivascular 
astrocytes and BECs (Zaccaria et al. 2001). The intracellular β-dystroglycan subunit binds the 
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cytoskeleton, via interaction with the extracellular α-dystroglycan subunit, to specific ECM 
ligands such as laminins, perlecan or agrin, thereby promoting anchorage of BECs and the 
astrocytic end-feet to the BM (Moukhles and Carbonetto 2001; Del Zoppo et al. 2006). 
 
1.2 The ageing BBB: process and highlights 
The process of ageing is an inevitable, continuous and time-dependent decline in tissues 
and organs with progressive loss of function, decreasing fertility and increasing mortality 
(Balcombe and Sinclair 2001). The brain, as any other organ in the body is affected by ageing 
at both cellular and molecular level, with the hippocampus and the cerebral cortex amongst the 
most affected regions (Anderton 2002). Ageing in the CNS has been reported to include 
changes in gene and protein expression, abnormal protein accumulation or mitochondrial 
dysfunction (Brunk and Terman 2002; Liang et al. 2007; Trojanowski and Mattson 2003). 
These age-related changes have been implicated in promoting neurodegeneration, declined 
cognitive function, reduced cerebral blood flow and vasculopathies such as stroke (Cabeza et 
al. 2018; Desjardins et al. 2014; Gupta et al. 2012; Wyss-Coray 2016). Accordingly, the BBB 
has been described to undergo several alterations in function and structure during ageing 
(Krause, Fautsmann, and Dermietzel 2002; Pelegrí et al. 2007). 
As previously discussed, the BBB plays a critical role in maintaining the homeostasis 
of the brain. Alterations and declined integrity of the BBB have been implicated in a variety of 
age-related neurodegenerative conditions, such as vascular cognitive impairment, Alzheimer’s 
disease (AD) and Parkinson’s disease (PD) (Marques et al. 2013; Zlokovic 2008). As the 
percentage of individuals over 60 years has increased from 9.2% in 1990 to 11.7% in 2013 and 
is projected to be 21.1% by 2050 (Sander et al. 2015), understanding the mechanisms that 
underlie age-related changes in the BBB in health and disease is of increasing importance 
(Aunan et al. 2016).  
 
1.2.1 Breakdown of the BBB during ageing 
During ageing, the cerebrovasculature undergoes several pathophysiological changes 
that lead to its dysfunction. For instance, cerebrovascular ageing is characterised by alterations 
in blood flow dynamics which induce changes in the expression of mechanosensitive genes 
that in turn promote vascular remodelling or pro-atherogenic modifications in the vessel wall 
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(Ungvari et al. 2010). Indeed, cerebral microvessels have been reported to become tortuous 
and show severe changes such as increased wall stiffness or decreased density, that contribute 
to a decline in cerebrovascular efficiency and cerebral blood flow (Riddle, Sonntag, and 
Lichtenwalner 2003). Interestingly, as cerebrovascular efficiency falls, the brain also suffers 
from impaired transport of essential elements like glucose or oxygen (Peters 2006; Yamazaki 
et al. 2016). In addition, aged cerebrovasculature might also undergo process of 
neuroinflammation and oxidative stress (Enciu, Gherghiceanu, and Popescu 2013). BBB 
alterations have also been observed to vary depending on the brain region in both aged humans 
and rodents, contributing to the complexity of the ageing process (Goodall et al. 2018; Hawkes 
et al. 2013). 
BBB dysfunction during ageing has been related to numerous alterations in the 
endothelium, at both cellular and molecular levels (Figure 3). These age-related changes 
include: 
▪ Increased BM thickness due to the accumulation of ECM components such as 
collagen IV, laminin and other proteoglycans, which in turn induces an increase 
in stiffness of the vessel wall (Candiello, Cole, and Halfter 2010). Higher BM 
thickness and stiffness may have detrimental effects on cerebral blood flow and 
clearance mechanisms across the BBB that may contribute to cognitive decline 
and neurodegeneration (Ito et al. 2013).  
 
▪ Weakening of TJ protein structures, which may lead to higher BBB 
permeability (Montagne et al. 2015). For example, levels of TJ proteins such as 
occludin, Cldn-5 and ZO-1 have been reported to decrease in aged rodent brain 
compared to their young counterparts (Elahy et al. 2015; Mooradian, Haas, and 
Chehade 2003; Stamatovic et al. 2019). Also, previous studies have shown an 
age-induced increase in matrix metalloproteinase (MMP) expression, including 
MMP-9 and MMP-2, in the aged mice upon brain injury, which contributes to 
the cleavage of ZO-1 and claudin-5 and the increase in barrier permeability (Lee 
et al. 2012). Additionally, MMP-mediated disruption of TJ protein complexes 
was enhanced by increased levels of cytokines (e.g. Tumour necrosis factor α, 
TNF-α) in previous studies using an in vitro dynamic BBB model with rat BEC 
cells (Krizanac-Bengez et al. 2006). Similarly, TJ disruption may also be 
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worsened by exposure to reactive oxygen species (ROS) derived from oxidative 
stress, which may induce redistribution and loss of occludin or claudin-5 as 
reported in rat BECs in vitro (Schreibelt et al. 2007).  
 
▪ BBB transport systems have been described to be altered with ageing, including 
enhanced pinocytosis or decreased expression of glucose transporter, insulin 
receptor or low density lipoprotein-related protein-1 (LRP-1), as observed in the 
ageing human and rodent brain (Cholerton, Baker, and Craft 2011; Mooradian 
et al. 1991; Ramanathan et al. 2015). Similarly, Pgp expression has been 
reported to decrease in the ageing BBB, although only in humans (Bartels et al. 
2009). In any case, these changes lead to a severe imbalance in brain vasculature 
nutrient uptake/waste elimination function (Silverberg, Messier, et al. 2010; 
Silverberg, Miller, et al. 2010).  
 
▪ Mitochondrial dysfunction is another prominent feature in the process of ageing 
in general and at the BBB in particular. Previous studies have described the age-
related decrease in mitochondrial number and impairment in the BBB of several 
species including human, mouse and monkey, mostly related to oxidative stress 
and pro-inflammatory processes (Burns et al. 1979; Sure et al. 2018). As stated 
above, oxidative stress might contribute to vascular and BBB disruption. In fact, 
age-induced increase in production of ROS has been linked to endothelial cell 
dysfunction (Brandes, Fleming, and Busse 2005). 
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Figure 3. BBB cellular and molecular alterations in ageing.  
During ageing, several alterations can be observed at structural and functional levels as the breakdown of the BBB 
progresses. A prominent feature is the increase in BM thickness due to the accumulation of extracellular matrix 
components. TJ protein structure becomes loose and weaker, which may lead to increased permeability. Transport 
systems are modified in the ageing BBB, including increased pinocytotic vesicles trafficking through the 
endothelium, as well as altered expression of transporters and membrane proteins such as glucose and insulin 
transporters and Pgp. In addition, there is a decrease in mitochondrial density and accumulation of ROS that 
contribute to oxidative stress and neuroinflammation, worsening the features of the ageing BBB. (Diagram by 
Eduardo Frías Anaya).  
Several of these age-related changes at both cellular and molecular level appear to 
correlate with changes in gene expression to a certain degree (Osgood et al. 2017; Stamatovic 
et al. 2019). Therefore, connecting age-related changes in structure and function with 
concomitant alterations in gene expression profiles might shed light on the mechanisms that 
promote BBB dysfunction during ageing.  
 
1.3 Gene expression modulation in the brain endothelium 
As previously discussed, endothelial cells across the body present phenotype 
heterogeneity, thus BECs show specific characteristics different to endothelial cells in the 
kidney or the liver for example (Vanlandewijck et al. 2018). This heterogeneity can be 
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explained as the endothelium meeting the needs of the underlying tissue, although it could also 
be related to specific combinations of input/output signals between the endothelium and the 
extracellular environment in conditions such as injury, barrier disruption or ischemia (András 
et al. 2005; Jin et al. 2000). These signalling pathways are often triggered on the cellular surface 
and conclude at the gene transcription level (Y. Chen et al. 2003), therefore the 
microenvironment in which endothelial cells are immersed will promote the expression of 
genes that vary depending on the tissue, and in the case of BECs, they are influenced by 
neighbouring cells such as astrocytes and pericytes but also by microglia, neurons and blood-
borne cells (Gaengel et al. 2009; Haseloff et al. 2005; Hordijk 2006). 
Changes in BEC transcription profile may also involve epigenetic modifications (Hu et 
al. 2006; Zhao et al. 2016). Epigenetics is defined as the interaction between environmental 
factors and the genome, that results in modified gene expression or phenotypical characteristics 
without changes in the actual DNA sequence (Jones and Takai 2001; Reik, Dean, and Walter 
2001). Indeed, epigenetic mechanisms are chromatin-based modifications that include DNA 
methylation, histone modifications and RNA-based modulation (e.g. microRNA (miRNA)-
mediated regulation), which ultimately have an effect on gene expression (Matouk and 
Marsden 2008). Amongst them, miRNA- and DNA methylation-dependent mechanisms will 
be described in more detail, as they have been recently demonstrated to play a crucial role in 
ageing (Harries 2014; Horvath and Raj 2018).  
 
1.4 MiRNAs as regulators of gene expression 
1.4.1 MiRNAs: definition  
MicroRNAs (miRNAs) are a classification of small RNAs (20-30 nucleotides) that can 
interact with Argonaute family proteins (Ago proteins) along with small interfering RNAs 
(siRNAs) and PIWI-interacting RNAs (piRNAs, bind the PIWI clade of the Ago family) 
(Grillari and Grillari-Voglauer 2010). Amongst them, miRNAs are a dominating class of small 
RNAs first discovered during the late 1980s in the nematode Caenorhabditis elegans (Ambros 
1989). They are highly conserved non-coding RNAs of ~22 nucleotides in length that regulate 
the expression of complementary messenger RNAs (mRNAs) by base-pair binding to the 3’ 
untranslated region (UTR), which typically promotes silencing of gene by blocking mRNA 
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translation or promoting mRNA degradation, among other mechanisms (Ambros 2004; Ha and 
Kim 2014). Throughout the genome, miRNA genes are located in intergenic regions but also 
in defined transcription units, including exons and introns of protein- and non-coding genes as 
well as UTR regions (Rodriguez et al. 2004).  
1.4.2 MiRNA biogenesis 
All miRNA genes share a stem-loop precursor RNA structure and their transcription is 
typically mediated by RNA polymerase II (RNA pol II) (Lee et al. 2004) (Figure 4). Intergenic 
miRNAs are mainly transcribed through the canonical pathway as primary miRNA (pri-
miRNA) transcripts that are typically spliced, capped and polyadenylated in a similar way to 
what happens with protein-coding mRNAs (Cai, Hagedorn, and Cullen 2004). Furthermore, 
during or subsequent to transcription, pri-miRNAs are processed by the endonuclease Drosha 
in interaction with the RNA-binding protein DGCR8, which is necessary for the cleavage of 
the pri-miRNA into an imperfect stem-loop precursor miRNA (pre-miRNA) of ~70 nucleotides 
with a hairpin structure (Han et al. 2004). Following this Drosha-mediated processing, the pre-
miRNAs are exported from the nucleus to the cytoplasm by a Ran-GTPase transporter, 
Exportin 5 (Bohnsack, Czaplinski, and Gorlich 2004). 
 
Figure 4. Canonical pathway for miRNA biogenesis and post-transcriptional regulation.  
Biogenesis of miRNAs start in the nucleus, where RNA pol II mediates the transcription of a pri-miRNA. This 
primary transcript is processed by the protein Drosha (interacting with RNA-binding protein DGCR8) into a ~70 
nucleotide precursor, pre-miRNA (1st processing). Pre-miRNAs are exported out of the nucleus and into the 
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cytoplasm by Exportin 5. Within the cytoplasm, pre-miRNAs are processed by Dicer into miRNA duplexes (2nd 
processing). These duplexes undergo a process of unwinding in which two strands are separated and only the 
mature miRNA strand is assembled into the RNA-induced silencing complex (RISC) by binding to Argonaute 2 
protein (Ago2). The mature miRNA guides the RISC complex to target messenger RNAs (mRNAs) that have a 
sequence complementarity with the miRNA. This complex can mediate silencing of target mRNAs by 
translational repression or mRNA degradation. ORF, open reading frame. (Diagram adapted from (Ha and Kim 
2014) and (He and Hannon 2004)). 
In the cytoplasm, the endonuclease Dicer cleaves the loop domain of the pre-miRNA 
liberating the mature miRNA, a small double stranded RNA (dsRNA) molecule of ~22 
nucleotides of length that is formed by both the mature miRNA strand (that will participate in 
the RNA silencing) and the complementary strand (which will typically be degraded) (Knight 
and Bass 2001). However, depending on the cellular context, both strands or primarily the 
complementary strand may play a role in the silencing process (Yang et al. 2011), therefore, 
the strand from 5’ end is referred to 5p whereas the one from the 3’ end is called 3p. The 
miRNA duplex undergoes a process of strand unwinding, separating the mature miRNA from 
the complementary strand by interaction with Argonaute2 (Ago2) (Khvorova, Reynolds, and 
Jayasena 2003). Afterwards, the mature miRNA in incorporated in the RNA-induced silencing 
complex (RISC) protein complex and guides it to target mRNAs with a complementarity to the 
miRNA (Kim 2005).  
In addition to this canonical pathway of miRNA biogenesis involving Drosha cleavage, 
multiple alternative pathways have been elucidated, the majority of which use different 
combinations of the proteins that participate in the canonical pathway. In fact, miRNAs from 
introns of mRNA during splicing have been reported to mimic pre-miRNAs structure without 
being processed by Drosha (Ruby, Jan, and Bartel 2007). Additionally, other miRNAs have 
been shown to be processed by Drosha but follow a Dicer-independent pathway, although they 
still need Ago2 to complete their biogenesis (Yang and Lai 2010). In any case, miRNA-
mediated recognition of target mRNAs promotes silencing and suppressed expression of the 
target genes (Hammond 2015; He and Hannon 2004). 
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1.4.3 Regulation of mRNA by miRNAs 
MiRNAs have been shown to play important roles in the maintenance of cellular 
function. Their primary activity consists in regulating gene expression post-transcriptionally, 
by binding to the 3’-UTR of the mRNAs via the seed region, essential for target recognition 
and located from position 2 on the 5’ end of the miRNA sequence (Hu and Bruno 2011). 
Furthermore, there are 2 known binding types, perfect or imperfect. Perfect Watson-Crick 
binding is complementary between the 5’ end of the miRNA and the 3’-UTR of the mRNA, 
although some miRNAs bind the 5’-UTR as well; whereas the second type is an imperfect 
binding between the 5’ end of the miRNA and the 3’-UTR region of the mRNA, although it 
shows a compensatory binding at the 3’ end of the mRNA molecules (Brennecke et al. 2005). 
The miRNA-mediated target recognition either represses translation or enhances the 
degradation of the mRNA (Valencia-Sanchez et al. 2006). Current models of miRNA targeting 
also suggest that the inactivation of the target mRNA starts by repressing its translation at first 
and subsequently continuing with its degradation (Meijer et al. 2013). All these mechanisms 
have in common the destabilization of target mRNAs which is the main cause of reduced 
protein levels. Moreover, a single miRNA can regulate many different mRNA targets, whereas 
different miRNAs can bind and supress a single mRNA target (Lewis et al. 2003). MiRNA-
mediated regulation of gene expression was originally identified to be crucial in cell 
differentiation, embryonic development, several signalling pathways (including JAK/STAT or 
TGFβ), muscle growth and morphogenesis, cancer, neuroinflammation and ageing (Carthew 
2006; Hausser and Zavolan 2014; Hayes, Peruzzi, and Lawler 2014; Lui, Jin, and Stevenson 
2015). 
1.4.4 Regulation of miRNA expression and biogenesis 
Transcription of miRNA genes is regulated in a similar way to protein-coding genes. In 
some cases, miRNA loci are located in clusters, which leads to co-transcription of a 
polycistronic unit, although the individual miRNAs can be regulated at post-transcription levels 
(Lee et al. 2002; Roush and Slack 2008). MiRNA localisation in the genome also plays a role 
in their transcription regulation. Indeed, intergenic miRNAs have been shown to have their 
own transcription regulatory elements, including promoters (Ozsolak et al. 2008). By contrast, 
intronic miRNAs have been reported to either share the promoter of the host gene, or to have 
their own promoters just like intergenic miRNAs (Monteys et al. 2010). In addition, several 
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studies have shown that some miRNAs may participate in regulatory feed-back loops that 
modulate their own expression (Spizzo et al. 2010).  
Levels of miRNAs can also be regulated by modulation of post-transcriptional miRNA 
biogenesis and processing. Indeed, Drosha and DGCR8 influence each other´s levels, and 
maintaining the ratio may be essential for Drosha processing activity (Han et al. 2009). 
Similarly, Dicer stabilisation is modulated by some of its protein partners such as TRBP, since 
low levels of TRBP have been shown to be concomitant with decreased Dicer expression and 
hindered miRNA processing (Chendrimada et al. 2005). Also, several binding proteins have 
been reported to regulate, both negatively and positively, miRNA processing. For instance, 
Lin28 has been reported to inhibit Drosha and Dicer cleavage by binding to pri- or -pre-miRNA 
loop region (Lightfoot et al. 2011; Viswanathan, Daley, and Gregory 2008). In contrast, p68 
and p72 helicases, components of the Drosha complex, have been suggested to promote the 
processing of pri-miRNAs in mouse (Fukuda et al. 2007). Recent studies have also reported 
that alterations in the sequence of the terminal loop of a pri-miRNA may lead to rearrangements 
in the structure that increase miRNA processing, as observed for miR-30c in HEK cells in vitro 
(Fernandez et al. 2017). Furthermore, another species of non-coding RNA, the long non-coding 
RNAs (>200 nucleotides) have been reported to modulate post-transcriptional miRNA levels, 
mainly acting as molecular sponges (or competing endogenous RNAs), thereby binding and 
negatively regulating several miRNAs in different types of cancer such as osteosarcoma, 
prostate cancer or glioblastoma (Cai et al. 2015; Du et al. 2016; Zhou et al. 2016). Undoubtedly, 
regulatory factors of miRNA expression are still being investigated but some of the regulatory 
mechanisms described above seem to be essential for the proper transcription, processing and 
modulation of miRNA production. 
 
1.5 DNA methylation and its role in gene expression 
1.5.1 DNA methylation as an epigenetic mechanism 
DNA methylation is well conserved among animals, plants and fungi and it was first 
described in the 1970s, being one of the best characterised epigenetic mechanisms to date (Bird, 
Taggart, and Smith 1979; Riggs 1975). In mammals, DNA methylation is primarily confined 
to CG dinucleotides termed CpG sites (a cytosine and a guanine separated by only one 
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phosphate group), which are infrequent in the genome and normally packed in forming the so-
called “CpG islands” (CGIs) (Bird 1980, 2002). These CGIs are often found in association with 
genes and regulatory regions, mostly colocalising with promoters (Antequera 2003; Cayrou et 
al. 2011; Larsen et al. 1992). CGIs have been considered to be mostly unmethylated, while the 
rest of the genome is considered to be methylated (Bird et al. 1985; Deaton and Bird 2011; 
Wang et al. 1997). Nonetheless, some studies using genome-wide profiling of DNA 
methylation have supported that CpG islands may also be predominantly methylated in some 
cases, especially those inside genes (Jones 2012; Shen et al. 2007). Methylation of CGIs has 
been observed in normal tissues promoting genomic imprinting, X-inactivation or cell 
specification between tissues, as well as in malignant cells inducing inappropriate silencing 
(Illingworth and Bird 2009). However, deregulated demethylation of certain promoters has also 
been reported in pathological conditions (e.g. PD, cancer ) (Matsumoto et al. 2010; Yanagawa 
et al. 2004). These observations suggest a fine balance between methylation and demethylation 
of promoters that appears to be essential for proper cellular function. The mechanisms 
underlying these changing patterns of methylation in CGIs still need further research, in order 
to shed light on their contribution to physiological processes and pathologies (Jeziorska et al. 
2017).  
During DNA methylation, there is covalent transfer of a methyl group from S-adenosyl 
methionine to the carbon in position five of the cytosine ring, producing 5-methylcytosine 
(5mC) (Hussain et al. 2013). This modification is generally associated with repressed 
chromatin and inhibition of gene expression, since methylation has been implicated in changing 
protein-DNA interactions, inhibiting association of important DNA-binding factors and 
promoting modifications in chromatin structure (Jones et al. 1998; Yoon et al. 2003). These 
methyl-CpG-binding proteins interact with co-repressor factors (e.g. histone deacetylases) that 
play a role in modulating transcription as well as chromatin remodelling and modification (Bird 
2002; Klose and Bird 2006; Smith and Meissner 2013).  
1.5.2 Regulation of DNA methylation  
DNA methylation is a reversable process that contributes to the regulation of gene 
expression throughout the life of the organism. The methylation pattern is mediated by the 
DNA methyltransferase (DNMT) family, which is well conserved and comprises DNMT1, 
DNMT3A and DNMT3B, considered the canonical DNMTs in mammals (Figure 5) (Laisné 
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et al. 2018). The maintenance of DNA methylation is mostly performed by DNMT1, whereas 
DNMT3A and B carry out de novo methylation in previously unmethylated CGIs (Okano et al. 
1999; Song et al. 2011). As opposed to DNMTs and methylation, DNA demethylation is often 
carried out by proteins of the ten-eleven translocation (TET) family (Williams, Christensen, 
and Helin 2012). Effects of methylation on the genome also depend on the interaction of 
DNMTs with transcription factors, DNA-binding proteins and non-coding RNAs (e.g. 
miRNAs) in addition to histone marks and sequence modifiers (Jones 2012; Lyko 2018). 
Genomic DNA methylation in mammals is suggested to represent cell-intrinsic regulation that 
is encoded in the DNA sequence by CG density or binding regions for transcription factors, 
thus being an essential mark in the contribution of cell fate determination (Schübeler 2015; 
Yadav, Quivy, and Almouzni 2018).  
 
Figure 5. Role of DNMTs in DNA methylation.  
DNA methylation is characterised by the addition of a methyl group onto the fifth position of a cytosine ring 
resulting in 5mC. The establishment of the methylation pattern de novo is mediated by DNMT3A and 3B. The 
maintenance of this methylated state is performed by DNMT1. This modification is generally related to repressed 
chromatin and inhibition of gene expression. Proteins from the TET family show an opposite activity to DNMTs 
and mediate demethylation of the DNA, from 5mC to demethylated cytosine. (Diagram by Eduardo Frías Anaya). 
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1.6 MiRNAs and DNA methylation in the ageing BBB 
1.6.1 The role of miRNAs in the ageing BBB 
Genetics and epigenetics are suggested to accelerate or delay the onset of ageing and 
age-related diseases. As established above, miRNAs have a role in regulating different genes 
at once, therefore contributing to the modulation of several interlinked pathways, including 
inflammation, vascular diseases or ageing, in human and different animal models and in 
different organs including the brain (Jazbutyte et al. 2013; O’Connell et al. 2010; Sun et al. 
2012, 2013). Accordingly, recent studies have proposed miRNAs as potential sensors of ageing 
and cellular senescence, contributing to the complexity of the age-related changes (Harries 
2014; Schroen and Heymans 2012). 
MiRNAs have also been implicated in ageing of the BBB. Indeed, different miRNAs 
have been recently been found to be expressed in the BBB, targeting genes related to BBB 
permeability. For instance, miR-132 has been reported to attenuate brain injury in a mouse 
model of stroke by repressing MMP9 activity (Zuo et al. 2019). By contrast, MiR-212/132 
expression induced by hypoxia in mouse and human BECs promotes downregulation of 
junctional protein such as Cldn1 or Jam3 (Burek et al. 2019). Similarly, miR-155 has been 
suggested to be a negative modulator of BBB function in neuroinflammation, by repressing TJ 
(e.g. Cldn1) and focal adhesion proteins (e.g. DOCK1) in both the mouse model of 
experimental allergic encephalomyelitis (EAE) in vivo and cultured human BECs in vitro 
(Lopez-Ramirez et al. 2014). These findings suggest that miRNAs participate in BBB integrity 
modulation. In addition, recent studies have also reported age-related changes in several 
miRNAs in the mouse and human BBB ex vivo, mostly associated with deregulation of DNA-
binding genes related to stress and immune response as well as apoptosis/autophagy pathways 
(Goodall et al. 2019). Indeed, the same study has reported age-related overexpression of miR-
155, which may be playing a similar role as the one observed in neuroinflammation, but also 
downregulation of miRNAs such as miR-182 and 183, which promote neuroprotection in 
conditions of oxygen and glucose deprivation (Bernstock et al. 2016). Taken together these 
observations suggest a potential role of miRNA deregulation in cerebrovascular dysfunction 
during ageing. However, future studies are needed in order to better understand the underlying 
mechanisms and how they actually impact on the age-mediated BBB disruption.  
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1.6.2 DNA methylation in the ageing BBB 
DNA methylation processes are also altered during ageing. Overall, ageing promotes 
an interesting pattern, with a global genomic hypomethylation observed in several species, 
including human and rodents, and in different organs including the brain, while specific CGIs 
may get hypermethylated, thereby promoting a mosaic-like distribution of methylation patterns 
in the aged genome (Bollati et al. 2009; Hannum et al. 2013). In addition, DNMT activity 
appears to be altered during ageing, including downregulation or upregulation patterns of the 
three canonical DNMTs, DNMT1, 3A and 3B, which add to the complexity of the ageing 
process (Lopatina et al. 2002; Oliveira, Hemstedt, and Bading 2012; Xiao et al. 2008). Aberrant 
DNA methylation patterns have also been reported in the ageing brain, including region-
specific alterations in genes that are involved in CNS development, neuron differentiation and 
neurogenesis (Davies et al. 2012; Horvath et al. 2012). DNA methylation changes also appear 
to have an effect on the integrity of the BBB, although its potential effect in the ageing BBB is 
largely unknown. Indeed, DNA methylation changes have been implicated in BBB 
permeability by modulating MMP activity in mice after stroke (Mondal et al. 2019). Also, 
although not in the context of ageing, previous studies have reported that miRNA-mediated 
downregulation of DNMT3B promotes increased BBB permeability, by indirect 
overexpression of MMP9 in cultured mouse BECs exposed to hyperhomocysteinemia (Kalani 
et al. 2014). Additionally, even though it has not been described in the BBB, DNA methylation 
patterns have been reported to be important for vascular function and pathogenesis in animal 
models (Nguyen et al. 2016; Toghill et al. 2015). Taken together, these observations suggest 
that DNA methylation plays a role in ageing and vascular function, and it may contribute to 
BBB function. Nonetheless, further research is needed to determine if the age-related changes 
observed in methylation pattern have an impact on cerebrovascular integrity.  
 
1.7 Chronic inflammation contributing to ageing: Inflammageing 
1.7.1 Inflammageing: definition and causes 
Inflammageing is the name given to the contribution of a chronic inflammation process 
to ageing in the absence of overt infection, characterised by high levels of pro-inflammatory 
molecules in cells and tissues, and it was first described by Franceschi and colleagues 
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(Franceschi et al. 2000). The theory of inflammageing considers that due to continuous 
antigenic load and stress throughout life, inflammatory response becomes detrimental during 
ageing and is characterized by a counterbalance between pro- and anti-inflammatory cytokines 
that ends up promoting a pro-inflammatory state (Lio et al. 2003; De Martinis et al. 2005). 
Moreover, as proposed by Franceschi and colleagues, there is a combination of a biological 
inflammatory background, induced by exposure to inflammatory stimuli over time, and the 
presence of frail or absence of robust gene variants that would be expressed in specific cells 
and organs, which would explain why some individuals are more susceptible to certain age-
related diseases with inflammatory components (Pericak-Vance and Haines 1995; Shulman et 
al. 2013). Accordingly, the immune system has been reported to promote an age-related 
increase of inflammatory cytokine circulating levels, including interleukin-1 (IL-1), 
interleukin-6 (IL-6) or TNF-α, which suggest a contribution to chronic inflammation 
intensified with ageing (Bruunsgaard 2006; Sergio 2008). In addition, the inflammasome, a 
multiprotein complex implicated in activating inflammatory signalling pathways and inducing 
secretion of several cytokines including IL-1β (Rathinam, Vanaja, and Fitzgerald 2012), has 
been shown to participate in inflammageing and to promote detrimental effects in several aged 
tissues, including the brain (Mejias et al. 2018). These pro-inflammatory processes induce 
significant overexpression of genes related to oxidative stress and inflammation, as well as 
exacerbating the immune response (C. K. Lee, Weindruch, and Prolla 2000). These alterations 
in expression participate in perpetuating a feed-forward cycle that contributes to the chronic 
inflammation observed in ageing, a low-grade and persistent phenomenon that induces 
responses leading to tissue degeneration (Ferrucci and Fabbri 2018).  
The mechanisms that contribute to inflammageing appear to be numerous and highly 
related to the immune state of the organism. One of the possible sources of inflammageing may 
be immunosenescence, which is the age-related decline in the immune system activity due to a 
lifelong exposure to pathogens, immune cells modifications/activation and genetic 
predispositions (McElhaney and Effros 2009; Shaw et al. 2010). Similarly, senescent cells 
normally express a senescence associated secretory phenotype (SASP) that results in secretion 
of cytokines, exacerbating the pro-inflammatory environment and the decline of normal tissue 
function (Coppé et al. 2010). The presence of circulating pro-inflammatory miRNAs (e.g. miR-
21, miR-126 or miR-146a) in blood may also contribute to the activation of immune response 
and vascular function in ageing (Olivieri, Lazzarini, et al. 2013; Olivieri, Rippo, et al. 2013). 
Age-related mitochondrial dysfunction has also been described to contribute to inflammation 
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by ROS production and cytokine secretion (Lerner, Sundar, and Rahman 2016). In addition to 
all of the inflammatory factors described above, some studies have proposed the endogenous 
cell debris to be an important stimulus in inflammageing, which suggests an auto-inflammatory 
component to inflammageing (Franceschi et al. 2016). 
1.7.2 Inflammageing effect on the BBB 
CNS ageing is also associated with a chronic low-grade inflammation that influences 
the function of all brain cell types, including the cells of the BBB (Grammas 2011; Stichel and 
Luebbert 2007). Despite the fact that inflammatory processes occurring on the ageing BBB are 
often related to neurodegeneration and neurological diseases exclusively (Takeda et al. 2013; 
Zlokovic 2005), several studies have assessed the effect of the age-related inflammatory state 
on neurovascular dysfunction during healthy ageing. In fact, BEC activation and cytokine 
secretion have been reported to promote increased BBB permeability and recruitment of 
immune cells under challenging conditions in aged mice and non-human primates (Reyes, 
Fabry, and Coe 1999; Wei et al. 2000). Accordingly, increase in circulating pro-inflammatory 
cytokines (e.g. TNF-α, IL-1β, IL-6) has been reported to increase expression of nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-kB) in BECs (Trickler, Mayhan, and 
Miller 2005), which is an essential transcription factor in inflammatory responses and induces 
secretion of TNF-α and IL-1β (Blackwell and Christman 1997; Hayden and Ghosh 2014). Also, 
astrocytes have been reported to express SASP during ageing, thereby secreting pro-
inflammatory modulators that induce cerebrovascular inflammation (Salminen et al. 2011). 
However, there exists some controversy regarding BBB dysfunction in normal, healthy ageing. 
Indeed, brain microvessels have been reported to show decreased expression of  cytokines with 
ageing, including TNF-α and IL-1β, in rats (Tripathy et al. 2010), whereas BBB breakdown 
has been associated with inflammatory processes in the ageing brain in humans, including 
upregulation of cytokines and chemokines (e.g. IL-8) (Bowman et al. 2018). In addition, more 
recent reports have described that the healthy aged BBB is characterized by a significant 
inflammatory process and a concomitant disruption of TJ proteins, but not by recruitment of 
immune cells into the brain (Elahy et al. 2015). Taken together, these findings suggest that the 
process of inflammageing affects the cerebrovasculature at several levels in a precise way. 
Nevertheless, the underlying mechanisms related to healthy ageing in absence of pathology 
need further analysis in order to assess their real impact on BBB function and age-related 
disruption.  
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1.8 Sex differences in the ageing blood-brain barrier 
Despite most of the available literature has been obtained studying the male 
cerebrovascular, the potential role of sex in certain processes must be considered. Indeed, sex 
differences have been observed in mitochondrial fission (division) and fusion (merging), which 
modulate the organelle shape, in mouse cortical astrocytes, suggesting potential effects on 
mitochondrial function and energy balance (Arnold, de Araújo, and Beyer 2008; Arnold, 
Victor, and Beyer 2012). Microglial cells have been reported to exhibit sexual dimorphism, 
with female mouse microglia exerting a  neuroprotective role after ischemic stroke when 
transplanted into a male mouse brain previously lacking endogenous microglia (Lenz and 
McCarthy 2015; Villa et al. 2018). Also, DNMTs, and specifically DNMT3A, have been 
reported to be differentially expressed between male and female rats in certain brain regions, 
with higher levels of DNMT3A in the female amygdala during brain development (Kolodkin 
and Auger 2011). Similarly, sex differences in longevity and ageing patterns have been 
observed in most sexually reproducing species, with females usually living longer than males 
(Regan and Partridge 2013). Higher life expectancy for women can be linked to greater 
incidence of certain neurodegenerative disorders such as AD (Altmann et al. 2014; Paganini-
hill and Henderson 1994), as well as to higher tendency to suffer cerebrovascular incidents and 
stroke. For instance, although women are generally more protected against neurovascular 
dysfunction than men over the life course, post-menopausal women have been reported to be 
at higher risk to suffer neurovascular incidents (e.g. stroke), and have less favourable outcomes 
than men of the same age (Chisholm and Sohrabji 2016; Reeves et al. 2008). The higher 
incidence of stroke, in addition to the fact that Alzheimer´s and other neurodegenerative 
diseases have a vascular component (Desai et al. 2007; Rosenberg 2014; Weller, Boche, and 
Nicoll 2009), suggest that sex-dependent differences during ageing may also involve changes 
in cerebrovasculature. 
Some of these differential processes appear to be associated with the role of sex 
hormones, whose levels have been shown to drastically change during reproductive senescence 
(Maffucci and Gore 2006). Interestingly, apart from their reproductive role, sex steroid 
hormones have been reported to participate in brain function (Moraga-Amaro et al. 2018). In 
fact, oestrogen and progesterone contribute to neuroprotection in several conditions including 
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neuroinflammation, oxidative stress and ischemic injury in both women and female rodents 
(Garay et al. 2007; Gavin et al. 2009). Specifically, oestrogen has been described to exert anti-
inflammatory effects on cerebrovascular endothelial cells and BBB, by blocking NF-kB 
signalling and cytokine production or reducing expression of adhesion molecules that mediate 
leukocyte recruitment across the brain endothelium (Galea et al. 2002; Mori et al. 2004). 
Oestrogen also shows beneficial effects on BECs by increasing mitochondrial efficiency and 
decreasing free ROS production, thereby promoting both cell survival and angiogenesis (Zeevi 
et al. 2010). Similarly, progesterone has been implicated in attenuating TJ degradation in rats 
by reducing MMP activity following ischemic injury (Ishrat et al. 2010). Additionally, 
testosterone is also present in the female brain despite being predominantly a male hormone. 
Testosterone can be metabolized into estradiol (more common form of circulating oestrogen) 
by aromatase or into a more potent androgen by 5-α reductase, and the balance of 
androgens/oestrogens might determine the final hormonal effect in endothelial function, 
oxidative stress and inflammatory responses in cerebral vessels (Krause, Duckles, and 
Gonzales 2011; Miller and Duckles 2008). These observations suggest that sex hormones, and 
mostly oestrogen and progesterone, mediate modulation of the cerebrovascular function, 
whereas the potential role of testosterone in the BBB function requires further research.  
Thus, the age-dependent reduction in hormone levels with reproductive senescence or 
menopause, might have some severe effects on brain and BBB function. Accordingly, previous 
studies suggest that menopausal depletion in sex steroid hormones is a risk factor in ageing and 
age-related diseases, showing an effect in brain function and BBB properties (Lutescu et al. 
2007; Siddiqui et al. 2016). In fact, progesterone neuroprotective role is decreased in the ageing 
female brain, although it appears to be recovered in post-menopausal hormone therapies 
(Tanaka et al. 2018). By contrast, oestrogen protective effect has been proved to become 
attenuated following reproductive senescence (Maggioli et al. 2016; Sunday et al. 2007), 
however, the administration of oestrogen as part of hormonal therapies  has been shown to 
worsen neural impairment due to neuroinflammation in aged female rodents, while increasing 
the risk of developing stroke in post-menopausal women (Marriott et al. 2002; Wassertheil-
Smoller et al. 2003). Strikingly, oestrogen has been shown to differentially affect the 
cerebrovascular function and the BBB integrity depending on the age in female rodents (Bake 
and Sohrabji 2004), which is consistent with a worsen BBB integrity in aged females compared 
to young females and also age-matched males. These observations are suggesting potential 
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changes at the molecular level that promote the shift in oestrogen protection towards a 
detrimental effect, although the real alterations are largely unknown. 
Therefore, the study of both, the mechanisms responsible for age-related BBB 
dysfunction and the sex differences observed in ageing, might aid understanding the potential 
synergy between them and the real impact on the female cerebrovasculature.   
 
1.9 Hypothesis and objectives of the present study 
BBB dysfunction, both functionally and structurally, is a common phenomenon in the 
ageing CNS. Modifications in the gene expression profile mediated by epigenetic mechanisms, 
such as miRNAs, are thought to modulate BBB breakdown (Tominaga et al. 2015). 
Deregulation of miRNAs has been reported in the ageing brain and BBB in several species 
(Goodall et al. 2019; Inukai et al. 2012), however, the molecular mechanisms underlying 
miRNA-mediated gene expression regulation and its role in BBB dysfunction during healthy 
ageing are not completely understood. Moreover, most of the knowledge available in this field 
has been obtained studying male physiology, despite the fact that post-menopausal women 
show a higher tendency to develop neurovascular incidents (Towfighi et al. 2007). Thus, a 
better understanding of structural and molecular age-related alterations in the female BBB is 
required in order to assess the functional changes and sex differences observed in 
cerebrovascular ageing. 
This PhD project has investigated the hypothesis that functional and structural 
alterations observed at the ageing female BBB are related to changes in gene expression and 
miRNA deregulation.  
Hence, the aims of the present study were: 
1) To analyse ultrastructural alterations in the ageing female mouse BBB using 
transmission electron microscopy (TEM). 
 
2) To investigate the molecular features that underlie ageing in the BBB of female 
mice, using RNA sequencing analysis.  
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3) To determine the putative role of selected age-deregulated pairs of miRNA and 
target mRNA in age-related changes in BBB function. 
 
4) To validate the actions of selected miRNA/mRNA pair on BBB permeability and 
leukocyte adhesion in vitro. 
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Chapter 2. Ultrastructural alterations in the ageing female blood brain 
barrier. 
2.1  Introduction 
The blood-brain barrier (BBB) is essential for the correct function of central nervous 
system, as well as to protect the brain parenchyma and maintain its homeostatic balance. The 
BBB is known to experience a breakdown during physiological ageing in different species 
including mouse, rat and human. Age-related changes to the BBB have been described at 
functional, cellular and molecular levels. Functional changes include BBB breakdown and 
increased permeability in several brain regions such as hippocampus and cortex (Cullen, Kócsi, 
and Stone 2005; Montagne et al. 2015; Simpson et al. 2010). Although the vast majority of 
studies have been performed in males, age-related BBB alterations have also been described in 
females, for instance, Elahy and colleagues have shown that the BBB is impaired in aged 
female mice and shows higher capillary permeability, attenuation of tight junction proteins, 
occludin-1 and ZO-1, and increased inflammation by TNF-α overexpression in BECs (Elahy 
et al. 2015). Also, earlier studies by Bake and colleagues showed an age-dependent decrease 
in the expression of the tight junction protein Cldn-5 in older, reproductively senescent female 
rats when compared to younger females (Bake and Sohrabji 2004). Interestingly, there appear 
to be sex differences regarding age-related alterations of the BBB. Indeed, Bake and colleagues 
also reported that age-dependent BBB disruption is paralleled by Cldn-5 mislocalisation in 
ageing female rats but not in age-matched males (Bake, Friedman, and Sohrabji 2009). The 
same study showed a similar disruption in microvessel Cldn-5 in post-menopausal women 
compared to young women, which suggests that something similar could be happening in the 
human brain, even though they did not analyse men brains. Also, microvessels from oestrogen-
sensitive brainstem regions in ageing female hamsters have been shown to present age-related 
changes such as TJ disruption and degenerative inclusions in pericytes (Gerrits et al. 2010). 
These findings suggest sex-dependent alterations in BBB dysfunction with ageing that might 
also be present at the ultrastructural level.  
Specific structural changes have also been observed in almost every cellular and 
subcellular component of the BBB, although as mentioned above these alterations have mainly 
been assessed in males. For example, according to early studies, the number of BECs appears 
to decrease in human and primate BBB with ageing, although a similar reduction has not been 
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observed in rodents (Burns, Kruckeberg, and Gaetano 1981; Mooradian 1988). Similarly, BEC 
luminal surface was reported to become irregular during ageing, with higher presence of 
pseudopod-like protrusions pinching off of the endothelial cytoplasm into the lumen (E. Y. Lee 
et al. 2000). The number of endothelial mitochondria in both the cortex and hippocampus has 
also been shown to decrease in the primate, mouse, rat and human brain (Hicks et al. 1983). In 
addition, one of the most characteristic structural changes observed during ageing is the 
increase in thickness of the BM, which can double in the microvessels of aged mice compared 
to young mice (Ceafalan et al. 2019). This morphological change is accompanied by 
biochemical alterations including changed levels of extracellular proteins such as collagen IV, 
laminin and other proteoglycans (Candiello et al. 2010).  
Pericytes and astrocytes also show alterations during the process of ageing. A decrease 
in pericyte numbers in human cerebral white matter (but not grey matter) has been previously 
reported in aged male mice (Farrell et al. 1987). However, number of pericytes appears to be 
increased in male rat cortex (Peinado et al. 1998), whereas no change is found in monkeys 
(Peters, Josephson, and Vincent 1991). In addition, previous publications have described loss 
of coverage and contact between aged pericytes and BECs (Bell et al. 2010; Hughes et al. 2006) 
and a decline in pericyte area/vessel profile in human BBB (P. A. Stewart et al. 1987). It has 
also been shown that mitochondrial area in pericytes is increased during ageing in both cortex 
and hippocampus of rats (Hicks et al. 1983; Mooradian 1988). During age-related astrogliosis, 
astrocytes show morphological changes into a swollen phenotype with thicker projections, 
accumulating in the ageing cortex, hippocampus and other brain regions (Amenta et al. 1998; 
Kanaan, Kordower, and Collier 2010); however, astrocyte number does not appear to change 
in the ageing brain, at least in humans (Fabricius, Jacobsen, and Pakkenberg 2013). Aged 
astrocytes also express a marked deregulation at the levels of cytoplasmic antigens, membrane 
proteins and growth factors (Cotrina and Nedergaard 2002) and, when activated, have a 
secretory phenotype which includes production of cytokines and neurotrophic factors (Clarke 
et al. 2018). In addition to this senescent, pro-inflammatory phenotype, ageing has been 
recently reported to induce neurovascular dysfunction by reducing astrocytic end-feet contacts 
on brain vessels (Duncombe et al. 2017). This pro-inflammatory environment in the ageing 
brain might link back to ultrastructural changes on BECs, which have been reported to form 
the beforementioned pseudopods also in neuroinflammatory conditions and as a response to 
cerebral ischemia (Øynebråten et al. 2015; Pluta et al. 1991). 
2. Ultrastructural alterations in the ageing female blood-brain barrier 
 
37 
 
Because of the small size and complex interrelationship between components of the 
BBB, ultrastructural analysis is one of the most useful techniques to study age-related changes 
in the cerebral vasculature. In particular, transmission electron microscopy (TEM) is one of the 
most commonly used techniques to study the ultrastructure of the BBB in multiple species 
across different ages (Castejón 2011; Cipolla et al. 2004; Haley and Lawrence 2017; Hawkes 
et al. 2013; Hirano, Kawanami, and Llena 1994; Nahirney, Reeson, and Brown 2016). 
Normally, TEM involves collecting serial tissue sections which are then imaged at high 
resolution. These 2D images can be used to analyse structure, number or interactions between 
cellular and subcellular elements of the BBB. However, this technique requires a considerable 
amount of manual labour when analysing several sections. In addition, a certain number of 
factors, such as section folding during the placement or electron beam damage, can lead to 
discontinuous or interrupted series as well as imperfect image stacks and therefore introduce 
artefacts which may affect interpretation (Knott et al. 2008). Automation protocols have 
significantly improved the efficiency of TEM image acquisition and processing, including 
image stacking and montage compilation, which has enabled the development of 3D 
reconstruction TEM techniques. This approach has several benefits over 2D analysis, such as 
in-depth analysis of structures of interest including volume, localisation in space and intimate 
contact between BBB elements alongside a whole reconstructed vessel (Mathiisen et al. 2010). 
However, despite the deeper insight allowed by 3D reconstruction analysis, it does have several 
limitations such as being restricted to particular structures, being highly time consuming and 
depending on the quality and size of the image stack for a successful outcome. 
Sex differences are undoubtedly multifaceted, and one of the common explanations for 
such differences, including those at the cerebrovascular level, relies on the role of sex steroid 
hormones such as oestrogen and progesterone, whose levels drastically change with menopause 
and reproductive senescence (Maffucci and Gore 2006; Sherman, West, and Korenman 1976). 
Experiments on stroke models of middle cerebral artery occlusion have shown smaller effects 
in young adult female rats and mice when compared to males, a protection that decreases when 
female rodents are ovariectomised and sex steroid hormone levels are altered (Park et al. 2006; 
Selvamani and Sohrabji 2010). Precisely, oestrogen and progesterone have been described to 
target brain vessels and intervene in regulation of BBB permeability and function in women 
and female mice (Krause, Duckles, and Pelligrino 2006; Wilson et al. 2008). During 
reproductive senescence, oestrogen decline has been reported to promote loss of BBB integrity 
and altered transport within the female mouse brain (Kastin, Akerstrom, and Maness 2001; 
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Wilson et al. 2008), as well as to hinder amyloid-β clearance in the human cortical 
cerebrovasculature (Li et al. 2000). Similarly, oestrogen-mediated anti-inflammatory effects 
also get compromised during ageing in female mice (Maggioli et al. 2016). These observations 
suggest that age-dependent changes in sex steroid hormones contribute to BBB alterations, 
with reproductive senescence having a greater impact on the BBB of females over males. 
Although much is known about the BBB in ageing, ultrastructural changes still require 
thorough investigation. Also, despite the evidence of sex differences across age, the vast 
majority of studies looking at age-related BBB dysfunction have focused on males, and there 
is still a lack of information regarding how the female BBB is structurally and functionally 
altered during ageing. Therefore, the aim of this chapter was to analyse the ultrastructural 
changes in cortical and hippocampal capillaries from young and aged C57BL/6J female mice. 
To first confirm whether our animal model replicated findings obtained in the ageing male 
BBB in literature, preliminary analyses of BM thickness, mitochondrial number and size and 
cell-cell contacts were carried out in 2D images of cortical capillaries only. However, as 
mentioned above, among the brain regions altered in ageing, two of the most understood and 
studied are cortex and hippocampus, which undergo processes of age-related shrinking, 
inflammation and BBB dysfunction (Popescu et al. 2009; Viggars et al. 2011). For that reason, 
when performing the more in-depth 3D reconstruction analysis, hippocampal capillaries were 
analysed together with cortical capillaries in order to assess potential differences between these 
regions. 
 
2.2 Material and Methods 
2.2.1 Animals 
6 and 24-month-old female C57BL/6J mice were used in this study. All animal work 
was approved by The Open University Animal Welfare and Ethics Research Board and the UK 
Home Office (PPL 80/2612). Animals were housed on a 12-hour light/dark cycle. Food and 
water were provided ad libitum.  
2. Ultrastructural alterations in the ageing female blood-brain barrier 
 
39 
 
2.2.2 Oestrous cycle monitoring  
To determine the stage of oestrous cycle, the protocol published by Byers and 
colleagues was followed (Byers et al. 2012). Vaginal lavage (approximately 0.2-0.4 ml of 
distilled water) was blindly carried out on young and aged mice at the start of the light phase 
for 7 consecutive days. The vaginal smears were examined under an LCD Brightfield 
Microscope (Bresser, Rhede, Germany). The stage of the oestrous cycle was classified as i) 
pro-oestrous if there were numerous nucleated epithelial cells and some cornified cells, ii) 
oestrous if there were cornified cells with some nucleated and non-nucleated epithelial cells, 
iii) metoestrous if there were numerous cells including cornified and non-nucleated, leukocytes 
start appearing and iv) dioestrous if there were mainly leukocytes and occasionally some non-
nucleated cells. 
2.2.2.1 Measurement of reproductive hormones in plasma of young and aged female mice  
Blood was collected from anaesthetised young and aged female mice (n=6/group). 
Plasma was separated by centrifuging (2000g, 3min) and stored at -80 oC. Concentrations of 
progesterone (#80559, Crystal Chem., Zaandam, Netherlands) and estradiol (#ES180S-100, 
Calbiotech, CA, USA), the most active type of oestrogen, were measured using ELISA kits 
according to manufacturer´s instructions. The ratio of progesterone/estradiol (P/E2) was 
calculated for both age groups.  
2.2.3 Brain collection and processing for TEM 
2.2.3.1 Perfusion and brain collection 
6 and 24-month-old female C57BL/6J female mice were used in this study. Mice were 
intraperitoneally injected with an overdose of pentobarbitine sodium (20% w/v; Pentoject, 
Animalcare, UK) and perfused intracardially with 0.01M phosphate-buffered saline (PBS, 
0.1M phosphate buffer (PB, Na2HPO4 10mM, KH2PO4 1.8 mM, 0.1% Tween) and 0.9% 
sodium chloride; Sigma-Aldrich, Dorset, UK). After PBS, mice were perfused with 3% 
paraformaldehyde (PFA, Sigma-Aldrich, Dorset, UK) and 1% glutaraldehyde (Agar Scientific, 
Essex, UK) in 0.1 M PB (pH 7.4). Brains were then extracted and maintained in 2.5% 
glutaraldehyde in 0.1 M PB for 5 days. 
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After the post-fixation time, brains were sliced coronally using a vibratome into slices 
of 50 µm thickness. Slices containing either prefrontal cortex or dorsal hippocampus were 
selected to be used for EM and stored in 0.1 M PB at 4 oC prior further processing.  
2.2.3.2 Slice processing 
Brain slices were post-fixed in 2.5% glutaraldehyde in PB 0.1M for 1h at RT and then 
rinsed 3 times for 10 min each in 0.1M PB. Afterwards, slices were incubated in 1% osmium 
tetroxide (OsO4, Agar Scientific, Essex, UK) in PB 0.1M for 1 hour at RT. Tissues were 
dehydrated by passing through increasing graded aqueous solutions of ethanol from 30% to 
100% (each for 10 min). After 100% ethanol, slices were incubated in 100% acetone for 3 
times (10 min each). Then samples were impregnated with a mixture of 50% epoxy resin (Epon 
812 epoxy resin, #45345, Sigma-Aldrich, Dorset, UK) and 50% pure acetone (50:50) for 2h at 
RT. The following steps were performed with the help of Radka Gromnicova and Igor Kraev. 
2.2.3.3 Resin Embedding 
Using a paintbrush, a small amount of 50:50 resin:acetone mixture was placed on a 
cleaned piece of aclar plastic film. Slices were then transferred on top of the film and air-dried 
to allow acetone evaporation. Then, a drop of pure resin was placed on them quickly and gently 
and excess resin was eliminated using filter paper. Another film of aclar was then slowly placed 
on top, ensuring all the bubbles were removed. Sections between both films of aclar were 
placed inside the oven and incubated at 60 oC. After the first 15 min, weights were placed on 
top to make sure excess resin were removed. Samples were left for 48h to ensure 
polymerisation of the resin.  
2.2.3.4 Capsule preparation 
Gelatine capsules were filled with an identifying number. A drop of resin was also 
pipetted inside each capsule. Capsules were then placed upside down on rubber platforms and 
incubated in the oven at 60 oC for 48h to polymerise. The aclar sheets were peeled off one from 
the other, trying to keep all the slices stuck in one of the sheets. A drop of pure resin was 
pipetted onto each polymerised slice. A labelled capsule of polymerised resin was then placed 
upside-down on the resin drop and polymerised again at 60 oC for 48h. Blocks were coded, and 
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all further analyses were carried out with the investigator blind to the experimental status of 
the tissue.  
2.2.3.5 Microsectioning 
Slices embedded on the block surface were trimmed with a glass knife along the entire 
area of interest. A pyramid of size 30 µm x 300 µm was prepared on the face of the block. The 
pyramid was then serially sectioned into sections of 50 nm of thickness by a diamond knife 
(Diatome, Nidau, Switzerland) which includes a small metal trough that can be filled with 
water. Ribbons of tissue were floated on the water surface and then collected onto copper grids 
covered by a carbon coated pioloform film. Sections on the grids were left air drying for at 
least 2h. Radka Gromnicova performed the microsectioning. 
2.2.3.6 Counter-staining 
Sections were pre-treated with 1% HCl for 1 min in order to reduce formation of crystals 
on the tissue. After this first treatment, sections were washed 3 times in distilled water. Sections 
were then stained with uranyl acetate (Agar Scientific, Essex, UK) for 20 min or with Uranyless 
(Delta Microscopies, Mauressac, France) for 10 min and then washed 3 times in distilled water. 
Grids were left to air dry for 2h before imaging. Finally, the grids were stained with Reynold’s 
lead citrate (Delta Microscopies, Mauressac, France) for 7 min, which recipe dates back to 
1963 (Reynolds 1963), and washed again 3 times in distilled water. Radka Gromnicova 
performed the counter-staining. 
2.2.3.7 Image collection 
Series of sections were imaged on a JEM 1400 (Jeol, Tokyo, Japan) electron 
microscope. Images were acquired automatically using an AMT XR60 camera and SerialEM 
software in montaging mode, following the method described by Mastronarde (Mastronarde 
2005). Acquisition was performed using a column magnification of 6000x and acceleration 
voltage of 80 kV. Each section was imaged taking images of 3x4 (x:y axis).  
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2.2.3.8 Image 2D analysis  
TEM images for the 2D analysis were processed by Image J 
(https://imagej.net/Welcome) to trace structures of interest and obtain their areas in 50 cortical 
capillaries per animal. A mean value of the measures in those 50 vessels was calculated for 
each animal. A total of 3 animals per age group (young and aged) were used in this experiment 
(n=3/ age group).  
2.2.3.9 Image 3D analysis of prefrontal cortex and hippocampus 
In the case of the 3D analysis, images were first corrected for chromatic aberrations 
using the ImageJ plugin bUwarpJ (Arganda-carreras et al. 2006). Individual images were then 
stitched together into montages using Photomerge in Adobe Photoshop CS6 (Adobe). A custom 
script was created by the head of the TEM unit, Igor Kraev, and used in Adobe ExtendScript 
Toolkit CS6 in order to automate the process for batch processing. Montages were 
automatically aligned using the ImageJ TrakEM2 plugin (Cardona et al. 2012). After montages 
were properly aligned, reconstruction of capillaries was performed using Reconstruct software 
(http://synapseweb.clm.utexas.edu/software-0). 
The final 3D reconstructions were smoothened, stylised and coloured using 3D Max 
software (Autodesk). Structures of interest were manually traced using Reconstruct in series of 
montages from 5 different capillaries per animal, a mean value of the measures in those 5 
vessels was calculated for each animal. A total of 3 animals per age group (young and aged) 
were used in this experiment (n=3/ age group). Main steps of the 3D reconstruction process are 
summarised below (Figure 6). A video of a whole 3D reconstructed capillary has been added 
as a non-book element to this thesis (ORDO DOI: https://doi.org/10.21954/ou.rd.12594641). 
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Figure 6. Protocol to obtain 3D reconstructions of images of mouse brain capillaries captured using TEM. 
 A) Multiple 2D images of the area of interest were collected. B) Montages were stitched together using 
Photoshop. C) Montages were then aligned using TrackEM2 plug in of Image J. D) Once aligned, cellular and 
subcellular components of interest were traced using Reconstruct software. E) At the end, same Reconstruct 
software was used to obtain a 3D model of the capillary. 3D Max software was used to smoothen and colour the 
3D models of each cellular and subcellular component of the BBB. 
Several features were measured. Volume and area of cellular and subcellular 
components were obtained directly from Reconstruct software. These values were used to 
calculate component volumes with respect to total cell volumes or contact between cells. In 
addition, BM thickness was obtained by 4 measures per section, and as an average value per 
vessel. TJ tortuosity refers to how much the junctional contact between BECs varies along the 
longitudinal axis of the vessel, and it was measured along the whole capillary length by taking 
reference points at the lumen, middle and basement membrane parts of the TJ and obtaining a 
mean value. In addition, TJ length or complexity was measured on the transversal section of 
the capillaries as the product of dividing the TJ length by the diagonal of a rectangle containing 
the length and height of the complete TJ (Figure 7) (Jackman et al. 2013). Both of these 
features give different information of the TJs but may be correlated.  
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Figure 7. TJ measurements in 3D modelled cortical and hippocampal capillaries.  
A) TJ tortuosity was calculated alongside the capillary as the average of three reference points in the actual TJ: 
abluminal (red), middle part of the TJ (green) and basolateral (blue). Each one of them was referred to a straight 
line joining directly the first and last sections of the whole vessel. B) TJ complexity was calculated by dividing 
the total length of the TJ (black solid line) by the diagonal (dotted line) of the rectangle (dashed line) containing 
the height and the length of the TJ. The final value was obtained as average of the TJ complexity every 5 sections 
of the 3D capillary.  
 
2.2.4 Statistical analysis 
Every statistical data analysis was performed using GraphPad Software (Prism 8.2.0, 
La Jolla, USA). Shapiro-Wilk normality test and Q-Q plots were used to assess distribution of 
the data. Data from 2D analysis was analysed using an unpaired two-tailed Student’s t test, 
whereas data from 3D analysis data was analysed using two-way ANOVA and Sidak’s 
correction test. In all cases, significance is set at p<0.05 and data are displayed as mean ± SEM. 
The selection of appropriate statistical tests is indicated in each figure legend. 
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2.3 Results 
2.3.1 Aged female mice show persistent vaginal cornification 
Assessment of oestrous cycle via vaginal lavage indicated that the young female mice 
were cycling normally through the 4 phases (Figure 8A – D). Aged mice showed persistent 
vaginal cornification, which is observed as a lack of epithelial cells and is consistent with 
reproductive senescence (Figure 8E). Vaginal smears were similar between young female 
mice in dioestrous and aged female mice. Previous studies have shown that plasma oestrogen 
and progesterone concentrations in aged females are most closely matched in the dioestrous 
phase of the cycle (Felicio, Nelson, and Finch 1984; Nelson et al. 1982). Therefore, to avoid 
the effect of hormone-induced fluctuations on BBB gene expression leading to the 
interpretation of the data between young and aged mice, all young females were confirmed to 
be in dioestrous on the day of tissue collection.  
 
Figure 8. Classification of oestrous cycle stages in young and comparison with aged C57BL/6J female mice. 
2. Ultrastructural alterations in the ageing female blood-brain barrier 
 
46 
 
 This classification is based on the amount and types of cells present in the vaginal smear. A) Pro-oestrous, 
presence of numerous nucleated epithelial cells (rounded and nucleated) and some cornified cells (needle-shaped, 
dark). B) Oestrous, presence of cornified cells with some nucleated and non-nucleated epithelial cells (similar 
shape to nucleated epithelial cells but without nucleus). C) Metoestrous, numerous cells including cornified and 
non-nucleated epithelial cells, leukocytes also start appearing. D) Dioestrous, mainly leukocytes with occasionally 
some non-nucleated cells. E) Young female mice in dioestrous showed a similar smear to aged acyclic female 
mice. Scale bars, 50 µm. 
Progesterone and estradiol concentrations were measured using plasma samples from 
both young female mice in dioestrous and aged female mice. According to the results obtained 
by ELISA, no significant differences were observed in progesterone or estradiol levels between 
young and aged female mice (Figure 9A). Similarly, the sex steroid hormone ratio 
(Progesterone/Estradiol, P/E2) did not differ between young and female mice (Figure 9B). 
 
Figure 9. Progesterone and estradiol concentration and ratio (P/E2) in young and aged female C57BL/6J 
mice.  
A) Progesterone and estradiol levels were measured in plasma samples by ELISA. No significant differences were 
observed between young and aged female mice for any of the hormones. B) P/E2 ratio was not significantly 
different between young and aged female mice. (n=6, Student’s t test; ns, not significant). 
 
2.3.2 Ultrastructural changes of female brain capillaries: preliminary 2D quantitative 
analysis  
Analysis of 2D images was performed first, in order to measure age-induced changes 
at the female BBB, previously described in the ageing male mouse cortex.  
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2.3.2.1 Basement membrane (BM) thickness is increased in cortical aged capillaries 
The BM was identified as a slightly electrodense layer located laterally to the 
endothelial cells (Figure 10A). A significant increase in the thickness of the BM was observed 
in aged capillaries compared to young capillaries (Figure 10B). The BM in aged capillaries 
was almost twice as thick as the BM of young capillaries. 
 
Figure 10. BM thickness in cortical capillaries of young and aged female C57BL/6J mice.  
A) BM (green dotted line) was identified on TEM images of young and aged capillaries (Red stars (*): basement 
membrane; a: astrocyte; bec: brain endothelial cell; p: pericyte; tj: tight junction). B) Quantification of BM 
thickness showed that BM of aged capillaries was almost twice as thick as the BM of young mice. (n=3/age group, 
Student’s t test; ***, p<0.001).  
2.3.2.2 Mitochondria of aged BECs in cortex are smaller and less numerous 
Mitochondria were observed in TEM images as electrodense inclusions of diverse size 
within the cytoplasm (Figure 11A). In this analysis, BEC mitochondria area and number were 
measured with respect to total area of the cell. Both the number of mitochondria (Figure 11B) 
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and mitochondrial area (Figure 11C) were significantly decreased in aged BECs compared to 
young animals.  
 
Figure 11. BEC mitochondria number and area in cortical capillaries of young and aged female C57BL/6J 
mice.  
A) Mitochondria (green dotted line) were identified on TEM images of young and aged BECs (Red stars (*): 
basement membrane; white dotted line: brain endothelial cell area; a: astrocyte; bec: brain endothelial cell; m: 
mitochondria; p: pericyte; tj: tight junction). B) Number of mitochondria was significantly decreased in aged 
BECs. C) Mitochondrial area was significantly reduced in aged BECs. (n=3/age group, Student’s t test; ***, 
p<0.001; ****, p<0.0001). 
2.3.2.3 Mitochondria of aged pericytes are larger and more abundant  
Pericyte mitochondria showed the same visual characteristics as described for BEC 
mitochondria (Figure 12A). However, in contrast to mitochondrial changes in BECs, the 
number of mitochondria in pericytes of aged capillaries was significantly higher than in 
pericytes at capillaries of young mice (Figure 12B). Mitochondrial area was also significantly 
greater in aged pericytes compared to those in young capillaries (Figure 12C). 
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Figure 12. Pericyte mitochondria number and area in cortical capillaries of young and aged female 
C57BL/6J.  
A) Mitochondria (green dotted line) were identified on TEM images of young and aged pericytes (Red stars (*): 
basement membrane; white dotted line: pericyte cell area; a: astrocyte; bec: brain endothelial cell; m: 
mitochondria; p: pericyte; tj: tight junction). B) Number of mitochondria was significantly increased in aged 
pericytes. C) Mitochondrial area was significantly greater in aged pericytes. (n=3/age group, Student’s t test; *, 
p<0.05).  
2.3.2.4 Contact between BECs and pericytes is not changed in ageing 
To determine whether the degree of contact between pericytes and BECs was altered 
by ageing, the percentage of pericytic coverage over BEC diameter was calculated (Figure 
13A). No significant differences in the degree of pericyte – BEC contact between young and 
aged mice were found (Figure 13B). 
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Figure 13. Pericyte – BEC contact in cortical capillaries of young and aged female C57BL/6J mice.  
A) Pericyte – BEC contact (green dotted line) was identified on TEM images of young and aged capillaries. (Red 
stars (*): basement membrane; white dotted lines: pericyte and brain endothelial cell area; a: astrocyte; bec: brain 
endothelial cell; p: pericyte). B) Quantification of pericyte – BEC contact showed that this contact was not 
changed in aged capillaries. (n=3/age group, Student’s T test; ns, not significant). 
2.3.2.5 Contact between BM and astrocytes is increased in ageing 
Astrocytic end-feet appear like a large light structure that surrounds BECs, pericytes 
and BM. They are variable in size and can be traced across the brain parenchyma. In this 
analysis, only the astrocytic structures included in an area of 1 µm away of the vessel were 
traced. Image J was used to trace the area of both astrocytes and BM and the contact between 
both components was calculated as the percentage of area per area (Figure 14). According to 
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these results, contact of BM and astrocytes is slightly but significantly increased in aged 
capillaries over young ones.  
 
Figure 14. BM – astrocyte contact in cortical capillaries of young and aged female C57BL/6J mice.  
A) Astrocyte – BM contact was identified on TEM images of young and aged capillaries. (Red stars (*): basement 
membrane; white line: astrocyte and BM area; a: astrocyte; bec: brain endothelial cell; m: mitochondria; p: 
pericyte). B) Astrocyte – BM contact was shown to be significantly increased in aged capillaries. (n=3/age group, 
Student’s t test; **, p<0.01). 
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2.3.3 Ultrastructure of cortical and hippocampal brain capillaries: A 3D quantitative 
analysis  
2.3.3.1 BM is thicker in aged capillaries of cortex and hippocampus 
After 3D reconstruction, the BM was visible as a continuous layer covering the whole 
microvessel (Figure 15A and B). Similar to the findings from the 2D images, a significant 
increase in BM thickness was observed in aged capillaries compared to young capillaries, in 
both the cortex and hippocampus (Figure 15C). In both cases, BM was almost twice as thick 
in aged capillaries than in young capillaries. Regional comparisons of BM thickness between 
the cortex and hippocampus did not show any significant differences in either age group.  
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Figure 15. BM thickness in 3D reconstructed cortical and hippocampal capillaries of young and aged female 
C57BL/6J mice.  
BM was identified in 3D reconstructed capillaries of young and aged mice, in both A) cortex and B) hippocampus. 
C) Cortical aged capillaries showed a significant increase in BM thickness when compared to young capillaries 
from the same region. Similarly, BM thickness was significantly higher in aged capillaries compared to young 
capillaries in the hippocampus, although the fold-change is smaller. In contrast, no regional differences were 
observed in BM thickness. (n=3/age group, Two-way ANOVA and Sidak’s correction test; *, p<0.05). 
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2.3.3.2 Mitochondrial number and volume are not changed in cortical or hippocampal BECs 
The 3D reconstruction showed mitochondria as rounded inclusion bodies within the 
cytoplasm of the endothelial cell (Figure 16A and B). Interestingly, the mitochondria grouped 
together alongside the length of the vessel. In contrast to the findings from the 2D analysis, 
mitochondrial number did not show significant differences between aged and young BECs in 
cortex or hippocampus (Figure 16B). Similarly, BEC mitochondrial volume was not 
significantly changed in aged capillaries compared to young capillaries in cortex and 
hippocampus (Figure 16C). No differences were observed either when comparing both regions 
in age-matched individuals.  
 
Figure 16. BEC mitochondria structural analysis in 3D reconstructed cortical and hippocampal capillaries 
of young and aged female C57BL/6J mice.  
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Mitochondria were identified as rounded inclusions within the BEC cytoplasm in 3D reconstructed capillaries of 
young and aged mice, in both A) cortex and B) hippocampus. C) Mitochondrial number was not significantly 
changed in aged capillaries from cortex or hippocampus when compared to young capillaries from the same 
region. D) Mitochondrial volume did not show significant changes in aged capillaries when compared to young 
capillaries in cortex or hippocampus. In addition, no regional differences were observed in mitochondrial number 
or volume when comparing age-matched individuals. (n=3/age group, Two-way ANOVA and Sidak’s correction 
test; ns, not significant). 
2.3.3.3 BEC pseudopod number and volume are increased in aged cortical capillaries  
When comparing young and aged capillaries, filamentous pseudopod-like structures 
were observed to protrude from the BECs into the lumen of the vessels. In 3D reconstructions, 
pseudopods were observed on the luminal surface of the vessels and show different sizes 
(Figure 17A and B).  
 
Figure 17. BEC pseudopod structural analysis in 3D reconstructed cortical and hippocampal capillaries of 
young and aged female C57BL/6J mice.  
2. Ultrastructural alterations in the ageing female blood-brain barrier 
 
56 
 
Pseudopods were identified as protrusions from the endothelial cytoplasm into the vessel lumen in 3D 
reconstructed capillaries of young and aged mice, in both A) cortex and B) hippocampus. C) Pseudopod number 
was significantly increased in aged cortical capillaries compared to young cortical capillaries, whereas no changes 
were observed between aged and young mice in hippocampus. In addition, Pseudopod number was significantly 
greater in aged capillaries from cortex than in aged capillaries from hippocampus. D) Volume of pseudopods was 
significantly higher in cortical capillaries from aged animals compared to young cortical capillaries. In contrast, 
no changes in pseudopod volume were observed between aged and young mice in hippocampus. Additionally, 
pseudopod volume was significantly greater in aged capillaries from cortex than in aged capillaries from 
hippocampus. (n=3/age group, Two-way ANOVA and Sidak’s correction test; **, ##, p<0.01; #, p<0.05; ns, not 
significant). 
Both pseudopod volume and number were significantly increased in aged cortical BECs 
when compared to endothelial cells from young cortical capillaries (Figure 17C and D). 
Pseudopod number was 4-fold higher in aged BECs than in young BECs, whereas pseudopod 
volume was 10-fold higher than the volume in young BECs. In the hippocampus, no significant 
differences were observed in pseudopod volume or number between young and aged vessels. 
Regional comparisons showed that both pseudopod number and volume were significantly 
higher in aged cortical capillaries than in aged hippocampal capillaries.  
2.3.3.4 Mitochondrial volume is increased in aged pericytes of cortex and hippocampus 
As mentioned above, the 3D reconstruction showed mitochondria as rounded inclusions 
within the cytoplasm of pericytes (Figure 18A and B). Assessment of the number of 
mitochondria in pericytes found that it was not changed in aged pericytes of cortical or 
hippocampal capillaries (Figure 18C). In contrast, mitochondrial volume was significantly 
increased in aged pericytes of cortex and hippocampus in comparison to young pericytes of the 
respective regions (Figure 18D). Volume of pericytic mitochondria was almost 5-fold higher 
in aged cortical capillaries when compared to young cortical capillaries, whereas almost twice 
as many mitochondria were observed in aged hippocampal capillaries compared to young 
hippocampal capillaries. It was also noted that, in some cases, pericyte mitochondria formed 
tubular networks in aged pericytes of the cortex. Regional comparisons did not show significant 
differences in number or volume of pericytic mitochondria between cortical and hippocampal 
capillaries at any age. 
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Figure 18. Pericyte mitochondria structural analysis in 3D reconstructed cortical and hippocampal 
capillaries of young and aged female C57BL/6J mice.  
Mitochondria were identified as rounded inclusions within the pericyte cytoplasm in 3D reconstructed capillaries 
of young and aged mice, in both A) cortex and B) hippocampus. C) Number of mitochondria did not show 
significant differences between aged and young capillaries in cortex or hippocampus. D) Volume of mitochondria 
was significantly increased in aged capillaries of cortex and hippocampus when compared to their young 
counterparts. In some cases, mitochondria were observed to form tubular networks in aged pericytes. In contrast, 
regional comparisons did not show significant changes in pericytic mitochondrial volume or number between 
cortical and hippocampal capillaries at any age. (n=3/age group, Two-way ANOVA and Sidak’s correction test; 
*, p<0.05; ns, not significant). 
2.3.3.5 Contact between pericytes and BECs is increased in cortical aged capillaries 
In the 3D reconstructed capillaries, pericytes appeared as projections that intermittently 
spread over the vessel wall (Figure 19A and B).  
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Figure 19. Structural analysis of the contact between pericytes and BECs in 3D reconstructed cortical and 
hippocampal capillaries of young and aged female C57BL/6J mice.  
Pericyte projections were identified intermittently spread over the vessel wall in 3D reconstructed capillaries of 
young and aged mice, in both A) cortex and B) hippocampus. C) Percentage of pericyte – BEC contact was 
significantly increased in cortical aged capillaries compared to cortical young capillaries. In contrast, pericyte – 
BEC contact did not change in hippocampal capillaries with ageing. Regional comparisons did not show 
significant changes in pericyte – BEC between cortical and hippocampal capillaries at any age. (n=3/age group, 
Two-way ANOVA and Sidak’s correction test; *, p<0.05; ns, not significant). 
Analysis of the degree of contact between BEC and pericytes showed a significant 
increase in the percentage of pericyte – BEC contact in aged cortical capillaries (Figure 19C). 
However, no significant differences were observed in pericyte – BEC contact in hippocampal 
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capillaries of young and aged female mice. Similarly, regional comparison showed no 
significant differences in pericyte – BEC contact in cortical versus hippocampal capillaries in 
either young or aged mice. 
2.3.3.6 Contact between astrocytes and capillary wall is not changed in age 
When capillaries were reconstructed, astrocytic end-feet were observed as large 
projections that ensheathed the capillary and established contact with the BM (Figure 20A and 
B). Quantification of contact between astrocytes and BM showed no significant differences 
between aged and young capillaries in cortex or hippocampus (Figure 20C). Regional 
comparisons did not show significant differences in astrocyte end-feet coverage between 
cortical and hippocampal capillaries in young or aged mice. 
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Figure 20. Analysis of the contact between astrocytes and BM in 3D reconstructed cortical and hippocampal 
capillaries of young and aged female C57BL/6J mice.  
Astrocytic end-feet were identified as large projections ensheathing the vessel and stablishing contact with the 
BM in 3D reconstructed capillaries of young and aged mice, in both A) cortex and B) hippocampus. C) Percentage 
of astrocyte – BM contact was not significantly changed in aged capillaries compared to young capillaries in 
cortex or hippocampus. Similarly, astrocyte – BM contact did not show regional differences in any age when 
comparing cortical and hippocampal capillaries. (n=3/age group, Two-way ANOVA and Sidak’s correction test; 
ns, not significant). 
2.3.3.7 Tight junction tortuosity is increased in aged cortical capillaries  
TJ are visible alongside the capillary in the 3D model where two BECs overlap (Figure 
21A and B). Analysis of TJs showed a significant increase in tortuosity in aged cortical 
capillaries compared to cortical young capillaries (Figure 21C). No differences were observed 
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between young and aged capillaries in the hippocampus. In addition, TJ tortuosity was 
significantly higher in aged capillaries of the cortex compared to aged capillaries of the 
hippocampus. 
 
Figure 21. TJ tortuosity analysis in 3D reconstructed cortical and hippocampal capillaries of young and 
aged female C57BL/6J mice.  
TJs were identified alongside the vessel where two BECs overlap in 3D reconstructed capillaries of young and 
aged mice, in both A) cortex and B) hippocampus. C) TJ tortuosity was significantly higher in aged cortical 
capillaries compared to young cortical capillaries, whereas no changes were observed in hippocampal capillaries. 
Regional comparisons showed a significantly higher TJ tortuosity in aged cortical capillaries in comparison to 
aged hippocampal capillaries. (n=3/age group, Two-way ANOVA and Sidak’s correction test; ###, p<0.001; *, 
p<0.05; ns, not significant). 
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Regarding TJ complexity, understood as length, it can be observed on the edges of the 
reconstructed vessel or in each TEM section (transversal view) (Figure 22A and B). Our 
results showed no significant differences between young and aged capillaries in either cortex 
or hippocampus (Figure 22C). However, when comparing both regions, a small but significant 
increase in TJ complexity was observed in aged hippocampal capillaries versus aged cortical 
capillaries. 
 
Figure 22. TJ complexity measured in 3D reconstructed cortical and hippocampal capillaries of young and 
aged female C57BL/6J mice.  
To analyse complexity, TJs were identified at the edges of the vessel (transversal section) in 3D reconstructed 
capillaries of young and aged mice, in both A) cortex and B) hippocampus. C) TJ complexity was not significantly 
changed by age in cortical or hippocampal capillaries. Regional comparisons showed a small but significant 
increase in TJ complexity in aged hippocampal capillaries versus aged cortical capillaries. (n=3/age group, Two-
way ANOVA and Sidak’s correction test; #, p<0.05; ns, not significant). 
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2.4 Discussion  
In the present study, structural features were analysed in cerebral capillaries from young 
and aged C57BL/6J female mice, in order to asses age-related changes in the female BBB 
ultrastructure. Sexual steroid hormone levels were measured by ELISA, and P/E2 was not 
significantly different between young and aged female mice. Preliminary structural analysis 
was performed in 2D TEM images of cortical capillaries only, whereas a further 3D 
reconstruction analysis was performed in both cortical and hippocampal capillaries. In general, 
2D and 3D analyses appear to have some differences although several age-related changes were 
observed in cortical capillaries. In addition, the region comparison results showed a higher 
impact of ageing on cortical capillaries compared to hippocampal capillaries. A summary of 
the results can be found in Table 2. 
Table 2. Summary of ultrastructural changes in the ageing female BBB assessed by TEM. 
 Young vs Aged Female Mice Cortex  
vs  
Hippocampus  Cortex Hippocampus 
Structural 
Features 
Preliminary 2D 
Analysis 
3D Reconstruction 
Analysis 
3D Reconstruction 
Analysis 
3D Reconstruction 
Analysis 
BM thickness 
Higher in aged 
capillaries 
 
Higher in aged 
capillaries 
 
Higher in aged 
capillaries 
 
No difference 
 
BEC 
mitochondria 
 
(Number and 
area/volume) 
Lower in aged 
capillaries 
No difference 
 
No difference 
 
No difference 
 
BEC 
Pseudopods 
 
(Number and 
area/volume) 
N/A 
Higher number and 
volume in aged 
capillaries 
 
No difference 
 
Higher number and 
volume in aged cortical 
capillaries 
 
Pericyte 
mitochondria 
 
(Number and 
area/volume) 
Higher in aged 
capillaries 
Higher volume in aged 
capillaries 
 
No difference in number 
 
Higher volume in aged 
capillaries 
 
No difference in number 
 
No difference 
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Pericyte 
coverage over 
BECs 
No difference 
Higher in aged 
capillaries 
 
No difference 
 
No difference 
 
Astrocyte 
coverage over 
BM 
High in aged 
capillaries 
No difference 
 
No difference 
 
No difference 
 
Tight 
junction 
tortuosity 
N/A 
Higher in aged 
capillaries 
 
No difference 
 
Higher in aged cortical 
capillaries 
 
Tight 
junction 
complexity 
N/A 
No difference 
 
No difference 
 
Lower in aged cortical 
capillaries 
 
 
The process of ageing in females is undoubtedly related to reproductive senescence and 
changes in sexual hormone levels, in humans, rodents and non-primate human (Maffucci and 
Gore 2006; Mobbs, Gee, and Finch 1984). However, the role of certain sex steroid hormones, 
such as oestrogen, progesterone or testosterone in BBB modulation with ageing is a matter of 
controversy (Lutescu et al. 2007; Sohrabji 2005; Viña et al. 2013). In the current study, 
reproductive senescence was confirmed by determination of acyclicity, using the protocol from 
Byers and colleagues (Byers et al. 2012). To determine progesterone and oestrogen (estradiol) 
levels, plasma samples from young and aged female mice in dioestrous were assessed by 
ELISA. Ratio between progesterone and estradiol (P/E2) did not change between young and 
aged female mice. However, these results are not consistent with previous studies that showed 
young P/E2 ratios to be closer to 50/1 – 300/1 and also described an age-related increase in the 
ratio itself (Nelson et al. 1981). These striking differences may be due to the use of 
immunoassay-based techniques as ELISA. Indeed, even though ELISA assays have been 
suitable for hormone level measurements in plasma (Elder et al. 1987; Relave et al. 2007), 
several studies have reported their questionable specificity, especially at lower concentrations 
(Haisenleder et al. 2011; Huhtaniemi et al. 2012). Ideally, gas chromatography-tandem mass 
spectrometry techniques would be a fitting option to measure hormone levels in plasma, as they 
have been reported to show high specificity even for low postmenopausal hormone 
concentrations (Lee et al. 2006; Nilsson et al. 2015), however, they required higher specimen 
volume and cost.  
Structural 2D analysis was performed only in cortical capillaries as a preliminary study 
in order to confirm previously described age-induced alterations in the male BBB 
ultrastructure. Additionally, structural 3D analysis was performed in capillaries from cortex 
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and hippocampus, since both regions have been reported to be altered in brain ageing and age-
related BBB dysfunction in both humans and rodents (Montagne et al. 2015; Pelegrí et al. 2007; 
Viggars et al. 2011). Interestingly, despite some features being similarly changed when 
assessed either by 2D or 3D technique (e.g. BM thickness or area/volume of pericytic 
mitochondria), some other structural characteristics did not correlate when investigated by the 
two approaches and appeared to highlight technical differences (e.g. BEC mitochondrial 
number and area/volume, pericyte – BEC coverage or astrocyte – BM coverage). The main 
differences between the two studies are the addition of cellular and subcellular interactions in 
space and the higher in-depth analysis achieved by the 3D reconstruction, which become useful 
when analysing complex and interrelated structures in brain microvessels (Mathiisen et al. 
2010). The lack of depth in the 2D analysis might hinder the assessment of certain features as 
it happened in the current study with BEC pseudopods or TJ tortuosity and complexity. 
Similarly, the three-dimensional reconstruction could facilitate the identification of alterations 
that did not show changes in the 2D analysis, such as pericyte coverage or the observation of 
pericytic mitochondria occasionally forming tubular networks. However, the experimental 
number might also contribute to these differences. Although the 3D analysis shows a higher 
resolution, it is limited by the processing and its time-consuming protocol. Therefore, future 
analyses should attempt to increase the number of vessels reconstructed, in order to enhance 
the power of the experiment and determine whether the non-altered features observed are truly 
unchanged. Nonetheless, a combination of both, 2D and 3D studies, might be a much better 
strategy in those cases in which the experimental number is limiting the experimental design.  
One of the most obvious alterations observed in the 2D analysis of cortical capillaries 
and the 3D analysis of both cortical and in hippocampal capillaries, was the increased BM 
thickness with ageing. In agreement with previous studies, BM thickness in aged microvessels 
in both cortex and hippocampus was double that of young animals (Ceafalan et al. 2019). The 
BM is an essential element of the BBB, enclosing pericytes and interacting via adhesion 
molecules with the astrocytic end-feet (Correale and Villa 2009). It has already been reported 
that cerebrovascular BM undergoes a series of molecular and morphological alterations during 
normal ageing and in neurodegenerative diseases in humans and rodents, with no particular 
changes due to sex (Alba et al. 2004; Farkas et al. 2000, 2006; A. W. J. Morris et al. 2014). 
Increased thickness and stiffness of the BM has been reported to happen in humans and rodents 
and is linked to changes in the proportion of extracellular matrix proteins, such as collagen IV 
and laminins (Candiello et al. 2010; Ceafalan et al. 2019; Uspenskaia et al. 2004). Apart from 
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the potential effect on blood flow, higher thickness and stiffness appear to be related to the 
accumulation of unwanted proteins in the brain, hindering clearance mechanisms in the mouse 
cerebral vasculature (Hawkes et al. 2011). Indeed, interaction of BM components with proteins 
such as amyloid-β (Aβ) have been reported to contribute to cerebrovascular pathology leading 
to AD in humans (Shimizu et al. 2009). Therefore, age-induce alterations in BM consequently 
lead and contribute to neurodegeneration, not only in AD but also in PD, where they are more 
enhanced than in normal ageing (Farkas et al. 2000). 
Mitochondrial changes and impairment have been described in the aged BBB in several 
studies and different species (e.g. mouse, monkey, human), mainly associated with oxidative 
stress and pro-inflammatory processes in the cerebral cortex (Burns et al. 1979; Enciu et al. 
2013; Sure et al. 2018). Indeed, ageing has been linked to endothelial cell dysfunction via 
production of ROS which also leads to a reduced mitochondrial number (Brandes et al. 2005). 
Mitochondrial morphology depends on the balance of fusion and fission mechanisms, which 
contribute to modulate respiratory function, mitochondrial DNA integrity or cell death (Aerts 
et al. 2008; Leadsham and Gourlay 2010). In addition, some studies have reported age-induced 
effects on fusion/fission dynamics, which might contribute to changes in morphology and 
accumulation of damage in the aged mitochondria (Jendrach et al. 2005; Scheckhuber et al. 
2011). In the current study, mitochondrial morphology has been assessed in BECs and 
pericytes, and was confirmed to change in ageing, although with some controversy between 
the techniques used. Age-related loss of BEC mitochondria has been supported by several 
studies that described a decrease in mitochondrial number and volume in BECs of aged male 
mice, primates and ageing human endothelial cells in vitro (Burns et al. 1979; Hicks et al. 1983; 
Jendrach et al. 2005). These findings are in agreement with changes observed in cortical 
capillaries in our 2D analysis, but not with the results from 3D analysis in both cortex and 
hippocampus, which showed no significant differences in number or volume. By contrast, 
pericytic mitochondrial area and number were significantly increased in our 2D in aged cortical 
capillaries, although only volume, and not number, was significantly higher in both aged 
cortical and hippocampal capillaries in the 3D analysis. One possible explanation for 
differences in pericyte mitochondrial number could be the observation that in aged capillaries, 
mitochondria occasionally tend to form tubular networks, a feature that would interfere in the 
counting in 2D analyses. Nevertheless, these results are consistent with very early studies that 
reported a significant increase in pericytic mitochondrial volume during healthy ageing in male 
mice (Hicks et al. 1983; Mooradian 1988), and also with more recent studies that showed 
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swollen mitochondria in pericytes of Notch3 mutant transgenic mice in the context of 
cerebrovascular pathology (Gu et al. 2012). In addition, changes in mitochondrial shape have 
also been linked to mitophagy (mitochondrial autophagy) in ageing (Sun et al. 2015). In the 
context of mitophagy, mitochondria might undergo numerous fission events that lead to 
senescence and cell death (Scheckhuber et al. 2011) or, on the contrary, show reduced fission 
activity and display network-like morphology with the potential to maintain cell viability and 
postpone mitochondrial dysfunction and ageing (Gomes, Benedetto, and Scorrano 2011). Our 
results suggest that BEC and pericyte mitochondria are differently affected by senescence. 
Mitochondria are highly related to cell physiology, a statement that is even more important 
when considering the higher metabolic demand of the BBB (Haddad-Tóvolli et al. 2017). 
Modifications in mitochondrial morphology and function might highlight the higher sensitivity 
of the BBB to oxidant stressors, which together with decreased expression of antioxidant 
proteins and increased presence of ROS in ageing, promote cerebrovasculature damage 
(Grammas, Martinez, and Miller 2011). However, our observation of the formation of tubular 
networks of mitochondria in aged pericytes suggests that differential alterations in 
mitochondrial shape between BEC and pericytes mitochondria might be understood as 
pericytes being more resistant to age-induced damage than BECs in the female BBB. 
Interestingly, sex-specific differences have been reported in mitochondrial fission/fusion 
balance of cultured mouse cortical astrocytes, with female astrocytes having a higher level of 
fusion and therefore increased cell viability, an effect described to be mainly mediated by 
oestrogen (Arnold et al. 2008). Although astrocytic mitochondria were not measured in the 
present study, these findings suggest that a similar beneficial effect might happen in 
mitochondria of female BECs and pericytes and, when reproductive senescence strikes and sex 
steroid hormones decrease, the mitochondrial component may promote cell viability in 
pericytes but not in BECs.  
BECs undergo further ultrastructural changes during ageing, especially on their surface. 
In the present study, BEC luminal surface projections or pseudopods, were observed to vary in 
size and number. Due to the limited view of the 2D analysis, this measurement was only 
performed in the 3D reconstructed vessels. Accordingly, pseudopods were observed in both 
cortex and hippocampus of young and aged female mice, but number and size of these 
projections were only significantly increased in aged cortical capillaries compared to young 
cortical capillaries. In addition, aged pseudopods were significantly higher in number and 
volume in cortex compared to hippocampus. The presence of pseudopods in the ageing cerebral 
2. Ultrastructural alterations in the ageing female blood-brain barrier 
 
68 
 
microvasculature is consistent with early reports of large luminal projections on the BEC 
surface described in senescence accelerated mice, however, the same study reported them in 
hippocampal vessels (E. Y. Lee et al. 2000), which is not consistent with the lack of significant 
hippocampal differences in our studies. Interestingly, pseudopod-like microstructures have 
been described in BECs under inflammatory conditions in injured mouse BBB during 
encephalomyelitis (Lossinsky et al. 1991), and in cultured human microvessel endothelial cells 
when stimulated with chemokines (CXCL10, CCL5) (Whittall et al. 2013). Also, recent studies 
in human endothelial cells in vitro, stimulated with TNF-α and interferon-y (INF-γ),  have 
shown surface structures that can be compared to the pseudopods observed in the present study, 
and also express and present adhesion molecules and chemokines (Øynebråten et al. 2015). 
Together, these findings suggest an increase in BEC surface in the ageing female BBB in 
cortex, but not in hippocampus, forming pseudopod-like structures that might mediate 
interaction with immune cells under pro-inflammatory conditions. In fact, a higher pro-
inflammatory state in the female BBB might be supported by previous studies on differential 
expression patterns in the human ageing brain that showed sex dimorphic differences, with the 
aged female brain being more immune activated than the aged male brain (Berchtold et al. 
2008).  
Intercorrelation between the different cellular components of the BBB, BECs, pericytes 
and astrocytes, is essential for its function. BEC and pericyte interaction is enhanced in the so-
called peg-and-socket interdigitations, where gap and adherens junctions allow close 
interconnection and passage of nutrients, metabolites or ions between both cell types (F. Li et 
al. 2011; S. Liu et al. 2012; Winkler, Bell, and Zlokovic 2011). Pericytes play an important 
role in vessel stabilization, BEC proliferation and capillary blood flow modulation, as they tend 
to cover BEC abluminal surface and share the same BM (Banerjee and Bhat 2007; Hellström 
et al. 1999), which allows endothelial-pericyte crosstalk by activating factors such as PDGF or 
VEGF (Darland et al. 2003; Ribatti, Nico, and Crivellato 2011). In addition, several studies 
have shown that BEC – pericyte contact induces TJ protein expression and therefore promotes 
BBB formation, integrity and maintenance (Dohgu et al. 2005; Shimizu et al. 2008). 
Accordingly, pericyte loss or reduced coverage is associated with vessel instability, BBB 
disruption and increased permeability in rodents and humans (Armulik et al. 2010; García-
Quintans et al. 2016; Winkler et al. 2013). BECs and pericytes also interact with astrocytes, 
which mediates attachment of the astrocytic end-feet to the neurovascular unit, promoting a 
virtually complete ensheathment of the vessel (Armulik et al. 2010; Mathiisen et al. 2010).  
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Astrocytes have also been proved to promote BBB formation and maintenance in 
human and rodents by inducing expression of TJ proteins (claudin-5, ZO-1), redistribution of 
AJ protein PECAM-1 and polarized distribution of barrier transporters such as Pgp or GLUT1 
(Abbott et al. 2006; Al Ahmad et al. 2011; Obermeier et al. 2013). Additionally, some studies 
have shown how coverage of astrocytes over BECs promotes a tighter barrier in BBB in vitro 
models of porcine, human and rat cells (Alvarez et al. 2011; Malina, Cooper, and Teichberg 
2009). Ageing has been reported to promote loss of pericytic and astrocytic contacts with the 
vessel wall in male mice and rats, which consequently promotes BBB breakdown and 
neurovascular dysfunction (Duncombe et al. 2017; Hughes et al. 2006). In the current study, 
3D reconstructed aged cortical capillaries showed an increase of BEC – pericyte contact in 
comparison to young cortical capillaries. Also, no changes were observed in hippocampal 
capillaries of any age. Astrocyte coverage over the vessel wall was shown to be higher in aged 
cortical capillaries in the 2D analysis but did not change with ageing in any of the regions 
analysed in the 3D reconstruction. These results are not in agreement with previous reports that 
showed a decrease in pericyte coverage in aged male (Bell et al. 2010) or female mice (Soto et 
al. 2015), or with recent studies that proved no change at all in pericyte coverage at the ageing 
BBB of male mice (Goodall et al. 2018) and male rats (Bors et al. 2018). Although more 
experiments are needed to determine the factors that contribute to these discrepancies, they 
may relate to technical differences between the analyses carried out using 2D images in 
previous experiments and the current 3D analysis, in addition to some difficulties in measuring 
pericyte projections. Nonetheless, as pericyte try to maximize their coverage over the 
endothelium during development (Berthiaume et al. 2018), perhaps something similar is 
happening during ageing, depending on the brain region. Together with the findings described 
above by Gomes et al. (2011) regarding a potential beneficial role of age-mediated changes in 
pericytic mitochondrial shape, these observations might suggest a compensatory mechanism in 
pericytes. Similarly, despite previous studies reporting a decreased astrocytic coverage over 
brain microvessels in male mice (Duncombe et al. 2017), our results suggest that either increase 
or no change in astrocytic coverage happens in the female BBB in cortex or hippocampus. 
Interestingly, astrocytic number has been reported to be higher in aged female mice compared 
to young female mice and aged male mice (Mouton et al. 2002), suggesting potential sex 
differences in both baseline astrocyte density and their response to age and changes in sex 
hormone concentrations. Indeed, sex-dependent increase in astrocyte number, and 
abovementioned astrocyte viability due to higher levels of mitochondrial fusion (Arnold et al. 
2008), might attenuate the ageing effect on astrocytic end-feet coverage in the female BBB. 
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Age-induced alterations in TJ have been previously described as a key event in 
cerebrovascular ageing and associated BBB dysfunction in male rodents (Goodall et al. 2018; 
Mooradian et al. 2003). In the present study, we aimed to assess TJ morphology by measuring 
both tortuosity and complexity (understood as length). TJ tortuosity was significantly higher in 
cortical capillaries of aged female mice compared to young cortical capillaries and aged 
hippocampal capillaries. By contrast, TJ complexity did not show any difference due to age in 
cortex or hippocampus, whereas regional comparisons showed that aged cortical capillaries 
had a lower TJ complexity compared to aged hippocampal capillaries. However, although 
significant, the interregional change in TJ complexity was very small and probably has little 
biological meaning. Nonetheless, reduced TJ tortuosity and complexity (length) have been 
linked to BBB disruption in granulin mutant male mice after ischemic stroke (Jackman et al. 
2013), which is not consistent with our observations in the female BBB in both cortex and 
hippocampus if considering the age-related BBB disruption. Also, changes in TJ morphology 
in blood vessels of human glioblastoma have been correlated with abnormal TJ expression and 
distribution (Liebner, Fischmann, et al. 2000). Therefore, if low TJ tortuosity means 
detrimental BBB function, the extent to which a higher TJ tortuosity is related to female BBB 
function according to our data is unclear. In relation, studies in middle-aged ovariectomised 
female rats have shown selective age-mediated loss of TJ proteins depending on the brain 
region, which leads to altered paracellular permeability in hippocampus (Bake et al. 2009; Bake 
and Sohrabji 2004), but not in cortex (Sandoval and Witt 2011), in the absence of pathology, 
and also in stroke. In the three studies, oestrogen activated form, estradiol, appeared to play a 
role in the regulation of BBB permeability. Altogether, these observations suggest that both 
tight junction arrangement and morphology are differentially regulated between brain regions, 
which may be related to loss of sex steroid hormones during reproductive senescence. Thus, 
further studies involving immunostaining and expression levels of specific TJ proteins would 
help to understand what is happening at the molecular level of these structures and if their 
morphological arrangement has a deeper effect on the female BBB function in ageing.  
In summary, the results obtained from the ultrastructural analysis, together with 
findings described in literature, suggest that the ageing female BBB shows certain differences 
respect to the male BBB when compared to young female BBB, particularly regarding potential 
beneficial regulation of mitochondrial fusion/fission, a more enhanced pro-inflammatory state, 
age-mediated increase in pericyte coverage, unchanged astrocyte coverage and more tortuous 
TJs. However, sex-specific changes at the ageing BBB and how these may affect 
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cerebrovascular function still need further attention and research. In addition to sex differences, 
the present study showed that cortical brain capillaries present more changes by age than those 
in hippocampus. These interregional differences observed in our analysis are not consistent 
with previous studies that have reported the hippocampus to be equally sensitive to ageing and 
BBB dysfunction (E. Y. Lee et al. 2000; Lourenço et al. 2018; Topple et al. 1991), however, a 
recent study in aged male mice has shown cortical blood vessels to be more strongly affected 
by cholinergic denervation than those in hippocampus (Nizari et al. 2019), which might have 
important consequences in age-related vasculopathies including BBB disruption. Based on 
these results, posterior molecular and sequencing analyses were focused on cortical capillaries. 
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Chapter 3. Massive Analysis of cDNA Ends sequencing (MACE-Seq) of 
cortical microvessels isolated from young and aged female mice. 
3.1 Introduction 
Transcriptomics are used to understand molecular processes that underline cell 
function, including modifications at DNA and RNA levels. Most recent approaches are next 
generation sequencing (NGS), parallel sequencing methods that allow for effective assessment 
of a large set of genomic targets and at the same time provide high accuracy and sensitivity 
mainly due to a high sequencing coverage (Gagan and Van Allen 2015; Sahm et al. 2016). In 
the last few years there has been an increasing development of NGS protocols and platforms, 
including tools for RNA analysis at massive scale via sequencing of cDNA (RNA-Seq). The 
advantages of these new techniques involve detection of unannotated exons, measurement of 
general and exon-specific expression levels and improved detection of alternative splicing 
(Ozsolak and Milos 2011; Pickrell et al. 2010). Among the emerging NGS techniques, new 
methods have been developed including Massive Analysis of cDNA Ends (MACE-Seq), which 
is based on the technique of gene expression profiling by massive parallel sequencing 
introduced by Torres and colleagues (Torres et al. 2008), and has recently been patented by 
GenXPro GmbH © (Frankfurt, Germany). MACE-Seq uses a 3’-end targeted, tag-based 
transcriptome profiling method that produces a reliable, unbiased and accurate quantification 
of polyadenylated transcripts (1 transcript – 1 molecule), at a lower sequencing depth than that 
of standard RNA-Seq. MACE- Seq does not need to perform rRNA depletion, which allows 
the use of small amounts of starting material. It analyses gene expression based on high-
throughput sequencing and generates a single sequence from the 3’-end of each polyadenylated 
transcript (Zhernakov et al. 2019a). Each cDNA molecule is represented by one cDNA 
fragment (tag or read) of 94 bp of size. The reads are originated from a region of 100-500 bp 
from the 3’ (poly-A) end of the transcript. The posterior throughput sequencing of reads has 
advantages over microarray and other types of RNA-Seq in that it provides high resolution 
gene expression analysis of differentially expressed low-abundant transcripts. In addition, a 
key feature of MACE-Seq is the application of the TrueQuant (unique molecular identifiers) 
method for the elimination of PCR copies which ensures correct quantification of the low-
complexity sequences (Zajac et al. 2015; Zawada et al. 2014). In contrast, sequencing of 
smaller RNA molecules (e.g. miRNA) cannot be performed using regular RNA-seq library 
preparation techniques nor following MACE-Seq protocol, due to their relatively small size. 
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Therefore, in this study Small RNA analysis was used to characterize non-coding small RNAs, 
focusing in miRNAs. Small RNA-seq library preparation is usually performed by ligation of 
adapters to the RNA molecules followed by reverse transcription and PCR amplification. 
Similarly to MACE-Seq, TrueQuant method was used for elimination of PCR copies and 
ensuring correct quantification (Müller et al. 2015). The most recent kits for library preparation 
avoid generation of adapter-adapter products and allow the use of even smaller amounts of 
starting material (Lipps et al. 2019). 
Ageing promotes accumulation of molecular modifications that affect several tissues 
including the brain (Lee, Weindruch, and Prolla 2000). In females, the ageing process is highly 
influenced by the effect of steroid sex hormones, which are important for brain function 
(Moraga-Amaro et al. 2018) and gene expression modulation (Rinn and Snyder 2005). 
Progesterone and oestrogen have several roles in neuroprotection (Berent-Spillson et al. 2015; 
Gibson, Coomber, and Murphy 2011; Jiang et al. 2016). Similarly, oestrogen has been linked 
to cerebrovascular protection by promoting mitochondrial efficiency and reducing oxidative 
stress (Stirone et al. 2005). Also, oestrogen has been reported to reduce expression of 
proinflammatory cytokines, adhesion molecule expression and leukocyte transmigration in the 
brain vasculature  (Corcoran et al. 2010; Maggioli et al. 2016). In addition, progesterone and 
oestrogen appear to modulate circulating antioxidant enzymes (Bellanti et al. 2013). Therefore, 
changes in sex hormone levels that happen during and after menopause might have an effect in 
some brain functions in aged women and female rodents. Indeed, oestrogen decline leads to 
loss of BBB integrity in animal models (Wilson et al. 2008). Moreover, reduced circulating 
oestrogen levels appear to have a negative effect on amyloid-β clearance (Li et al. 2000). 
Several miRNAs are also differentially expressed in the ageing mouse brain in comparison to 
young mice (Goodall et al. 2019; Inukai et al. 2012; N. Li et al. 2011). Indeed, miRNAs have 
been suggested as useful ageing biomarkers and they also contribute to the modulation of 
several processes including neuroinflammation, response to DNA damage or cellular 
senescence (Lal et al. 2009; X. Li et al. 2011; Olivieri, Lazzarini, et al. 2013). Furthermore, 
miRNA role in cerebrovascular dysfunction has also been highlighted. In fact, previous studies 
have reported miRNA contributing to regulation of TJ protein expression as well as BEC 
survival, thus affecting BBB permeability and integrity (Fang et al. 2016). Similarly, previous 
studies have shown how miRNAs such as miR-155 promote increased leukocyte adhesion on 
brain endothelium during neuroinflammation (Cerutti et al. 2016). Conversely, other miRNAs 
such as miR-125a promote decreased expression of adhesion molecules and leukocyte adhesion 
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on brain endothelium (Reijerkerk et al. 2013). Thus, the balance of miRNA expression is also 
essential for both brain and BBB function. All these observations suggest that age-induced 
molecular alterations in the female brain might be related to hormonal changes and may 
contribute to impaired stress response, neuroinflammation and BBB dysfunction, by 
modulating changes in both mRNA and miRNA expression. 
The aim of this chapter was to perform MACE-Seq and Small RNA analysis (GenXPro 
GmbH ©, Frankfurt, Germany) on RNA samples of brain microvessels from young and aged 
C57BL/6J female mice, in order to assess age-related changes in gene and miRNA expression 
at the female BBB. Potential molecular changes at gene expression could explain functional 
and structural changes observed at the ageing BBB. After sequencing analyses were performed, 
miRNA target prediction tools were used in order to select an age-deregulated pair of 
miRNA/target mRNA for further analysis regarding their putative role in cell function and 
BBB properties.  
 
3.2 Material and Methods 
3.2.1 Animals 
All animal work and welfare were performed as described in Chapter 2 of this thesis. 
3.2.2 Microvessel Isolation protocol 
3.2.2.1 Brain collection and processing of the cortex 
For this protocol, young and aged C57BL/6J female mice were perfused intracardially 
using 0.5% bovine serum albumin (BSA) solution (BSA fraction V, 25%  (#05482, Sigma-
Aldrich, Dorset, UK), HEPES, 10 mM (#H0887, Sigma-Aldrich, Dorset, UK), antibiotics 
Penicillin/Streptomycin, 100 U/ml (#15140-122, ThermoFisher Scientific, Loughborough, 
UK)) in DMEM (#21063045, ThermoFisher Scientific, Loughborough, UK). After perfusion, 
brains were carefully extracted and stored in ice-cold 0.5% BSA solution until the left and right 
cortices were dissected. Cortices were then rolled on a dry filter paper to remove the meninges. 
Dissected cortices of 5 mice were pooled together in a same tube for each sample in each age 
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group (n=3 pooled samples/group). An initial trituration was performed using a sterile scalpel 
to secure an efficient digestion in the following steps.  
3.2.2.2 BEC isolation protocol testing – Magnetic bead isolation 
To determine the isolation method that yielded the purest and more concentrated 
fraction of BECs for transcriptomic analysis, 7 different protocols were tested (n=1 mouse 
brain per protocol). These initial protocols used a combination of double enzymatic digestion, 
filtration with different mesh sizes and use of puromycin or magnetic beads to increase the 
presence of BECs in the suspension. Only the magnetic bead-mediated isolation protocol was 
replicated 3 times. For single BECs isolation by magnetic beads, source tissue was digested by 
a solution of collagenase/dispase (collagenase/dispase (#10269638001, Sigma-Aldrich, 
Dorset, UK), 1mg/ml, DNAse I (#DN25, Sigma-Aldrich, Dorset, UK), 10 mg/ml; N-Tosyl-L-
lysine chloromethyl ketone (TLCK), 147 µg/ml (#T7254, Sigma-Aldrich, Dorset, UK)) in 
DMEM for 1h at 37 oC with occasional vigorous shaking. Glass Pasteur pipettes were used to 
homogenize the suspension until reaching a creamy texture. The suspension was then 
centrifuged at 700g for 5 min, supernatant was removed, and the pellet was resuspended in 20 
ml of 25% BSA solution in DMEM. Centrifugation (1000g, 20min) was performed to create a 
BSA gradient that dragged microvessel fragments to the bottom of the tube, whereas the rest 
of contaminants and debris formed a plug-in at the top. The plug-in and BSA were transferred 
to another tube, microvessel fragments retained at the bottom were resuspended in 0.5% BSA 
solution and this procedure was repeated three times. A second enzymatic digestion was 
performed using porcine trypsin-EDTA 0.25% (w/v) (#11570626, ThermoFisher Scientific, 
Loughborough, UK) at 37oC for 5 min, and suspension was then filtered (40 µm cell strainer 
(#10737821, ThermoFisher Scientific, Loughborough, UK)). Finally, positive separation was 
performed using anti-CD31 coated magnetic beads and columns from Miltenyi Technologies 
(#130-097-418 and #130-042-201, Miltenyi Technologies, Bergisch Gladbach, Germany). 
CD31-positive cells were retained in the column, then flashed out and collected into fresh 
RNAse-free tubes. Three experimental replicates were performed, samples from 5 animals per 
age group were pooled together in each independent repeat (n=3/age group), centrifuged at 
300g for 10 min and then resuspended in lysis buffer for RNA extraction and stored at -80oC. 
Relative expression values were calculated as the expression in the isolated fraction referred to 
the whole cortex as control. 
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3.2.2.3 Microvessel fragments isolation protocol  
The protocol to isolate microvessel fragments was a variation of the one described 
above for BEC isolation with magnetic beads. Following the initial trituration, the suspension 
was incubated in the same enzymatic collagenase/dispase solution for 1h at 37 oC, with 
occasional vigorous shaking. Glass Pasteur pipettes were used to homogenize the suspension, 
which was then centrifuged at 700g for 5min, supernatant was removed, and the pellet was 
resuspended in 20 ml of 25% BSA solution in DMEM. Microvessel fragments were retained 
at the bottom of the tube, following the same BSA gradient as the one mentioned above for the 
magnetic bead protocol. Suspension was secondly digested using trypsin-EDTA 0.25% at 37oC 
for 3 min. Finally, filtration using cell strainers of 40 µm was performed. Three independent 
experimental repeats were performed, and all microvessel fragments from 5 mice per age group 
were pooled together in each repeat (n=3/age group). Microvessels were then centrifuged at 
300g for 10 min, resuspended in lysis buffer for RNA extraction and stored at -80oC. Again, 
relative expression values were calculated as the expression in the isolated fraction referred to 
the whole cortex as control. The RNA extracted from these samples was used for both MACE-
Seq and relative expression analyses. 
3.2.3 RNA isolation 
For the testing, total RNA from BECs and microvessel fragments was extracted using 
a commercial kit, RNeasy Plus Mini (50) (#74134, Qiagen, Manchester, UK) according to 
manufacturer’s instructions. For the samples used in the RNA-Seq, total RNA was extracted 
using miRCURY RNA isolation kit (#300112, Exiqon, Vedbaek, Denmark) following the 
protocol provided by the manufacturer. In every case, final RNA samples were stored in the 
freezer at -80 oC until further analysis. 
3.2.4  RNA- sequencing: Massive Analysis of cDNA Ends (MACE-Seq)  
3.2.4.1 Generation of MACE-Seq libraries and RNA sequencing 
A quantitative genome-wide expression profiling was performed with RNA extracted 
from microvessel fragments of 6 and 24-month-old female mice. This analysis was performed 
in collaboration with Ricardo Figueiredo and Peter Winter from GenXPro GmbH. MACE-Seq 
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technique follows a modified protocol described in Nold-Petry et al. (Nold-Petry et al. 2015) 
and was performed at GenXPro GmbH. Samples of 100 ng of DNase-treated RNA were used 
for library preparation. A total of 27 MACE-Seq libraries were generated using the MACE-
Seq kit v2.0 (GenXPro GmbH, Frankfurt-Am-Main, Germany) according to the supplier’s 
protocol by the researchers ‘blinded’ to the identity of the samples. Reverse transcription was 
performed to synthesise cDNA molecules using oligo primers, which were fragmented to an 
average size of 200 bp by sonication using a bioruptor (Diagenode, Seraing, Belgium). Total 
DNA was quantified using Qubit HS dsDNA assay (#Q33230, ThermoFisher Scientific, 
Loughborough, UK). Afterwards, cDNA fragments were ligated to DNA adapters containing 
TrueQuant unique molecular identifiers included in the MACE-Seq kit v2.0. For library 
amplification, PCR was used following purification by solid phase reversible immobilization 
beads Agencourt AMPure XP (#A63881, Beckman Coulter, Brea, CA, USA). Lastly, 
sequencing was performed using a NextSeq Illumina platform (Illumina Inc., San Diego, CA, 
USA). For transcript quantification and abundance comparison between samples, sequencing 
reads were normalized to the mean of each replicate.  
3.2.4.2 Bioinformatic analysis 
Around 6 million MACE-Seq reads were obtained from all the libraries. PCR-
duplicates were removed from raw data after identifying them using the aforementioned 
TrueQuant identifiers. After eliminating the PCR duplicates, the remaining reads were poly(A)-
trimmed and the low-quality ones were also removed. After this treatment, the resultant reads 
were aligned to the mouse reference genome (Mus musculus, GRCm38. p2, Ensembl release 
74, December 2013) using bowtie2 mapping tool. As a result, a dataset with a total of 28552 
identified genes was obtained. The gene count data was normalized to account for differences 
in sequencing depth. Differential gene expression was assessed using the statistical 
programming software R (www.rproject.org). DeSeq2 R/Bioconductor package was used to 
estimate fold change and calculate p-values, as described previously (Love, Huber, and Anders 
2014). This resulted in a p-value and log2-fold change (log2FC) for every gene sequenced. 
False discovery rate (FDR) analysis was estimated to account for multiple testing. Genes with 
a p-value lower than 0.05 and a log2FC equal to or higher than [1] were considered 
differentially expressed. These differentially expressed genes were later categorized into 
upregulated or downregulated genes. Up- and downregulated genes were further assigned to 
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biological pathways to analyse age-mediated alterations by gene set enrichment analysis using 
DAVID Bioinformatics. 
3.2.4.3 Quantification of microRNA expression 
Ultra-deep miRNA sequencing was performed from pooled small RNA from young and 
aged mice, to assess whether changes in gene expression could be related to deregulation of 
miRNA expression in ageing. Total RNA, including small RNA, was extracted using 
miRCURY RNA isolation kit from Exiqon as mentioned above. The following protocol was 
performed at GenXPro GmbH in collaboration with Ricardo Figueiredo and Peter Winter. 
Small RNA libraries were prepared using TrueQuant technology for elimination of PCR bias. 
Briefly, 3’ and 5’ adapters were ligated onto small RNA (<200 nucleotides) using T4 RNA 
Ligase 2 and T4 RNA Ligase 1 (#M0239S and #M0204S, New England Biolabs, Frankfurt-
Am-Main, Germany) respectively. Reverse transcription of adapter-ligated RNA was 
performed with SuperScript III reverse transcriptase (#18080044, ThermoFisher Scientific, 
Loughborough, UK) and amplified by PCR with KAPA HiFi Hot-Start Polymerase (#KK2602, 
KAPA Biosystems, Roche; Darmstadt, Germany). Afterwards, amplified libraries were 
sequenced using Illumina sequencing platform (Illumina Inc., San Diego, CA, USA). Analysis 
of Small RNA-seq data was performed using omiRas mapped to the mouse genome by Bowtie2 
tool. Differentially expressed mature miRNAs between young and aged samples showed a p-
value lower than 0.05 and a log2FC equal to or higher than [1]. 
3.2.4.4 MiRNA target prediction analysis 
Targets for the significantly deregulated miRNAs were selected from the list of 
deregulated genes sequenced in the MACE-Seq analysis. Two target prediction tools were used 
in combination, TargetScan7.2 and miRWalk2.0, to narrow down the list of genes based on 
their identification as miRNA targets in at least 6 out of 11 databases. The list of targets was 
reduced by excluding target genes where the pattern of expression (e.g. increased or decreased) 
was the same between the mRNA and predicted miRNA regulators.  
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3.2.5 Reverse transcription – Quantitative PCR 
Reverse Transcription-Quantitative PCR (RT-qPCR) analysis was performed as a way 
of measuring the purity of the isolated fractions as well as to validate the age-related changes 
in expression observed in the MACE-Seq results. Distinct cell markers were used for the 
preliminary purity assessment, including PECAM-1 (or CD-31) for BECs (Mus musculus, 
F:5’-GGACGATGCGATGGTGTATAA-3’; R: 5’-GCATCACTGTGCATTTGTACTT-3’) , 
glial fibrillary acidic protein (GFAP) for astrocytes (Mus musculus, F:5’-
CAGAGGAGTGGTATCGGTCTAA-3’; R: 5’-GATAGTCGTTAGCTTCGTGCTT-3’), 
SMA-α for smooth muscle cells (Mus musculus, F:5’-TCAGGGAGTAATGGTTGGAATG-
3’; R: 5’-GGTGATGATGCCGTGTTCTA-3’), PDGFβ receptor (PDGFR-β) for pericytes 
(Mus musculus, F:5’-GACAGACATGATGGACAGTGAG-3’; R: 5’-
TGGCAGTTGAGGTGGTAATC-3’) and actin-β as a reference gene (Mus musculus, F:5’-
CTCCCTGGAGAAGAGCTATGA-3’; R: 5’-CCAAGAAGGAAGGCTGGAAA-3’). This 
technique was also used to validate the expression changes observed on the RNA-seq data for 
several genes, including Bambi (Mus musculus, F:5’-ACTCCAGCTACTTCTTCATC-3’; R: 
5’-TAGCATCTGATCTCTCCTTTG-3’), Ccl5 (Mus musculus, F:5’-
AGGAGTATTTCTACACCAGC-3’; R: 5’-CAGGGTCAGAATCAAGAAAC-3’), Mmp9 
(Mus musculus, F:5’-GTTTTCTTCTTCTCTGGACG-3’; R: 5’-
CTAGACCCAACTTATCCAGAC-3’), Tirap (Mus musculus, F:5’-
GTTATACACTATCTGGAGACAC-3’; R: 5’-GATCTGATCCTGTGTCATAAAC-3’), Tle1 
(Mus musculus, F:5’-GAAGGTGGATGATAAGGATAAC-3’; R: 5’-
CAGACGGTTTTTGTCAATTC-3’), Mapk7 (Mus musculus, F:5’-
AGATCTGTCTATGTGGTACTG-3’; R: 5’-CTGGTACAGGAAGTATCTCAC-3’) and 
Dnmt3a (Mus musculus, F:5’-TTACTTCTGGGGTAACCTTC-3’; R: 5’-
CTTTATAGAGTTTGACCTGGTG-3’). All primers used were pure and simple primers 
obtained from Sigma-Aldrich (#VC00026, Sigma-Aldrich, Dorset, UK). For mRNA, two 
commercial kits were used to perform RT-qPCR, High Capacity Reverse Transcription Kit 
(#4368814, ThermoFisher Scientific, Loughborough, UK), to obtain cDNA from the RNA 
samples, and QuantiTect SYBR Green PCR Kit (#204141, Qiagen, Manchester, UK) to 
perform the qPCR itself. For miRNAs, TaqMan Expression Advanced Assays miRNA cDNA 
synthesis kit, TaqMan Fast Advanced Master Mix plus specific probes (#A28007, #4444557 
and #A25576, ThermoFisher Scientific, Loughborough, UK) were used. All the protocols used 
in this section were provided by the manufacturer.  
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3.2.6 Relative expression and tags per million normalization 
For RT-qPCR analysis, expression of each marker relative to the control was calculated 
using the ΔC(t) method previously described (Tai et al. 2010). The samples from young mice 
were considered as control in this study. The reference gene used to measure relative expression 
of mRNA was actin-β and miRNA-24-3p was used as the reference for relative expression of 
miRNAs.  
Tags (or reads) per million (TPM) is a normalization method for sequencing results and 
it was used to represent normalized expression levels of selected genes and miRNAs from 
MACE-Seq and Small RNA analysis. This method is understood as the number of RNA 
molecules that come from a certain gene/transcript for every 1,000,000 RNA molecules in the 
sequencing sample.    
3.2.7 Immunofluorescence staining 
Frozen brains from young and aged mice (n=4/group) were sectioned by cryostat at 20 
µm thickness, collected onto slides and stored at -20 oC for further analysis. Sections were post-
fixated by incubation in acetone for 10 min on ice. Sections were washed with 0.01M PBS (3 
times, 5 min), then incubated with citrate buffer (0.01 M Sodium Citrate in 0.01% tween pH 
6) (Sigma-Aldrich, Dorset, UK) at ~90 oC (3 times, 5 min) in order to perform antigen retrieval. 
Afterwards, sections were blocked with 15% goat serum (ThermoFisher Scientific, 
Loughborough, UK) in 0.01M PBS for 15 min and then incubated overnight at 4 oC with anti-
DNMT3A (1:200, #MA5-16171, ThermoFisher Scientific, Loughborough, UK) in 0.01M PBS. 
The next day, sections were washed with 0.01M PBS (3 times, 5 min) and incubated with 
AlexaFluor488 anti-rabbit (1:200, #A32731, ThermoFisher Scientific, Loughborough, UK) in 
0.01M PBS for 2h at RT, protected from light. Slides were coverslipped using Mowiol ® 
(Sigma-Aldrich, Dorset, UK) containing 0.1% v/v Citifluor (Citifluor ltd, London, UK) as 
mounting media. Slides were left in the fridge to dry and sections were later imaged using 
confocal microscopy Leica confocal N1057 (Leica Microsystems Ltd, Milton Keynes, UK). 
To assess immunofluorescence staining of Dnmt3a in mouse brain tissue, 4 animals per age 
group were used (n=4/ age group), with 3 replicates each. 
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3.2.8 Statistical analysis 
In the case of MACE-Seq and pathway analysis, DeSeq2 R/Bioconductor and Fisher’s 
Exact Test were used respectively. For the rest of analyses, GraphPad Software (Prism 8.2.0, 
La Jolla, USA) was used. Shapiro-Wilk normality test and Q-Q plots were used to assess 
distribution of the data. Data from purity and cell marker expression experiments was analysed 
using one-way ANOVA and Dunnett’s correction test. Unpaired two-tailed Student’s t test was 
used to analyse qPCR validation and immunofluorescence analyses. Significance was set at 
p<0.05 and results are presented as mean ± SEM. The selection of appropriate statistical tests 
is indicated in each figure legend. 
 
3.3 Results 
3.3.1 Microbead-mediated isolation generates high purity of brain endothelial cells but low 
RNA yield 
To determine the isolation method that generated the best BEC purity and yield, 
different isolation methods including density centrifugation, addition of puromycin and 
immunopanning with magnetic beads were tested on mouse cortices (data not shown). Among 
these, tissue processing using anti-CD31-coated microbeads yielded fractions that were 
significantly enriched in BECs. Other BBB markers were also present in the fraction but no 
significant differences where observed in comparison to the whole cortex (Figure 23).  
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Figure 23. Relative expression of blood-brain barrier cell markers in isolated BEC fractions compared to 
the whole cortex as control.  
The markers used were PECAM-1 (or CD-31; for BECs), GFAP (for astrocytes), SMA-α (for smooth muscle 
cells), PDGFR-β (for pericytes) and actin-β as the inner control gene. According to these results, the samples were 
significantly enriched in BECs, however, other BBB cell types were still present. (n=3, One-Way ANOVA and 
Dunnett’s correction test; ****, p<0.0001; ns, not significant). 
However, the yield of total RNA obtained from BEC-enriched fractions was quite low 
in both young and aged mice (0.15µg ± 0.04 for young; 0.15µg ± 0.03 for aged, per pooled 
cortices), and therefore unlikely to be sufficient for posterior sequencing analysis. Thus, to 
determine whether RNA yield could be improved, microvessel fragments were isolated from 
dissected cortices instead of single BECs. As shown in Figure 24, endothelial purity was lower 
than that obtained when using microbeads. Also, in addition to PECAM-1-positive BECs, 
smooth muscle cells and pericytes were also significantly increased in the microvessel fraction. 
GFAP-positive astrocytes were also present but not significantly different from cortical levels.  
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Figure 24. Relative expression of blood-brain barrier cell markers in isolated microvessel fragment 
fractions compared to the whole cortex as control.  
The markers used were PECAM-1 (or CD-31; for BECs), GFAP (for astrocytes), SMA-α (for smooth muscle 
cells), PDGFR-β (for pericytes) and actin-β as the inner control gene. According to these results, the samples were 
significantly enriched in BECs, smooth muscle cells and PDGFR-β when compared to expression levels of their 
markers in the whole cortex. GFAP mRNA expression levels were found to be not significantly different between 
the cortex and the isolated microvessel fragments. (n=3, One-Way ANOVA and Dunnett’s correction test; ****, 
p<0.0001; ns, not significant). 
Total RNA was extracted from microvessel fragments as explained before but using in 
this case miRCURY RNA isolation kit from Exiqon. The yield of total RNA obtained was 
improved compared to single BEC isolation (1.8µg ± 0.08 for young; 1.81µg ± 0.01 for aged, 
per pooled cortices). This protocol ensures the amount of RNA required to perform posterior 
sequencing analysis even though BBB marker analysis suggests that there is presence of other 
cells from the BBB in the microvessel fragment fractions. Therefore, this was the protocol 
selected to collect the samples from young and aged female mice for MACE-Seq analysis.  
To determine whether the abundance of different BBB cell types within the microvessel 
fraction changed with age, microvessel fractions from young and aged mice were analysed by 
RT-qPCR and levels of BBB marker expression in aged mice relative to young animals were 
calculated. No differences were noted in the relative levels of endothelial cell and astrocyte 
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markers between young and aged microvessel fractions. However, RNA levels of smooth 
muscle cells and pericytes were significantly lower in the aged samples (Figure 25). 
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Figure 25. Relative expression of BBB cell markers in isolated aged microvessel fragments compared to 
young microvessels as control.  
Differences in sample purity of aged versus young microvessel fragments were assessed by calculating relative 
expression of different BBB cell markers. The markers used were PECAM-1 (or CD-31; for BECs), GFAP (for 
astrocytes), SMA-α (for smooth muscle cells), PDGFR-β and Actin-β as the control gene. Young microvessel 
fragments were used as control, thereby changes in fold-change represent how gene expression changes in aged 
microvessels respect to young microvessels. According to these results, the samples are enriched in BECs 
although other BBB cell types are still present. Only the ratio of smooth muscle cells and pericytes seems to be 
significantly decreased in aged animals (n=3, One-way ANOVA and Dunnett’s correction test; *, p<0.05; ns, not 
significant). 
 
3.3.2 Ageing promotes deregulation of inflammation, signalling and metabolic related 
pathways by promoting the differential expression of messenger RNAs and 
microRNAs in the female BBB 
RNA samples extracted from the cortical microvessel fractions of young and aged 
female mice were analysed using MACE-Seq and small RNA analysis. Over 300 mRNAs were 
found to be differentially expressed between young and aged microvessels samples in the 
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MACE-Seq analysis (Figure 26A). Of these, 211 genes were upregulated and 94 were 
downregulated in aged animals (Figure 26B). Pathway analysis was then performed on 
DAVID bioinformatics. A total of 10 most upregulated and 10 most downregulated pathways 
were selected and according to the GO terms obtained, the majority of upregulated genes were 
associated with immune system process, cytokine production, leukocyte migration and 
inflammatory response related pathways (Figure 26C). Significantly, downregulated genes 
were associated with pathways related to metabolic and signalling pathways including 
intracellular signal transduction and MAPK cascade. Interestingly, both deregulated gene 
groups also showed enrichment for genes related to common GO terms such as response to 
stress and regulation of vascular development. A list with all differentially expressed genes can 
be found in the appendix of this thesis (page 208, Table 5). 
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Figure 26. Upregulation (positive log2FC) and downregulation (negative log2FC) of mRNAs in aged female 
brain microvessel fragments compared to young female mice. 
MACE-Seq analysis performed in brain microvessel fragments of aged and young female mice showed more than 
300 differentially expressed genes (p-value<0.05; log2FC>[1]). A) Volcano plot distribution of deregulated 
mRNAs from young and aged microvessel fragments (upregulated: green; downregulated: red). B) Pie plot 
representing the number total of deregulated mRNAs (305), among them 211 were upregulated and 94 were 
downregulated. Top 10 upregulated and downregulated genes are presented in the table. C) Pathway analysis was 
performed on DAVID Bioinformatics and, according to GO terms obtained, upregulated genes were mostly 
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associated with immune system process, cytokine production, leukocyte transmigrations and inflammatory 
response. The majority of downregulated genes were associated with metabolism and signalling pathways (e.g. 
intracellular signal transduction and MAPK cascade). (n=3, Fisher Exact’s Test, p<0.001 to p<0.05). 
3.3.2.1 Age-mediated deregulation of microRNA expression in the female BBB 
Analysis for small RNAs was also performed on brain microvessel fragments from 
young and aged female mice, in order to assess alterations in miRNA expression. This analysis 
showed that 9 miRNAs were differentially expressed between young and aged mice, which 
included 4 upregulated and 5 downregulated miRNAs (Figure 27A-B). Target prediction tools 
(TargetScan 7.2, miRWalk 2.0) were used to identify potential predicted targets of these 9 
deregulated miRNAs among the list of differentially expressed mRNAs previously identified. 
Pathway analysis via DAVID Bioinformatics indicated that deregulated predicted targets were 
mostly involved in small GTPase signal transduction, cell death, angiogenesis, vascular 
development, cell migration or response to stress (Figure 27C). 
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Figure 27. Age-deregulated miRNAs and predicted targets in female brain microvessel fragments.  
Small RNA analysis performed in brain microvessel fragments of aged and young female mice showed 9 
differentially expressed miRNAs (p-value<0.05; log2FC>[1]). A) Volcano plot distribution of deregulated 
miRNAs from young and aged samples (upregulated: green; downregulated: red). B) Pie plot representing the 
total number of deregulated miRNAs (9), of which 4 were upregulated and 5 were downregulated. Both 
upregulated and downregulated miRNAs are presented in the table. C) TargetScan 7.2 and miRWalk 2.0 were 
used to identify predicted targets of these deregulated miRNAs. Pathway analysis was performed on DAVID 
Bioinformatics using predicted target mRNAs and the GO terms obtained showed that these deregulated targets 
were mostly associated with small GTPase signal transduction, cell death, angiogenesis, vascular development, 
cell migration and response to stress. (n=3, Fisher Exact’s Test, p<0.001 to p<0.05). 
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3.3.3   The effect of age-mediated deregulation on gene expression may vary depending on 
the analysis used 
To confirm the MACE-Seq results, age-related changes in gene expression were 
validated using qPCR with the same RNA samples from young and aged microvessel 
fragments. Genes were selected to be validated if they were found to be both significantly 
deregulated in the aged brain and associated with pathways involved in cerebrovascular 
function, according to literature. In total, 3 mRNAs that were upregulated in MACE-Seq 
(Bambi, Ccl5 and Mmp9) and 4 mRNAs that were significantly decreased (Tirap, Dnmt3a, 
Mapk7 and Tle7) were selected for validation (Figure 28A–B). Bambi did not show any 
differences in expression in aged microvessels compared to young mice. Ccl5 and Mmp9 
expression levels showed a non-significant trend towards upregulation in aged animals. In 
contrast, Tirap showed a trend towards downregulation in aged mice. On the other hand, Tle1, 
Dnmt3a and Mapk7 mRNA levels were significantly lower in aged microvessels compared to 
young animals. 
 
Figure 28. Validation of age-mediated mRNA deregulation by qPCR in brain microvessel fragments of 
aged and young female C57BL/6J mice.  
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A) A total of 7 mRNAs were assessed in order to validate the age-mediated deregulation in expression observed 
in the MACE-Seq analysis. B) Relative expression was measured by qPCR using actin-β as internal control. Out 
of 7 miRNAs tested, only 3 mRNAs (Tirap, Dnmt3a, Mapk7) showed a significant deregulation by qPCR, being 
downregulated in aged microvessel fragments compared to young mice. (n=3, Student’s t test; *, p<0.05; **, 
p<0.01; ***, p<0.001; ****, p<0.0001). 
Changes in expression of age-deregulated miRNAs were also validated by qPCR. Out 
of the original 9 miRNAs identified from the Small RNA analysis, only 7 were tested due to 
lack of commercial qPCR primers for miRNA-6243 and miRNA-5109. In total, 4 mRNAs that 
were upregulated in Small RNA analysis (miRNA-3084-5p, miRNA-3084-3p, miRNA-144-3p 
and miRNA-142-5p) and 3 mRNAs that were significantly decreased (miRNA-2137, miRNA-
6236 and miRNA-5115) were selected for validation (Figure 29A–B). MiR-5115, miR-6236 
and miR-2137 expression levels did not show significant differences in aged mouse 
microvessels compared to those of young mice. In contrast, miR-3084-5p, miR-3084-3p, miR-
144-3p and miR-142-5p levels were significantly higher in aged microvessels in comparison 
to young mice.  
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Figure 29. Validation of age-mediated microRNA deregulation by qPCR in brain microvessel fragments of 
aged and young female C57BL/6J mice.  
A) A total of 7 miRNAs were assessed in order to validate the age-related changes in expression obtained from 
Small RNA sequencing analysis. B) Relative expression was measured by qPCR using miR-24-3p as internal 
control. Out of 7 miRNAs tested, only 4 (miR-3084-5p, miR-3084-3p, miR-144-3p and miR-142-5p) showed a 
significant deregulation, being overexpressed in aged microvessel fragments compared to young animals. (n=3, 
Student’s t test; *, p<0.05; **, p<0.01).    
From the differentially expressed mRNAs and miRNAs, Dnmt3a and miR-144-3p were 
of great interest due to their described role in literature. Prediction tools used in this study, 
TargetScan 7.2 and miRWalk 2.0, showed that Dnmt3a is predicted to be targeted by miR-144-
3p in human and mouse, in both of which this relationship appears to be conserved (Figure 
30). 
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Figure 30. Sequence alignment of Dnmt3a/DNMT3A and miR-144-3p in mouse and human by TargetScan.  
A) Prediction of Dnmt3a as a biological target of miR-144-3p in mouse. B) DNMT3A is predicted to be a 
biological target of miR-144-3p in human. TargetScanMouse and TargetScanHuman were used to assess this 
prediction. 
Results in both mRNAs and miRNAs presented above showed a certain degree of 
variability between sequencing analyses and qPCR techniques. Nonetheless, significant 
differences in expression levels of miR-144-3p and Dnmt3a due to ageing were confirmed by 
qPCR and sequencing results (assessed by tags per million, TPM). According to these results, 
Dnmt3a RNA levels were significantly reduced in aged mice compared to young animals 
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(Figure 28). By contrast, miR-144-3p was significantly overexpressed in aged brain 
microvessels compared to young microvessels (Figure 29). Therefore, combining the target 
prediction analysis and validation by qPCR of deregulated miRNAs and mRNAs, miR-144-3p 
and its predicted target Dnmt3a were selected as an age-deregulated pair of interest. 
 
3.3.4 Confirming the age-induced deregulation of Dnmt3a protein levels in the female 
BBB by immunohistochemistry 
To determine whether changes in Dnmt3a gene expression were also related to protein 
levels, Dnmt3a protein expression was assessed by immunofluorescence of microvessels in 
brain sections from young and aged female C57BL/6J mice (Figure 31). Quantification of 
Dnmt3a staining showed a significant decrease in both staining intensity and percentage area 
of Dnmt3a-positive microvessels of aged mice compared to those of young mice.  
 
Figure 31. Immunofluorescent staining of Dnmt3a in young and aged brain microvessels of female 
C57BL/6J mice.  
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Brain microvessels positive for Dnmt3a are shown in green. Quantification of Dnmt3a staining shows a significant 
decrease in brain microvessels of aged m mice in both intensity (A) and percentage of area stained (B) Therefore, 
these results suggest a decreased Dnmt3a expression at the protein level in aged brain microvessels when 
compared to young brain microvessels of female C57BL/J6. (n=4/age group, Student’s t test; **, p<0.01). 
 
3.4 Discussion 
In the present study, age-related BBB changes in gene expression and miRNA 
deregulation were assessed by MACE-Seq and Small RNA analysis using isolated microvessel 
from young and aged female C57BL/6J mice. According to our results, the ageing female BBB 
showed a significant upregulation in genes associated with inflammation and immune 
response, where the majority of downregulated genes were related to metabolic and signalling 
pathways. Similarly, a few miRNAs were deregulated in ageing, and their predicted targets 
were associated with pathways involved in vascular development, cell migration or response 
to stress. Amongst them, miR-144-3p and Dnmt3a were selected for further analysis assessing 
their putative role and the effect of their deregulation on BEC function. MiR144-3p was 
observed to be upregulated in ageing. By contrast, Dnmt3a mRNA levels were shown to 
decrease in ageing and Dnmt3a protein expression was also observed to be significantly lower 
in the aged female brain vasculature.  
Transcriptomic analysis of age-related changes at the BBB was carried out using 
microvessel fragments, which generated a higher yield of RNA but from a mix of cells within 
the neurovascular unit. Classical approaches to isolating cerebrovascular components include 
tissue homogenization combined with filtration steps to ensure enrichment of a certain type of 
blood vessel (Yousif et al. 2007). Additional specificity regarding the selected vascular fraction 
is achieved by density gradient separation (Bowman et al. 1983; Debault et al. 1979). 
Techniques such as FACS-sorting or antibody-coated microbeads allow for isolation of single 
cells and thereby limit the contributing RNA to a single source (Miebach et al. 2006). However, 
when RNA is extracted from a mix of cells as is the case of the present study, some 
considerations need to be made when interpreting the findings. Indeed, the exact source of 
RNA is unknown and the transcriptome of individual cells (i.e. BECs, pericytes) cannot be 
distinguished, in contrast to other studies that used purified cell fractions with higher specificity 
in the post-analysis (Daneman et al. 2010). Also, our results showed expression levels of SMA-
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α and PDGFR-β to be decreased in the ageing brain, which may suggest differences in cell 
composition (pericytes and smooth muscle cells, especially) of the microvessel fraction when 
comparing young and aged mice. Although changes in cell markers do not necessarily 
correspond to changes in quantity of specific cells, they need to be considered when analysing 
sequencing data. For instance, differential starting RNA due to different levels of isolated 
BECs, pericytes, smooth muscle cells or astrocytes between age groups might lead to consider 
simple compositional differences as true age-related alterations when assessing relative 
expression levels. 
In addition to the isolation method, the sequencing technique will also influence the 
analysis. Samples with low-abundant transcripts, such as the ones used in this project, may be 
beyond the scope of traditional RNA-Seq. In that case, alternative methods such as MACE-
Seq, a modification of RNA-Seq, may be of use (Torres et al. 2008; Zhernakov et al. 2019b). 
For the sequencing analysis it is equally important to consider the advantages and limitations. 
MACE-Seq provides high resolution gene expression analysis of differentially expressed low-
abundant transcripts, however it does so by focusing on the 3’-end of the transcript which limits 
the reads per sample that can be obtained. Furthermore, our results have shown an age-
dependent change in BBB cell proportions, which in addition to the heterogeneous mixture, 
might affect the interpretation of the sequencing data. A major contribution from certain cell 
types in the aged sample, but not in the young sample, together with the 3’-focused sequencing, 
might conceal subtle changes in gene expression and complicate the comparison between age 
groups. In fact, the relative level of pericyte and astrocyte markers appears to change in ageing, 
thereby some of the alterations in mRNA levels observed in our data may be due to differential 
enrichment of cells in the aged microvasculature rather than ageing itself. Interestingly, these 
qPCR results are consistent with the potential ultrastructural changes addressed more in 
pericytes than in astrocyte in the previous chapter. Although not completely, alternate tools can 
be used to address some of these limitations and determine whether a gene of interest is 
enriched in a certain cell type. These tools include gene expression databases such as the 
molecular atlas developed by Betsholtz group (He et al. 2018; Vanlandewijck et al. 2018) 
(http://betsholtzlab.org/VascularSingleCells/database.html) which used data from single-cell 
RNA sequencing analysis to define vascular-associated cells in mouse brain and provided a 
comprehensive profile for cerebrovascular gene expression classified by cell types. Assessing 
expression patterns by in silico tools (e.g. databases, sequencing datasets) provides better 
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understanding of the results and helps making decisions for further analyses. However, the 
caveats derived from sample purity are harder to solve.  
More than 300 genes were identified as deregulated between young and aged 
microvessel samples, with more genes found to be upregulated genes than downregulated in 
the aged mice. This prominent upregulation of genes is consistent with recent studies in which 
mouse ageing is characterized for more upregulated genes than downregulated, in contrast to 
human ageing (Goodall et al. 2019).  In our study, many of the upregulated genes (Fpr2, Ccl5, 
Ccr2, Tlr13, Itga2, Oas1b) are involved in pathways related to inflammatory response, immune 
system, leukocyte adhesion and cell activation, whereas downregulated genes are mostly 
related to metabolic and signalling pathways. Therefore, these results suggest that the brain 
microvasculature becomes pro-inflammatory in aged female mice in comparison to brain 
microvessels of young female mice. These findings are in line with the hypothesis of 
inflammageing, which was firstly defined by Franceschi and colleagues (Franceschi et al. 
2000). This theory suggests that the antigenic load and stress throughout a lifespan induces a 
detrimental effect on the inflammatory response that ultimately promotes a pro-inflammatory 
state due to the altered balance between anti- and pro-inflammatory modulators (e.g. cytokines) 
(De Martinis et al. 2005). In line with Franceschi´s observations, previous studies have shown 
that a low-grade pro-inflammatory chronic process contributes to the progression of 
physiological ageing (Vasto et al. 2007). During ageing, the immune system has been shown 
to undergo gradual functional alterations, including increase of autoimmune responses and 
higher levels of circulatory pro-inflammatory cytokines (IL-1β, IL-6 or TNF-α primarily), 
which gradually lead to a chronic inflammatory state and may contribute to pathological 
conditions in age-related diseases (Bruunsgaard 2006; Bruunsgaard et al. 2003; Forsey et al. 
2003; Sergio 2008).  
Age-induced inflammatory processes have also been described in brain tissue, 
promoting overexpression of genes related to inflammation and oxidative stress, as well as 
exacerbation of immune responses and microglia activation that may lead to neurodegeneration 
(Barrientos et al. 2010; C. K. Lee et al. 2000; Stephenson et al. 2018). Furthermore, the age-
related chronic inflammation appears to have a vascular effect as well. For instance, endothelial 
dysfunction has been linked to vascular inflammation and oxidative stress in the human ageing 
process (Rodríguez-Mañas et al. 2009), whereas endothelial cells themselves have been 
reported to increase expression of pro-inflammatory cytokines (Donato et al. 2007). Several 
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studies have described that the chronic increase in peripheral cytokines during normal ageing 
induces an inflammatory state in BECs (Krabbe, Pedersen, and Bruunsgaard 2004). In fact, 
secretion of cytokines (e.g. IL-6, IFN-γ) was observed in BECs of aged mice and non-human 
primates, where it has been suggested to play a role in BBB breakdown and recruitment of 
immune cells into the brain (Reyes et al. 1999; Wei et al. 2000). Accordingly, more recent 
studies have reported ageing to exacerbate BEC senescence inducing inflammation in brain 
arterial vasculature (Fulop et al. 2018), and other studies have associated this age-induced 
cerebrovascular inflammation with barrier dysfunction, supporting the idea of an increased pro-
inflammatory environment at the ageing BBB (Takechi et al. 2013). In addition, recent studies 
showed how under chronic stress and inflammation, both pericytes and astrocytes become pro-
inflammatory and secrete modulators that may enhance cerebrovascular inflammation 
(Persidsky et al. 2015; Salminen et al. 2011). These results are very much in line with the 
upregulation of inflammation-related pathways observed in our sequencing analysis, although 
the functional effect of this pro-inflammatory state on the BBB requires further attention. Both 
in vivo and in vitro studies have reported cytokines such as TNF-α and IL-1β to modulate 
expression of TJ proteins (ZO-1, occludin-1, claudin-5) via NF-kB signal transduction 
(important transcription factor for pro-inflammatory proteins) or regulation of matrix 
metalloproteinases (e.g. MMP9, MMP2), alterations that lead to higher BBB leakage and 
disruption (Trickler et al. 2005; Wu et al. 2010). According to these observations, the changes 
in pro-inflammatory modulators happening at the ageing BBB would ultimately increase its 
permeability. In addition, our results also suggest an increase in pathways related to leukocyte 
adhesion, a phenomenon often described in the context of vascular inflammation (Dos Santos 
et al. 2005). However, this potential age-related increase of leukocyte adhesion and recruitment 
is not consistent with other studies reporting increased expression of adhesion molecules (e.g. 
intercellular cell adhesion molecule 1 (ICAM-1)) in the ageing brain vasculature, but in 
astrocytes (Miguel-Hidalgo et al. 2007; Xu et al. 2010), or those considering the ageing BBB 
to be characterized by inflammation but not leukocyte recruitment (Elahy et al. 2015). 
Nevertheless, potential effects of the pro-inflammatory state described in our sequencing data 
on BBB function are further assessed in the next chapter.  
Although most studies support a general effect of inflammageing at the BBB, sex 
differences might happen in neuroinflammatory and brain vascular alterations partly due to the 
role of sexual hormones. For instance, in addition to its reproductive and neuroprotective roles, 
oestrogen has been found to participate in cerebrovascular inflammation modulation, mainly 
3. Microvessel isolation and RNA-sequencing (MACE-Seq) 
 
98 
 
in protective roles such as increasing eNOS expression/activation, reducing adhesion molecule 
expression and leukocyte recruitment across the BBB and  decreasing the DNA binding activity 
of NF-kB in BECs, therefore hindering pro-inflammatory processes such as cytokine 
production (Galea et al. 2002; Gavin et al. 2009; Mori et al. 2004). Recent studies have also 
shown that oestrogen prevents inflammation-derived alterations at the BBB, including 
downregulation of adhesion molecule ICAM-1 and  upregulation of BBB integrity promoter 
ANXA1, although this effect gets compromised during ageing when reproductive senescence-
associated decline of oestrogen happens (Maggioli et al. 2016). Accordingly, previous studies 
have reported the loss of protective and anti-inflammatory effect of oestrogen on the ageing 
cerebrovasculature (Maggioli et al. 2016; Sunday et al. 2007), which has also been suggested 
to correlate with the higher incidence of neurodegenerative diseases and stroke in post-
menopausal women (Jamshed et al. 2014; Koellhoffer and McCullough 2013).  
Apart from oestrogen, other steroid sex hormones such as progesterone and androgens 
may play a role in age-related inflammageing contribution to BBB alteration. In fact, 
progesterone has been reported to participate in neuroinflammation mainly playing a protective 
role after brain injury and promoting regeneration in young adult rats (Jiang et al. 2009), as 
well as aged rats (Jiang et al. 2016). Early studies showed how progesterone induces 
downregulation of cytokines TNF-α and IL-1β right after brain injury, reducing cerebral 
oedema (He et al. 2004). Progesterone-induced protection against oedema appears to be 
mediated by blocking in vivo interactions between polymorphonuclear neutrophils and BECs 
in the BBB (Pascual et al. 2013). Additionally, progesterone protective effects include 
reduction of MMP-9 and -2 activity and TJ protein degradation which attenuates inflammatory 
response and BBB disruption after stroke in rats (Ishrat et al. 2010). In contrast to both 
oestrogen and progesterone, androgens such as testosterone have been reported to increase 
inflammatory responses in brain vasculature even in the absence of cytokines (Gonzales, 
Duckles, and Krause 2009). Testosterone is more abundant in males; however, females are 
sensitive to the hormone. Testosterone in females has been shown to be decreased in 
reproductive years, followed by a small tendency to increase in ageing, however, no sharp 
changes are shown in testosterone levels as seen in oestrogen or progesterone during 
menopause (Davison et al. 2005). The potential role of testosterone in inflammatory responses 
at the ageing female BBB remains unknown, although it is important to highlight the balance 
between testosterone and oestrogen in cerebral vessels. Testosterone can be metabolized into 
estradiol, and the cerebrovascular balance of androgens/oestrogens appears to have an effect 
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on endothelial function, oxidative stress and cerebrovascular inflammation (Krause et al. 
2011). Nevertheless, more information is needed to understand the potential consequence of 
balance or imbalance of androgens/oestrogens on cerebrovascular function and age-related 
BBB dysfunction.  
According to the findings described above, hormonal decline during menopause would 
leave the brain and cerebrovasculature vulnerable to the toxic influence of a pro-inflammatory 
environment enhanced with ageing. Therefore, hormone replacement therapies in post-
menopausal women, mainly focused on oestrogen and progesterone, were thought to provide 
the most beneficial effect and bring back the brain vasculature to a pre-menopausal state, 
however, there is great inconsistency depending on the hormone used. In fact, randomized trials 
treating post-menopausal women with oestrogen showed a higher risk of developing ischemic 
stroke (Wassertheil-Smoller et al. 2003). Similarly, oestrogen therapy has been proved to 
worsen neural impairment induced by chronic inflammation in aged female rats (Marriott et al. 
2002). Also, other studies have shown how oestrogen replacement differently affects the 
female BBB depending on age, reducing barrier leakage in young mice but increasing it in 
reproductive senescent mice (Bake and Sohrabji 2004; Chi et al. 2006). Altogether, these 
observations suggest that oestrogen has a beneficial effect on brain vasculature and BBB 
integrity in young rodents and women, but it becomes detrimental when they reach 
reproductive senescence. Although the mechanisms remain unknown, several potential 
explanations have been addressed. These age-dependent shifts might rely on the time of 
treatment, since alternate studies have shown how initiating replacement therapy in the period 
closer to menopausal transition might provide more of a beneficial effect than treatments that 
start long passed the menopause (F. Liu et al. 2012; Selvamani and Sohrabji 2010). However, 
it could also depend on the receptors, since early studies showed that oestrogen receptor alpha 
(ER-α), and not beta (ER-β), is critical for oestrogen-mediated brain protection (Dubal et al. 
2001). Also, previous studies have highlighted that expression levels of ER-α may modulate 
the beneficial or detrimental effects of exogenous oestrogen (Bake, Ma, and Sohrabji 2008), 
and age has been described to deregulate expression of ER-α and ER-β (Wilson et al. 2002), 
although their deregulation in brain vessels is not clear. In addition, an enhanced inflammatory 
state in the aged female brain might be contributing to these differences, especially when 
referred to higher incidence of stroke in post-menopausal women (Ritzel, Capozzi, and 
McCullough 2013). Furthermore, recent studies have suggested synergistic effects between age 
and oestrogen in reproductively senescent females via inflammatory and oxidative stress 
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processes, such as increased ROS production or Cyclooxygenase-2 activity, that might 
exacerbate cerebrovascular dysfunction also following brain damage (Deer and Stallone 2016). 
Interestingly, in the case of progesterone treatments, not only the natural hormone is used but 
several synthetic progesterone-like steroids as well (e.g. progestins), which may have diverse 
biological effects (Pluchino et al. 2006). Indeed, combination of synthetic progestins with 
oestrogen has been reported to show non-beneficial effects (Campagnoli et al. 2005; 
Wassertheil-Smoller et al. 2003), whereas natural progesterone has been shown to maintain its 
protective and anti-inflammatory effects when administered after ischemic stroke in aged male 
and female rodents but not in ovariectomised females (Gibson et al. 2011; Yousuf et al. 2014). 
This body of research keeps expanding and further work must be done to assess the cellular 
and molecular mechanisms behind synergistic effects of age and hormone levels on 
cerebrovascular dysfunction and inflammation, which will also aid in our understanding of 
pathophysiological states such as stroke.  
Transcription profiles can be modulated by epigenetic variations that participate in the 
regulation of gene expression and include histone and post-translational modifications, RNA-
based mechanisms (e.g. miRNA-mediated regulation) or DNA methylation (Matouk and 
Marsden 2008). In the current study, a significant decrease was observed in both mRNA and 
protein levels of Dnmt3a. Despite the single fluorescent staining used in the present study 
showing a significant decrease in Dnmt3a, multiple staining including the vascular marker 
PECAM-1 or nuclear staining agent DAPI, would have helped showing that Dnmt3a is actually 
expressed in the vessels, as well as confirming equivalent amounts of cellular material from 
both age groups. Dnmt3a is a member of the Dnmt family that includes mainly Dnmt1, Dnmt3a 
and Dnmt3b, whose function is to mediate DNA methylation. Different patterns of DNA 
methylation have been proved to be essential for mammalian development, acting as a 
regulatory element that can increase or decrease transcription of certain genes depending on 
the cell type, the tissue or the stage of the individual (Deaton and Bird 2011; Jones and Takai 
2001). Ageing has been linked to aberrant DNA methylation patterns, mostly observed as 
global genomic DNA hypomethylation and specific hypermethylation of CpG islands in 
several tissues including the brain (Bollati et al. 2009; Christensen et al. 2009). Moreover, 
altered DNA methylation normally correlates with deregulated gene expression, either 
increased or decreased (Mangold et al. 2017); however, there is still little information on how 
age-related changes in DNA methylation may affect transcriptome or functions of certain 
tissues such as cerebrovasculature. Accordingly, BBB function may also be modulated by 
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DNA methylation patterns. Indeed, Sirtuin1 (Sirt1), a factor associated with endothelial cell 
dysfunction in ageing, has been suggested to regulate expression of several TJ proteins in mice 
by modulating methylation of their promoters (Stamatovic et al. 2019), as it does in lung 
(Hasegawa et al. 2013); thus, age-induced decrease of Sirt1 in BECs might have relevant 
effects on BBB permeability. Similarly, DNA methylation alterations have also been described 
in cultured murine BECs exposed to Aβ, promoting overexpression of genes related to amyloid 
pathology and promoting a vicious cycle of damage that accumulates during ageing and leads 
to neurodegeneration (Chen et al. 2009). Dnmt expression including Dnmt3a appears to be 
significantly decreased in brain during ageing (Cui and Xu 2018). For instance, the age-
dependent decrease in Dnmt3a expression observed in our results is consistent with previous 
studies that showed lower levels of this methyltransferase in neurons of the ageing brain 
(Siegmund et al. 2007), which may contribute to the age-associated genomic hypomethylation 
of non-CpG regions (H. Liu et al. 2016).  
Transcriptional modulation mediated by miRNAs is normally based on suppression and 
leads to downregulation of their target mRNAs (Bartel 2004). Interestingly, miRNAs have also 
been reported to play essential roles in the ageing brain and BBB (Mohammed et al. 2017). For 
instance, recent studies have reported age-induced overexpression of miR-155-5p, well known 
miRNA related to neuroinflammation and BBB dysfunction that targets TJ proteins (Lopez-
Ramirez et al. 2014), although it did not change in our data. Similarly, miR-107 is 
downregulated in elderly individuals during early AD stages and has been related to BBB 
integrity protection by targeting endophilin-1 (W. Liu et al. 2016); however, it was not age-
deregulated in our data either. In fact, in the current study, 9 miRNAs were identified from the 
MACE-Seq analysis to be significantly altered in microvessel fractions of aged versus young 
animals. Among these miRNAs, miR-144-3p, which was confirmed to be increased in aged 
microvessels, was identified as a predicted negative modulator of Dnmt3a expression. This 
prediction is consistent with recent reports that also predicted DNMT3A to be a target of miR-
144-3p in serum samples of women highly exposed to perfluoroalkyl substances (Xu et al. 
2020). Our results are also in line with previous studies that have reported a significant 
overexpression of miR-144  in cortex and cerebellum of ageing non-human primates and AD 
patients (Persengiev et al. 2011). Additionally, miR-144 has also been related to 
neuroinflammation in the context of intracerebral haemorrhage in mice, promoting microglia 
autophagy and inflammation response in vivo, which enhances brain damage after injury (Yu 
et al. 2017). Recent studies have also described miR-144 overexpression after brain injury in 
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rats, supressing proteins related to neuroprotective, antioxidant and anti-inflammatory roles 
such as Nrf2, suggesting a potential role regulating cerebral ischaemia (Chu et al. 2019; Liu et 
al. 2014). Despite the lack of evidence of miR-144-3p expression in the BBB, previous studies 
have reported its role in TJ protein regulation in blood-tumour barrier (human glioma), 
promoting increase in permeability (Cai et al. 2015); thus, something similar could be 
happening in the brain vasculature.  
All of these findings suggest that miR-144-3p is an interesting pro-inflammatory factor 
with a potential role in BBB dysfunction during ageing. Similarly, Dnmt3a might modulate 
several processes in the ageing brain vasculature and BBB contributing to transcriptional 
regulation. These are the main reasons why miR-144-3p and Dnmt3a were chosen, and the 
effects of their deregulation in BEC function are assessed in the next chapter.  
4. MiR-144-3p and DNMT3A in hCMEC/D3 cells 
 
103 
 
Chapter 4. Role of microRNA-144-3p and DNMT3A in inflammation-
mediated alterations to permeability and leukocyte adhesion in the 
hCMEC/D3 cell model of the human BBB. 
4.1 Introduction 
In the previous chapter, results of the MACE-Seq analysis showed that hundreds of 
transcripts were deregulated in the microvessels of aged female mice compared to young 
animals. Amongst these, miR-144-3p and DNMT3A, which are inversely deregulated in 
ageing, were suggested to interact according to targeting prediction tools (TargetScan7.2 and 
miRWalk2.0).  
MiRNA-144 (miR-144), which includes miR-144-3p and -5p, is a well-known onco-
mediator which has been shown to be deregulated in several types of tumour such as glioma or 
lung cancer, playing beneficial roles (Cai et al. 2015; Chen et al. 2015). However, miR-144 is 
also expressed in the CNS and in recent years both its role and deregulation have been strongly 
linked to neuronal dysfunction in ageing and neurodegenerative diseases (X. Cheng, Ku, and 
Siow 2013). In fact, miR-144 has been reported to be upregulated in neurons of the ageing 
cerebellum and cortex of chimpanzees and non-human primates (i.e. rhesus macaques) but also 
in aged humans with AD (Persengiev et al. 2011). The same study suggested a beneficial role 
of miR-144 in spinocerebellar ataxia, by suppressing ATXN1, however, high levels of this 
miRNA might be detrimental in other processes of the ageing brain. Indeed, miR-144-3p 
suppression has been reported to reduce oxidative neuronal injury by promoting signalling 
pathways that involve Nrf2 and antioxidant response element (ARE) (Li et al. 2018). For 
instance, Chu and colleagues showed that miR-144 negatively regulates Nrf2 expression in 
mouse neurons in the context of oxygen and glucose deprivation and reperfusion-derived 
injury, which leads to hindered Nrf2/ARE activation and reduced anti-oxidant and anti-
inflammatory activities (Chu et al. 2019). Accordingly, additional studies have also reported 
miR-144 to be overexpressed in aged brains of male rodents related to brain injury and 
Alzheimer´s (Sun et al. 2017). In addition, Cheng and colleagues have also shown that miR-
144 supresses the expression of ADAM10, which participates in the accumulation and 
clearance mechanisms of Aβ in the brain, thereby suggesting a role of miR-144 and its 
regulation in AD pathogenesis (C. Cheng et al. 2013). Furthermore, miR-144-3p 
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overexpression has recently been reported to contribute to neuron apoptosis and brain injury in 
male rat intracerebral haemorrhage (Fan et al. 2019). 
At the vascular level, miR-144 overexpression in glioma vascular endothelial cells has 
been reportedly associated with downregulation of occludin, ZO-1 and claudin-5 and increased 
permeability at the blood-tumour barrier in vitro by negatively regulating HSF2, which 
participates in modulating the expression of these tight junction proteins (Cai et al. 2015). 
Higher levels of miR-144 in aged male rats have also been associated with angiogenesis, by 
suppressing the proangiogenic Nrf2, as well as oxidative stress damage of BECs, via 
downregulation of antioxidative proteins in aged brain microvessels (Csiszar et al. 2014). In 
addition, miR-144 has also been reported to increase both microglia autophagic activity and 
neuroinflammation after intracerebral haemorrhage in mice (Yu et al. 2017). However, the 
implications of its age-induced deregulation in the brain microvasculature and BBB function 
have not been elucidated. 
DNMT3A is a DNA methyltransferase which along with DNMT3B modulates de novo 
methylation while DNMT1 regulates the maintenance of methylation patterns (Delgado-
Morales et al. 2017; De Jager et al. 2014). DNMT3A was originally described as an essential 
regulator for the establishment and stable inheritance of methylation patterns on genomic DNA 
during early mouse embryonic development (T. Chen et al. 2003). Additional studies have 
reported DNMT3A to also be important for both neural and hematopoietic stem cell 
differentiation, which also makes it a key factor in pathological conditions such as acute 
myeloid leukaemia (Challen et al. 2012). DNMTs are widely expressed throughout the adult 
and postnatal developing brain in rodents, although they have differential distribution 
depending on the region. In the case of DNMT3A, it is highly expressed in several regions of 
the forebrain and hippocampus (Simmons et al. 2013). Accordingly, recent studies in adult 
male mice have reported that overexpression of DNMT3A in neurons of the prefrontal cortex 
attenuates anxiety-like behaviour and stress (Elliott et al. 2016). Also in male mice, DNMT3A 
appears to be essential for associative learning and normal memory formation in neurons of the 
forebrain, a role that cannot be substituted by DNMT1, for example (M. J. Morris et al. 2014). 
In the context of ageing, DNMT3A activity has been shown to be altered in human senescent 
cells, in which this enzyme may play a role determining certain apoptotic pathways mostly in 
tumour conditions (e.g. colorectal cancer) (Zhang et al. 2011). DNMT3A expression has been 
shown to decrease in mouse cerebral cortex and other brain regions from birth to adulthood 
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and during ageing (Kraus et al. 2016). In addition, DNMT3A decreased expression has been 
described in both mouse cortex and hippocampus during ageing (Cui and Xu 2018). Similarly, 
loss of DNMT3A in the brain has been associated with cognitive impairment in male mice 
(Oliveira et al. 2012). Although DNMT3A has not been described to change in the ageing BBB, 
Kalani and colleagues reported MMP-induced BBB permeability in a mouse brain endothelial 
cell line during hyperhomocysteinemia to be regulated by miRNA-induced modulation of 
DNMT3B (Kalani et al. 2014), and since DNMT3A has indeed been shown to change in the 
ageing mouse brain, it might as well be related to some of the age-related changes observed in 
BBB function in a similar way to DNMT3B. Also, despite the lack of available data regarding 
DNMT3A role in neuroinflammation, recent studies have proved that DNMT3A loss leads to 
activation of inflammatory responses in mouse mast cells in vivo and in vitro, suggesting an 
anti-inflammatory role for this methyltransferase (Leoni et al. 2017).  
Interestingly, although most of the abovementioned studies were performed in males 
(human and rodent), some sex differences have been observed in the expression of DNMTs. 
Indeed, female rats have been shown to express higher levels of DNMT3A in the amygdala 
during brain development (Kolodkin and Auger 2011). The same study suggests that DNMT3A 
expression might be regulated by sex steroid hormones, which is consistent with previous 
studies that reported oestrogen and progesterone to promote downregulation of DNMT3A in 
the human endometrium during the secretory phase of the menstrual cycle (Yamagata et al. 
2009). In contrast, another study performed in mouse brain, has shown that intrahippocampal 
injection of estradiol in aged female mice induces neuronal overexpression of DNMTs, 
including DNMT3A, and mediates memory-enhancing effects (Zhao, Fan, and Frick 2010). 
Together, these findings highlight the potential role of hormones in the establishment of sex 
differences in DNA methylation, an effect that might change depending on the tissue.  
In Chapter 3, genes associated with pro-inflammatory pathways were found to be 
significantly upregulated in the brain microvasculature of aged female mice. 
Neuroinflammation has been widely reported to promote BBB disruption and increased 
permeability via deregulation of TJ proteins (occludin, claudin-5) (Argaw et al. 2012), which 
is also related to BEC dysfunction and activation of MMPs that promote degradation of 
extracellular matrix (Cardoso et al. 2012). Additionally, another one of the highlights of CNS 
inflammation is leukocyte infiltration into the brain parenchyma which in turn depends, among 
other mechanisms, on leukocyte adhesion to and migration across BECs. According to several 
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studies, T cells are the predominant population to undergo brain infiltration in 
neuroinflammation, although neutrophils, granulocytes and macrophages may be present as 
well (Jin, Yang, and Li 2010; Mracsko et al. 2014; Yilmaz and Granger 2010). Two of the main 
cell adhesion molecules (CAMs) that participate in leukocyte transmigration are vascular cell 
adhesion molecule 1 (VCAM-1) and ICAM-1 (Wong, Prameya, and Dorovini-Zis 1999). 
VCAM-1 and ICAM-1 have been shown to participate in mechanisms related to 
neuroinflammation and ischemic injury after stroke in the human brain, where they promote 
activation of endothelial cells and transendothelial migration of leukocytes (Supanc et al. 
2011). Pro-inflammatory cytokines commonly related to neuroinflammation such as TNF-α or 
IFN-γ have been shown to upregulate the expression of VCAM-1 and ICAM-1 in BECs (Stins, 
Gilles, and Kim 1997). In spite of both of them participating in processes of leukocyte adhesion 
to brain endothelium, some studies in a model of human BBB have reported that ICAM-1 and 
VCAM-1 participate differentially depending on the leukocyte population, with both of them 
mediating migration of T cells, while only ICAM-1 appears to be essential for the migration of 
polymorphonuclear leukocytes (Wong, Prameya, and Dorovini-Zis 2007). Additionally, 
several chemokines such as CCL2, CCL4 or CCL5 (RANTES) participate in mediating 
leukocyte trafficking across the cytokine-activated brain endothelium and may also have an 
effect on BBB function in neuroinflammation, an effect observed in human BECs cells in vitro 
and in female EAE model mice in vivo (Quandt and Dorovini-Zis 2004; Dos Santos et al. 2005; 
Subileau et al. 2009). Interestingly, although in a LPS-stimulated macrophage cell line, 
DNMT3A inactivation has been recently reported to promote CCL5 expression, which once 
again suggests a potential anti-inflammatory role for this methyltransferase (Sano et al. 2018). 
Nevertheless, although leukocyte adhesion and transmigration are principally associated with 
pathological conditions such as MS, some studies have also shown an accumulation of T cells 
in the brain parenchyma of healthy aged mice (Chan-Ling et al. 2007; Xu et al. 2010). 
Accordingly, adhesion molecules could be overexpressed in the ageing brain due to the 
inflammatory environment linked to normal ageing (inflammageing), although only reported 
in astrocytes (Miguel-Hidalgo et al. 2007). In contrast, previous studies have reported increased 
inflammatory state but no significant increase in adhesion molecule expression or leukocyte 
migration across the brain vasculature of healthy aged female mice (Elahy et al. 2015). These 
observations show the ongoing controversy regarding the extravasation of leukocytes into the 
ageing brain in the absence of pathology. 
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In summary, recent reports have suggested potential interactions between miRNAs and 
DNMTs in mediating alterations in BBB integrity (Kalani et al. 2014). In addition, as described 
above, miR-144-3p and DNMT3A play potential roles in ageing and inflammation, which 
could be related with age-mediated BBB dysfunction. The aims of this part of the study were 
to elucidate the consequences of miR-144-3p/DNMT3A deregulation in cerebrovascular 
function using a simplified in vitro human BBB model, hCMEC/D3 cell line, brain endothelial 
cells originally isolated from the temporal lobe of an adult woman with epilepsy (Poller et al. 
2008). Therefore, paracellular permeability and leukocyte adhesion were assessed under miR-
144-3p/DNMT3A deregulation conditions.  
 
4.2 Material and Methods 
4.2.1 hCMEC/D3 culture conditions 
hCMEC/D3 cells were cultured in EBM-2 MV media (#00190860, Lonza, Slough 
Wokingham, UK). This media was then supplemented with Microvascular Endothelial Cell 
Growth Medium-2 SingleQuots Kit (#CC-4147, Lonza, Slough Wokingham, UK), which 
includes 0.025% (v/v) rhEGF, 0.025% (v/v) VEGF, 0.025% (v/v) IGF, 0.1% rhFGF, 0.1% 
(v/v) gentamycin, 0.1%(v/v) ascorbic acid, 0.04% (v/v) hydrocortisone and 2.5% (v/v) fetal 
bovine serum (FBS); hereafter this media is referred to as EBM-2 Full Cell (FC) media. Cells 
were seeded onto previously collagen-coated flasks of different sizes (Greiner Bio-one, 
Gloucestershire, UK) and maintained at 37 oC in 95% air and 5% CO2 until confluence. For 
the coating, collagen type I (#C3867, Sigma-Aldrich, Dorset, UK) stock solution was diluted 
1:20 in Hank’s balanced salt solution (HBSS) (#H9269, Sigma-Aldrich, Dorset, UK) and left 
for 1 hr at room temperature (RT) or 30 min at 37 oC on the plastic surface of the flask. After 
the incubation time, collagen solution was removed, and the flasks were filled with EBM-2 FC 
media in preparation for cell culture.  
For those experiments only focused on assessing the levels of mRNA and miRNA 
expression after transfection, cells were plated on 12-well plates (#665180, Greiner Bio-one, 
Gloucestershire, UK). In the experiments that used transwell polyester membrane inserts (0.4 
µm pore, 12mm diameter, #CLS3401-48EA, Corning Costar, Sigma-Aldrich, Dorset, UK), 
filters were first coated with collagen type I as previously described for flasks and left in 12-
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well plates. Afterwards the collagen was removed, and the inserts were coated with fibronectin 
(#F1141, Sigma-Aldrich, Dorset, UK). Fibronectin stock was diluted 1:100 in HBSS and left 
for 1 hr at RT on the already collagen-coated filters. As before, once the incubation time was 
finished, fibronectin was removed, and cells diluted in the EBM-2 FC media were seeded onto 
the inserts. For those experiments assessing adhesion, Ibidi cell chambers µ-slide VI 0.4 
(#80606, Ibidi ® GmbH, Martinstreid, Germany) were used. Each chamber had six channels 
that were coated with collagen as described for 1 hr at RT. Collagen was removed and cells 
diluted in EBM-2 FC media were seeded in each channel.  
 
4.2.2 hCMEC/D3 culture maintenance 
Human hCMEC/D3 were grown until 80-90% confluence (~1 x 105 cells/cm2) and 
culture media was changed every 2 days. For splitting, hCMEC/D3 cells were washed in HBSS 
without Ca2+ and Mg2+ (#55021C, Sigma-Aldrich, Dorset, UK) a couple of times and then 
incubated with porcine trypsin-EDTA 0.25% (#11570626, ThermoFisher Scientific, 
Loughborough, UK) at 37 oC for 4-5 min until detached. Fetal bovine serum (FBS) solution 
(#12103C, Sigma-Aldrich, Dorset, UK) was then added to neutralise trypsin activity. Cells 
were counted using a hemocytometer and split as 1 x 106 cells per flask. For all experiments, 
hCMEC/D3 cells between passage (p) 25 and 34 were used.  
 
4.2.3 T cell (Jurkat) culture conditions 
Immortalised T lymphocyte cell line Jurkat (Jurkat cells) (Dr V Male, Cambridge 
University) were grown in RPMI 1640 w/GLUTAMAX I culture media (#R8758, Sigma-
Aldrich, Dorset, UK), supplemented with 10% FBS (#12103C, Sigma-Aldrich, Dorset, UK) 
and 100 µg/ml + 100 U/ml of Penicillin/Streptomycin (#15140-122, ThermoFisher Scientific, 
Loughborough, UK); hereafter referred to as RPMI Full Cell (FC) media. Jurkat cells were 
cultured in suspension in 75 ml flasks (Greiner Bio-one, Gloucestershire, UK) and 95% air, 
5% CO2 at 37 
oC. 
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4.2.4 T cell (Jurkat) culture maintenance 
Jurkat cells were maintained at a concentration of 0.3-0.5 x 106 cells/ml. Volume was 
readjusted to fit the proper concentration every 2 days and media was changed once per week. 
To change media, Jurkat cells were spun down (190g, 5 min) and resuspended in a known 
volume of RPMI FC media. Cells were counted and resuspended in RPMI FC in order to reach 
0.3 x 106 cells/ml. Once every 3 weeks, Jurkat cells were renewed.  
 
4.2.5 MicroRNA (miRNA) and siRNA transfection 
For transfection, hCMEC/D3 cells were seeded at different concentrations depending 
on the technique. Cells had to reach 70% confluence 24 hours after seeding, therefore the 
seeding densities varied between experiments and growth surface used (i.e. 12-well plates, 
inserts or Ibidi chambers).  
At the end of seeding day, EBM-2 FC media was replaced with EBM-2 MV media 
supplemented with same components as EBM-2 FC media except for antibiotics (gentamycin). 
The following day, with cells at 70% confluence, transfection of either miRNA precursors (pre-
MiRs) or antagonists (anti-miRs) and silencing RNAs (siRNAs) was performed. For hsa-
premiR transfections, siPORT Polyamine Transfection Agent (#AM4502, ThermoFisher 
Scientific, Loughborough, UK) was used, whereas for hsa-anti-miR and hsa-siRNA 
transfections, Lipofectamine 2000 Transfection reagent (#11668019, ThermoFisher Scientific, 
Loughborough, UK) was used. Cyanine-3 (Cy3)-labelled controls were also used to test 
transfection efficiency. The protocol used for transfections is shown in Figure 32. hCMEC/D3 
cells were transfected either with pre-miR144-3p, anti-miR144-3p (#PM11051 and 
#AM11051, ThermoFisher Scientific, Loughborough, UK; mature miRNA sequence: 
UACAGUAUAGAUGAUGUACU) or silencing DNMT3A (siDNMT3A) (SMARTpool, 
mixture of 4 siRNAs, no sequence specified, #M-006672-03-0005, Dharmacon, Colorado, 
USA).  
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Figure 32. Protocol for transfection of hCMEC/D3 endothelial cells.  
On the first day, cells were seeded on a different surface depending on the experiment planned to do. At the end 
of the day, cell media was changed to EBM-2 media without antibiotics. After 24h, when cells reached 70% 
confluency, transfection protocol started by incubation with pre-miR-144-3p (diluted in siPORT), anti-miR-144-
3p, siDNMT3A (both diluted in lipofectamine) or the scrambled RNAs (diluted in siPORT or lipofectamine). For 
those cells exposed to lipofectamine, the transfection reagent solution was changed to transfection media only 
after 6h. Last day, after 24h for the cells in siPORT and 18h for the cells in transfection media only, media was 
changed to EBM-2 Full Cell (FC) or without growth factors, depending on the following experiment.  
In general, transfection agents, siPORT and lipofectamine, were mixed in OptiMEM 
(#31985070, ThermoFisher Scientific, Loughborough, UK) reduced-serum media (siPORT, 
1:25 and lipofectamine, 1:70) to reach the proper concentration according to the supplier’s 
protocol. Cy3-labelled controls, inhibitor or precursor control constructions (scrambled RNA), 
pre-, anti- and silencing RNAs were also mixed in OptiMEM at the indicated concentration. 
Afterwards, both the transfection agent and the oligonucleotide were mixed together in EBM-
2 MV media supplemented with 0.1% rhFGF, 0.1% ascorbic acid, 0.04% hydrocortisone and 
1.25% FBS (hereafter referred to as transfection media) and dispensed onto ~70% confluent 
hCMEC/D3 cells. Non transfected cells used as negative control were incubated with 
transfection media only. The final ratio RNA:siPORT in the case of pre-miR-144-3p and 
precursor control (10 µM stock) was 1.5 (v/v). In the case of anti-miR144-3p, inhibitor control, 
siRNA and silencing control (20 µM stock), the final ration RNA:lipofectamine is 3.3 (v/v).  
Regarding oligonucleotides, pre-miR-144-3p, anti-miR-144-3p (1:10 and 1:4) and 
siDNMT3A (1:4) were used to regulate expression levels of the pair miR-144-3p/DNMT3A. 
Scrambled RNA (#AM17111 and #AM17010, ThermoFisher Scientific, Loughborough, UK) 
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and non-targeting siRNAs (#D-001206-14-05, Dharmacon, Colorado, USA), used as negative 
control of transfection, were undisclosed random sequence RNA oligonucleotides tested in 
human cell lines and validated to not produce effects on known miRNA and mRNA function 
by the supplier. Efficiency of transfection was validated using RT-qPCR analysis with the RNA 
extracted from transfected cells. When using lipofectamine as a transfection agent, due to its 
higher toxicity, it was necessary to change media to transfection media only 6 hr after starting 
the protocol. At the end, 24 hr after the start of transfection, media was changed to EBM-2 FC 
or EBM-2 without growth factors depending on the posterior experiments (adhesion or 
permeability analysis respectively).  
 
4.2.6 Static paracellular permeability assay in vitro 
For static paracellular permeability assay, hCMEC/D3 cells were seeded onto collagen 
and fibronectin-coated permeable polyester transwell inserts as previously explained in section 
4.2.1. Cells were transfected 24h after seeding, when 70% confluence was reached. After 24h, 
media was changed to EBM-2 media without growth factors and cells were maintained in static 
conditions in 12-well plates until reaching 100% confluence. The day before, non-transfected 
cells were either treated with TNFα/IFNγ (1ng/ml, positive control) or left untreated (negative 
control).  
The protocol followed to assess permeability was based on the one used previously in 
our lab (Lopez-Ramirez et al. 2014). On the same day of experiment, dextran – FITC 70 KDa 
(#46945, Sigma-Aldrich, Dorset, UK) was diluted in transport buffer made at the lab, 2% (v/v) 
FBS in DMEM without phenol red, at a concentration of 2mg/ml. A volume of 1.5 ml of the 
same transport buffer alone was added in 12-well plates, considering 6 wells per condition 
(insert). Transendothelial electrical resistance (TEER) of hCMEC/D3 cell monolayers was 
determined in each insert using an Endohm 12 chamber and an Endohmeter (World precision 
instruments, Florida, USA). Cell media was removed from the upper chamber of each insert 
and 500 µl of transport buffer containing the dextran tracer was added. Inserts were then placed 
in the corresponding first well (out of 6) allocated for each of them and passed to the next one 
every 5 minutes. After 30 minutes, paracellular flux of the tracer to the lower chamber was 
assessed by measuring fluorescence in the 12-well plate at λexc 485 nm and λem 525 nm using 
a plate reader (BMG, Ortenberg, Germany). For the posterior analysis, volume cleared was 
calculated from the fluorescence values of each condition, background (or blank) and the initial 
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solution (2mg/ml dextran – FITC).Volume cleared values were then plotted against time and 
the slopes of the curves were used to calculate permeability coefficient of endothelial 
monolayers (PE, cm/min) as described previously (Tai et al. 2010). When assessing PE in 
transfected hCMEC/D3 cells, 4 independent experiments were performed, with 3 replicates per 
condition in each independent experimental repeat (n=4). 
 
4.2.7 Flow-based adhesion assay in vitro 
A flow-based adhesion assay was performed using a system previously described by 
Cerutti et al. (Cerutti et al. 2016). For adhesion, hCMEC/D3 cells were seeded in an Ibidi cell 
chamber as explained in section 4.2.1 of this chapter. Transfection protocol was followed as 
discussed previously, 24h after seeding when cells reached 70% confluence. Following 
transfection, media was changed to EBM-2 FC media and maintained in static conditions. The 
day before, non-transfected cells were either treated with TNFα/IFNγ (1ng/ml, positive control) 
or left untreated (negative control). 
On the day of experiment, hCMEC/D3 cells were washed with fresh EBM-2 FC media 
right before and T lymphocyte Jurkat cells were marked with fluorescent green cell tracker 
CMFDA (5-chloromethylfluorescein diacetate) as indicated by the manufacturer (Invitrogen, 
Paisley, UK). Cell labelling was performed by incubation with CMFDA during 30 minutes at 
37 oC in absence of light. After incubation time, cell concentration was adjusted to 2x106 
cells/ml. 
Thin plastic tubes connected two pumps with the Ibidi chamber. Pre-warmed and 
degassed EBM-2 FC media was used to establish a flow circuit between the pumps and the 
chamber. Jurkat cells (leukocytes) were then allowed to flow through the channel with 
endothelial monolayers and accumulate at 0.5 dyn/cm2 for 5 min. Afterwards, suspension cell 
was changed to EBM-2 FC media only and the flow was increased to 1.5 dyn/cm2 (venular 
vessel wall shear stress) for 30 seconds to remove leukocytes not firmly adhered on the 
monolayer. Firm adhesion was defined by leukocytes that adhered on the endothelial 
monolayer in the field of view (FOV 640 x 480 µm) throughout the accumulation time (5 min) 
and then remained adhered after increasing the flow to 1.5 dyn/cm2. Firmly adhered leukocytes 
were quantified using Image J in 10 different FOVs per channel. Average value was calculated 
every 10 FOVs. Results were presented as number of Jurkat cells per FOV referred to control. 
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Images were acquired using 10X objective of an inverted fluorescence microscope (Olympus 
IX70, Tokyo, Japan) controlled by Image Pro Plus software (Media Cybernetics Inc. Bethesda, 
USA). This microscope used a Q-IMAGING QICAMFAST 1394 on a 12-bit camera (40 
images/min). When assessing leukocyte adhesion onto transfected hCMEC/D3 cell 
monolayers, 4 independent experiments were performed, with 3 replicates per condition in each 
independent experiment (n=4). 
 
4.2.8 Flow cytometry 
Flow cytometry assay was used to measure efficiency of transfection with Cy3-labelled 
controls. After transfection, confluent hCMEC/D3 cells were washed in HBSS without Ca2+ 
and Mg2+ and harvested using trypsin-EDTA 0.25%. Cells were then washed again, centrifuged 
at 1500 rpm 5 min and resuspended in a final volume of 500 µl of HBSS. A total of 10,000 
events (cells) were counted per experiment using a Becton Dickinson FACScan (Bio-rad, 
Oxford, UK). Data was later analysed using Cell Quest Software (BD Biosciences, San Jose, 
CA, USA). To assess transfection efficiency by Cy3-labelling, 3 independent experiments were 
performed, with 3 repeats or replicates per condition in each independent experiment (n=3). 
  
4.2.9 RNA extraction 
Total RNA from isolated cells and microvessel fragments was extracted using 
miRCURY RNA isolation kit (#300112, Exiqon, Vedbaek, Denmark) as referenced in Chapter 
3 of this thesis. The final RNA samples were frozen at -80 oC. 
 
4.2.10 Reverse transcription – Quantitative PCR 
RT-qPCR analysis was used to test the successful transfection of endothelial cell as 
well as to assess expression changes in certain genes (adhesion molecules and inflammation-
related factors) following deregulation of miR-144-3p and DNMT3A. Genes measured 
included DNMT3A (Homo sapiens, F: 5’-ATTACTACGAGGTCAAACTCC-3’; R: 5’-
GGGAAACCAAATACCCTTTC-3’), CCL5 (Homo sapiens, F: 5’-
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GTCTTTGTCACCCGAAAG-3’; R: 5’-GACAAGAGCAAGCAGAAAC-3’), and ACTIN-β 
as reference gene (Homo sapiens, F: 5’-GATCAAGATCATTGCTCCTC-3’; R: 5’-
TTGTCAAGAAAGGGTGTAAC-3’). Sequences of ICAM-1 and VCAM-1 primers were not 
specified. All primers used were pure and simple primers obtained from Sigma-Aldrich 
(#VC00026, Sigma-Aldrich, Dorset, UK). Same kits and protocols explained in Chapter 3 of 
this thesis were used. To measure relative expression levels of miR-144-3p, DNMT3A, ICAM-
1, VCAM-1 and CCL5 after transfection, 3 independent experiments were performed, with 3 
replicates per condition in each independent experiment (n=3). 
 
4.2.11 Relative expression and tags per million normalization 
Relative expression by the ΔC(t) method and normalized expression levels by TPM 
normalization method were calculated as described in Chapter 3 of this thesis.  
 
4.2.12 Immunofluorescence staining 
Immunofluorescence staining was performed as explained in the previous chapter. 
Frozen brains were sectioned by cryostat at 20 µm thickness, collected onto slides and stored 
at -20 oC. Sections were post-fixated by incubation in acetone for 10 min. Sections were then 
washed with 0.01M PBS (3 times, 5 min) and incubated with citrate buffer (0.01 M Sodium 
Citrate in 0.01% tween pH 6) at ~90 oC (3 times, 5 min) for antigen retrieval. Unspecific 
binding sites were blocked by incubation with serum of the antibody host organism diluted in 
0.01M PBS for 15 min. Directly after, sections were incubated with anti-VCAM-1 (1:200, 
#ab134047 rabbit IgG; Abcam, Cambridge, UK) or anti-ICAM-1 (1:200, # MA5407 rat IgG; 
ThermoFisher Scientific, Loughborough, UK) in 0.01M PBS overnight at 4 oC. The day after, 
sections were washed with 0.01M PBS (3 times, 5 min) and incubated with AlexaFluor488 
anti-rabbit or AlexaFluor555 anti-rat (1:200; Molecular Probes, Eugene, USA) diluted in 
0.01M PBS for 2h at RT, protected from light. Slides were coverslipped using Mowiol ® 
(Sigma-Aldrich, Dorset, UK) containing 0.1% v/v Citifluor (Citifluor ltd, London, UK) as 
mounting media. Slides were left in the fridge to dry and sections were later imaged using 
confocal microscopy Leica confocal N1057 (Leica Microsystems Ltd, Milton Keynes, UK). 
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To assess immunofluorescence staining of Vcam-1 and Icam-1 in mouse brain tissue, 4 animals 
per age group were used (n=4/ age group), with 3 experimental repeats each. 
 
4.2.13 Statistical analysis 
GraphPad Software (Prism 8.2.0, La Jolla, USA) was used for analysis. Shapiro-Wilk 
normality test and Q-Q plots were used to assess distribution of the data. Data of transfection 
efficiency was analysed using one-way ANOVA and Dunnett’s correction test. Endothelial 
permeability coefficient and leukocyte adhesion data was analysed using one-way ANOVA 
and Tukey’s correction test. Finally, relative expression and immunofluorescence data was 
analysed by unpaired two-tailed Student’s t test. Significance is set at p<0.05 and results are 
presented as mean ± SEM. The selection of appropriate statistical tests is indicated in each 
figure legend. 
 
 
4.3 Results 
4.3.1 The role of miR-144-3p in regulating the expression of DNMT3A in human brain 
endothelial cells (hCMEC/D3) 
4.3.1.1 hCMEC/D3 cells are efficiently transfected and transfectant levels maintained for at 
least 72h 
To mimic the age-related changes in miR-144-3p and DNMT3A that were observed in 
the cerebral microvessels of aged mice via MACE-Seq in the in vitro model, hCMEC/D3 cells 
were transfected with pre-miR-144-3p, anti-miR-144-3p and siDNMT3A. General transfection 
efficiency was first verified using a Cy3-labelled pre-miR negative control (Figure 33). 
Efficiency of the technique was measured by flow cytometry at 24h, 48h and 72h after 
performing the transfection with Cy3-labelled controls. As determined by fluorescence 
microscopy and flow cytometry (Figure 33A), over 85% of hCMEC/D3 cells were found to 
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be transfected (Figure 33B). The transfectant was detected as early as 24h following 
transfection and remained stable for at least 72h post-transfection.  
 
Figure 33. Efficiency of miRNA precursor transfection in hCMEC/D3 cells.  
hCMEC/D3 cells were transfected using Cy3-labelled pre-miR negative control. A) To determine efficiency of 
transfection, cells were visualized using bright and fluorescent microscopy and the percentage of fluorescent cells 
was measured by flow cytometry using FACS. B) Over 85% of hCMEC/D3 cells were detected to be transfected 
for at least 48h. The percentage of positive cells decreased to ~80% at 72h. (n=3, One-Way ANOVA and 
Dunnett’s correction test; ****, p<0.0001). 
4.3.1.2 Transfection of hCMEC/D3 cells with miRNA precursors and antagonists successfully 
modulates expression levels of miR-144-3p 
hCMEC/D3 cells were then transfected with either pre-miR-144-3p or anti-miR-144-
3p (Figure 34). Levels of miR-144-3p were increased by more than 50-fold in cells transfected 
with pre-miR-144-3p compared to cells transfected with scrambled pre-miR (Figure 34A). By 
contrast, the relative expression of of miR-144-3p was decreased by 20-fold in cells transfected 
with anti-miR-144-3p compared to control cells (Figure 34B). 
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Figure 34. Relative expression of miR-144-3p in hCMEC/D3 cells transfected with pre-miR-144-3p and 
anti-miR-144-3p.  
hCMEC/D3 cells were transfected with pre- and anti-miR-144-3p, whereas scrambled pre- and anti-miR were 
used as control. Relative expression was calculated over the expression of miR-24-3p as control miRNA. Actin-β 
was used as internal control gene. A) Cells transfected with pre-miR-144-3p showed an increase of 50-fold in the 
relative expression versus those transfected with scrambled pre-miR. B) hCMEC/D3 cells transfected with anti-
miR-144-3p showed a decrease of 20-fold in the levels of miR-144-3p in comparison to scrambled anti-miR144-
3p transfected cells. (n=3, Student’s t test; *, p<0.05; ***, p<0.001). 
4.3.1.3 Transfection of hCMEC/D3 cells with silencing RNAs successfully modulates 
expression of DNMT3A at RNA level 
Additionally, hCMEC/D3 cells were transfected using siDNMT3A (Figure 35). In 
those cells transfected with siDNMT3A, the relative expression of DNMT3A was significantly 
decreased compared to cells transfected with scrambled siRNA.  
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Figure 35. Relative expression of DNMT3A in hCMEC/D3 cells transfected with siDNMT3A.  
hCMEC/D3 cells were transfected with siDNMT3A, whereas cells transfected with scrambled siRNA were used 
as control. Relative expression was calculated over the expression of actin-β as control gene. Cells transfected 
with siDNMT3A show a decrease of half in the relative expression of DNMT3A when compared to those 
transfected with scrambled siRNA. (n=3, Student’s t test; *, p<0.05).  
4.3.1.4 Transfection of hCMEC/D3 cells with pre-miR-144-13p and anti-miR-144-3p 
modulates changes in the RNA expression of DNMT3A 
To confirm the predicted targeting relationship between miR144-3p and DNMT3A, 
DNMT3A mRNA levels were measured in hCMEC/D3 cells transfected with pre- and anti- 
miR144-3p (Figure 36). Cells transfected with pre-miR-144-3p showed a significant decrease 
in relative expression of DNMT3A compared to control cells (Figure 36A). In contrast, 
DNMT3A mRNA expression was significantly upregulated in cells transfected with anti-miR-
144-3p compared to control cells transfected with scrambled anti-miR (Figure 36B). 
. 
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Figure 36. Relative expression of DNMT3A in hCMEC/D3 cells transfected with pre-miR-144-3p and anti-
miR-144-3p.  
DNMT3A mRNA expression levels were measured in hCMEC/D3 cells transfected with pre- and anti-miR144-
3p. Relative expression was calculated referred to expression in control cells transfected with scrambled pre- and 
anti-RNA. Actin-β was used as internal control gene. A) In cells transfected with pre-miR-144, relative levels of 
miR-144-3p showed a significant decrease from 1 to 0.5 compared to control cells. B) Cells transfected with anti-
miR-144-3p showed a significant increase from 1 to 1.5 in relative expression of DNMT3A in comparison to 
control cells transfected with scrambled anti-miR. (n=3, Student’s t test; **, p<0.01).  
 
4.3.2 Paracellular permeability of hCMEC/D3 cells does not change following miR-144-
3p deregulation 
To determine if changes in miR-144-3p and/or DNMT3A expression contributed to 
dysregulation of BBB permeability, static paracellular permeability was assessed in 
hCMEC/D3 cells transfected with pre-miR-144-3p. hCMEC/D3 monolayer showed TEER 
values around 15 ·cm2. No significant change in paracellular permeability was observed in 
cells transfected with pre-miR-144-3p compared to control cells transfected with scrambled 
pre-miR. By contrast, non-transfected cells simulated with TNF-α/IFN-γ for 24h as positive 
control did show an increase in permeability (Figure 37). Based on these results, permeability 
assay was not repeated with hCMEC/D3 cells transfected with anti-mir-144-3p nor 
siDNMT3A. 
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Figure 37. Endothelial Permeability Coefficient (PE) of hCMEC D3 cells transfected with pre-miR-144-3p.  
hCMEC/D3 cells are seeded onto transwell inserts and grown until 70% confluence. After 24h, cells were 
transfected with pre-miR-144-3p and scrambled pre-miR as negative control, and then maintained in culture until 
100% confluence (48h post-transfection). Static paracellular permeability was assessed using dextran-FITC 70 
KDa and fluorescence was measured in a plate reader. In addition, cells stimulated with TNF-α/IFN-γ for 24h 
were used as positive control. According to these results, hCMEC/D3 cells transfected with pre-miR-144-3p did 
not show a significant increase in paracellular permeability compared to cells transfected with scrambled pre-
miR. (n=4, One-Way ANOVA and Tukey’s correction test; *, p<0.05; ##, p<0.01; ns, not significant).  
  
 
4.3.3 DNMT3A downregulation promotes a significant increase of leukocyte adhesion to 
hCMEC/D3 cell monolayer  
4.3.3.1 Flow-based adhesion onto hCMEC/D3 monolayer is increased when DNMT3A is 
downregulated but not when miR-144-3p is upregulated 
To determine whether miR-144-3p and/or DNMT3A expression regulates leukocyte 
adhesion at the BBB, Jurkat T lymphocyte adhesion to hCMEC/D3 cells transfected with pre- 
and anti-miR-144-3p, siDNMT3A or scrambled pre-/anti-miR and siRNA, was assessed. Non 
transfected cells stimulated with TNF-α/IFN-γ for 24 hours were used as positive control 
(Figure 38). Leukocyte adhesion was not significantly changed in hCMEC/D3 cells transfected 
with pre- or anti-miR-144-3p (Figure 38A and B). By contrast, a significant increase in T cell 
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adhesion was observed when DNMT3A was silenced by transfecting the cells with siDNMT3A 
(Figure 38C).  
 
Figure 38. Adhesion of Jurkat T cells to transfected hCMEC/D3 cell monolayer.  
hCMEC/D3 cells were transfected with pre-miR-144-3p, anti-miR-144-3p, siDNMT3A and scrambled pre-/anti-
miRs or siRNAs as negative controls. Non transfected cells stimulated with TNF-α/IFN-γ were used as positive 
control. A) No significant differences in leukocyte adhesion were observed in hCMEC/D3 cells transfected with 
pre-miR-144-3p compared to cells transfected with scrambled pre-miR. B) Similarly, hCMEC/D3 cells 
transfected with anti-miR-144-3p did not show significant differences versus cells transfected with scrambled 
anti-miR-144-3p. C) In contrast, hCMEC/D3 transfected with siDNMT3A showed a significant increase in 
leukocyte adhesion compared to cells transfected with scrambled siRNA. (n=4, One-way ANOVA and Tukey’s 
correction test; ****, ####, p<0.0001; *, p<0.05; ns, not significant). 
4.3.3.2 Relative RNA expression level of adhesion molecules VCAM-1 and ICAM-1 is 
altered with miR-144-3p/DNMT3A deregulation 
The mRNA levels of adhesion molecules, VCAM-1 and ICAM-1, were then measured 
in hCMEC/D3 cells transfected with pre-miR-144-3p, anti-miR-144-3p and siDNMT3A 
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(Figure 39). Relative levels of VCAM-1, but not ICAM-1, were significantly increased in cells 
transfected with pre-miR-144-3p compared to cells transfected with scrambled pre-miR 
(Figure 39A). On the other hand, no significant changes were observed in VCAM-1 and ICAM-
1 mRNA expression in cells transfected with anti-miR-144-3p versus cells transfected with 
scrambled anti-miR (Figure 39B). By contrast, silencing of DNMT3A resulted in a significant 
increase in both VCAM-1 and ICAM-1 mRNA levels compared to cells transfected with 
scrambled siRNA (Figure 39C). Together these results support the idea of a functional change 
in leukocyte adhesion process when miR-144-3p/DNMT3A are deregulated that may be 
mediated by differential expression of ICAM-1 and VCAM-1 as part of a complex mechanism. 
 
Figure 39. VCAM-1 and ICAM-1 mRNA expression levels in transfected hCMEC/D3 cells.  
hCMEC/D3 cells were transfected with pre-miR-144-3p, anti-miR-144-3p, siDNMT3A and scrambled pre-/anti-
miRs or siRNAs as negative controls. A) VCAM-1, but not ICAM-1, was significantly increased in cells transfected 
with pre-miR-144-3p. B) hCMEC/D3 cells transfected with anti-miR-144-3p did not show any significant 
differences in VCAM-1 and ICAM-1 expression. C) The mRNA levels of both VCAM-1 and ICAM-1 were 
significantly increased when DNMT3A was directly silenced by siDNMT3A transfection in hCMEC/D3 cells. 
(n=3, Student’s t test; **, p<0.01; * p<0.05; ns, not significant). 
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4.3.3.3 Relative RNA expression of CCL5 is increased when DNMT3A is directly silenced in 
hCMEC/D3 cells but does not change after miR-144-3p deregulation 
CCL5 is a chemokine related to inflammation and leukocyte migration and was one of 
the highest upregulated genes in the MACE-Seq dataset. To determine whether expression of 
CCL5 was also induced by miR-144-3p and/or DNMT3A, CCL5 levels were measured in 
transfected hCMEC/D3 cells (Figure 40). No significant differences were observed between 
cells transfected with pre- or anti-miR-144-3p and their respective scrambled controls (Figure 
40A and B). However, when DNMT3A was downregulated using siDNMT3A, CCL5 mRNA 
levels showed a small but significant upregulation (Figure 40C). 
 
Figure 40. CCL5 mRNA expression levels in transfected hCMEC/D3 cells.  
hCMEC/D3 cells were transfected with pre-miR-144-3p, anti-miR-144-3p, siDNMT3A and scrambled pre-/anti-
miRs or siRNAs as negative controls. A) hCMEC/D3 cells transfected with pre-miR-144-3p did not show 
significant changes in CCL5 expression versus cells transfected with scrambled pre-miR. B) CCL5 mRNA levels 
were not significantly changed in cells transfected with anti-miR-144-3p compared to cells transfected with 
scrambled anti-miR. C) A small but significant increase in CCL5 mRNA expression was observed in cells 
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transfected with siDNMT3A compared to cells transfected with scrambled siRNA. (n=3, Student’s t test; *, 
p<0.05; ns, not significant). 
 
4.3.4 Adhesion molecules in aged female mice microvessel fragments 
4.3.4.1 RNA expression levels of Icam-1 and Vcam-1 are not changed in microvessel 
fragments of aged female C57BL/6J mice 
To determine if Icam-1 and Vcam-1 levels were also altered in the brain microvessels 
of aged female mice, mRNA levels of both were measured by MACE-Seq (Figure 41A and 
B) and qPCR (Figure 41C and D), in order to validate. As shown in Figure 41, neither Icam-
1 or Vcam-1 expression at RNA level were altered between young and aged mice as determined 
by MACE-Seq and validated by qPCR.  
 
Figure 41. Vcam-1 and Icam-1 mRNA expression levels in brain microvessel fragments from female 
C57BL/6J mice.  
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Vcam-1 and Icam-1 RNA levels were measured by both sequencing and qPCR techniques. A, B) Icam-1 and 
Vcam-1 expression did not show significant changes in aged brain microvessels compared to young capillaries in 
MACE-Seq analysis. C, D) Similarly, Icam-1 and Vcam-1 RNA relative expression is not significantly modified 
in aged brain microvessel fragments when compared to young brain microvessel fragments. (n=3, Student’s t test; 
ns, not significant).  
4.3.4.2 Icam-1 but not Vcam-1 protein expression is changed in aged microvessel fragments 
of female C57BL/6J mice 
Levels of protein expression of Vcam-1 were assessed by immunohistochemistry in 
cortical brain sections from young and aged female C57BL/6J mice (Figure 42). No significant 
differences were observed in intensity (Figure 42A) or % area positive for Vcam-1 protein 
expression (Figure 42B) between brain microvessels of young and aged female mice. 
 
Figure 42. Immunofluorescent staining of Vcam-1 in young and aged brain microvessels of female 
C57BL/6J mice.  
Brain microvessels positive for Vcam-1 were identified as green. Measurement of Vcam-1 staining in young and 
aged microvessels did not show significant d differences in A) intensity or B) percentage of area stained from 
young to aged. (n=4/age group, Student’s t test; ns, not significant). 
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Levels of protein expression of Icam-1 were also assessed by immunohistochemistry in 
cortical brain sections from young and aged female C57BL/6J mice (Figure 43). Both staining 
intensity (Figure 43A) and % area positive for Icam-1 protein expression (Figure 43B) were 
significantly increased in aged microvessels compared to young microvessels.  
 
Figure 43. Immunofluorescent staining of Icam-1 in young and aged brain microvessels of female C57BL/6J 
mice.  
Brain microvessels positive for Icam-1 where identified as red. Measurement of Icam-1 showed a significant 
increase in both A) intensity and B) percentage of area stained in aged brain microvessels compared to those in 
young mice. (n=4/age group, Student’s t test; **, p<0.01; ***, p<0.001). 
 
4.4 Discussion 
In this chapter, we aimed to confirm the interrelation between miR-144-3p and 
DNMT3A in hCMEC/D3 and assess the effect of their deregulation in paracellular permeability 
and leukocyte adhesion to BEC monolayers. Altogether, our findings support the hypothesis 
that miR-144-3p regulates DNMT3A expression in brain endothelial cells, and that DNMT3A 
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in turn regulates levels of inflammatory mediators. Alterations in miR-144-3p expression did 
not affect static BBB permeability or leukocyte adhesion. However, decreased expression of 
DNMT3A was associated with an increase in leukocyte adhesion in human BECs. This increase 
in adhesion was concomitant with increased RNA levels of VCAM-1, ICAM-1 and CCL5 in 
hCMEC/D3 cells. Protein expression of Icam-1 but not Vcam-1 was significantly increased in 
aged female brain microvessels compared to young animals. These results suggest that the age-
related increase of miR-144-3p negatively regulate DNMT3A expression, and DNMT3A 
independently affects DNA methylation patterns in BECs leading to overexpression of pro-
inflammatory factors such as ICAM-1, VCAM-1 and CCL5, contributing to an increase in 
leukocyte adhesion to the endothelial cells of the BBB.  
Target prediction analysis of transcriptomic data generated from the MACE-Seq 
experiments showed DNMT3A as a predicted target of miR-144-3p. Consistent with the ex vivo 
analyses in female mouse tissue, levels of DNMT3A RNA were found to change in the opposite 
direction to miR-144-3p in human BECs transfected with pre- and anti-miR-144-3p. These 
results confirm the reciprocal relationship between miR-144-3p and DNMT3A in hCMEC/D3 
cells. Age-mediated deregulation of both miR-144-3p and DNMT3A in opposite directions 
have been previously reported in different studies in humans and rodents and mostly occurring 
in neurons (Cui and Xu 2018; Fan et al. 2019; Persengiev et al. 2011). In addition, although 
not in the context of endothelial cells or BBB, recent studies in women of different ages 
exposed to perfluoroalkyl substances have predicted DNMT3A as a target of miR-144-3p (Xu 
et al. 2020). Nevertheless, no correlation between miR-144-3p and DNMT3A had been 
confirmed in the brain cerebrovasculature to our knowledge. Interestingly, miR-144-3p and 
DNMT3A have both been implicated in inflammatory processes: MiR-144-3p overexpression 
has been reported to correlate with increased neuroinflammation and decreased anti-
inflammatory protein expression in male mice and rats (Chu et al. 2019; Yu et al. 2017), 
whereas DNMT3A appears to play an anti-inflammatory role in male and female mice, since 
its loss or decrease have recently been linked to promote inflammatory activation (Jacquelin et 
al. 2018; Leoni et al. 2017). Taken together, these observations suggest a role of miR-144-3p 
and/or DNMT3A deregulation in inflammatory processes that may be occurring at the ageing 
BBB. To determine whether miR-144-3p and/or DNMT3A had any effect on BEC function and 
inflammation, paracellular permeability and leukocyte adhesion were assessed in hCMEC/D3 
cells in the context of miR-144-3p/DNMT3A deregulation. According to our results, 
deregulation of miR-144-3p did not change paracellular permeability or leukocyte adhesion to 
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BECs. In contrast, despite the effect of DNMT3A deregulation was not assessed in paracellular 
permeability, DNMT3A silencing was shown to correlate with increased leukocyte adhesion to 
human BECs. These findings suggest that despite the regulatory relationship established 
between miR-144-3p and DNMT3A, the latter may have a more prominent and independent 
role in modulating leukocyte adhesion to BECs. In fact, something similar might be happening 
in paracellular permeability, which we did not assess due to the lack of alteration by miR-144-
3p deregulation, however, it could be possible that DNMT3A, and not miR-144-3p, has the 
strongest effect. Nonetheless, we can speculate that miR-144-3p negatively modulates 
DNMT3A, which in turn, independently, contribute to inflammatory processes such as 
leukocyte adhesion. Consequently, we can speculate that DNMT3A plays an anti-inflammatory 
role in the brain vasculature that would be attenuated due to its age-mediated downregulation. 
However, additional measurements of paracellular permeability in the context of silencing 
DNMT3A would aid understanding the actual impact of DNMT3A deregulation in BBB 
function. Also, it is important to acknowledge that a TEER of 15 ·cm2 as observed in the 
present experiment does not represent a restrictive barrier, thereby a different strategy for the 
BBB model, like including astrocytes or pericytes, or a different method of measuring 
permeability, might give higher power to the analysis. 
In the present study, DNMT3A anti-inflammatory role appeared to also have an effect 
on the expression of several pro-inflammatory mediators related to adhesion. In fact, silencing 
of DNMT3A mRNA in hCMEC/D3 cells was concomitant with overexpression at RNA level 
of adhesion molecules, ICAM-1 and VCAM-1, and the chemokine CCL5. Although no 
significant effect of miR-144-3p was observed in leukocyte adhesion, cells transfected with 
pre-miR-144-3p showed a significant overexpression of VCAM-1, which might be due to the 
indirect downregulation of DNMT3A mediated by miR-144-3p. ICAM-1 and VCAM-1 have 
been reported to be upregulated in human BECs under inflammatory conditions including 
exposure to cytokines (Stins et al. 1997). Also, BEC activation mediated by ICAM-1 and 
VCAM-1 has been implicated in neuroinflammatory processes by contributing to leukocyte 
transendothelial migration after ischemic stroke in the human brain (Supanc et al. 2011), where 
they allow leukocytes such as T-cells to firmly adhere to the brain endothelium via interaction 
with integrins (Nagai and Granger 2018). In addition, chemokines such as CCL5 have been 
reported to be upregulated under inflammatory conditions or after brain injury in rodents and 
humans (Arisi et al. 2015; Kiguchi, Kobayashi, and Kishioka 2012). Similarly, CCL5 was 
reported to contribute to leukocyte adhesion and migration across the BBB in several species, 
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including human BECs in vitro and female EAE model mice (Quandt and Dorovini-Zis 2004; 
Dos Santos et al. 2005; Subileau et al. 2009). Additionally, CCL5 has been described to 
increase in women and men during normal ageing (Mansfield et al. 2012). Interestingly, 
ICAM-1 and VCAM-1 have been recently reported to be at least partly regulated by DNA 
methylation, involving NF-kB signalling, in human atherosclerosis (Hai and Zuo 2016). 
However, no correlation has been reported between DNMT3A and ICAM-1/VCAM-1. By 
contrast, although not in the context of BBB, Dnmt3a downregulation has been previously 
linked to overexpression of Ccl5 among other chemokines and cytokines in a LPS-stimulated 
macrophage line in male and female mice (Sano et al. 2018). These results suggest that 
DNMT3A is excessing a direct or indirect suppression on ICAM-1, VCAM-1 and CCL5 
expression and when DNMT3A is downregulated, these inflammatory mediators are 
significantly overexpressed, contributing to leukocyte adhesion to BECs.  
Despite the three inflammatory mediators being significantly overexpressed, ICAM-1 
and VCAM-1 showed a higher fold change than CCL5, which made us focus on these adhesion 
molecules for further measuring their protein expression levels in the female brain. 
Notwithstanding the significant change in RNA expression of VCAM-1 and ICAM-1 in the in 
vitro analysis, results of the MACE-Seq analysis had shown that mRNA of Icam-1 and Vcam-
1 remained unchanged in both aged and young brain capillaries from female mice. Therefore, 
to determine potential changes in protein levels of Icam-1 and Vcam-1, immunofluorescence 
staining was performed in mouse brain cortical sections. The results showed that 
cerebrovascular Vcam-1 protein expression did not differ between aged and young female 
mice. In contrast, Icam-1, although not changed at RNA levels, showed a significant increase 
in protein expression in the ageing female cerebrovasculature compared to young brain vessels. 
As mentioned for Dnmt3a staining in the previous chapter, a multiple staining including a 
vascular marker (e.g. PECAM-1) and DAPI, would have helped showing Vcam-1 and Icam-1 
location in the vessels, as well as confirming equivalent amounts of cellular material from both 
age groups. In any case, the findings suggest, first, a differential regulation of Icam-1 and 
Vcam-1, and second, modifications in Icam-1 at the protein level in the ageing female mouse 
brain. Differences in Icam-1 and Vcam-1 modulation might be in turn associated with an age-
deregulation of Dnmt3a that induces overexpression of Icam-1, but not Vcam-1, in brain 
microvessels. A differential mechanism of Dnmt3a-mediated regulation might be supported in 
the present study by a higher overexpression of ICAM-1 compared to VCAM-1 when DNMT3A 
was silenced in hCMEC/D3 cells. Interestingly, previous studies have already shown 
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differences in ICAM-1 and VCAM-1 function, such as differential contribution to leukocyte 
adhesion and migration across the human BBB in vitro, depending on the leukocyte population 
(Wong et al. 2007). Also, Icam-1 levels on the surface of BECs have been reported to influence 
the pathway of T cells across the inflamed monolayer, with higher levels of Icam-1 promoting 
a transcellular pathway (Abadier et al. 2015). Interestingly, these observations might support 
the theory of different regulatory mechanisms depending on the adhesion molecule. In addition, 
differences between mRNA and protein levels of Icam-1 during ageing, are pointing at 
potential post-translational regulation mechanisms. Indeed, several post-translational 
modifications may alter the structure and function of proteins, going from amino acid changes 
(e.g. phosphorylation) to the addition of macromolecules (Nalivaeva and Turner 2001). 
Western blot analysis of Icam-1 protein levels in isolated microvessels of aged and young 
female mice, in addition to the analysis of potential post-translational modifications in Icam-1 
protein structure, might give some insight to its Dnmt3a-mediated regulation. In any case, the 
age-induced upregulation of Icam-1 observed in our analysis is in contrast with recent studies 
that described inflammation and TJ alterations in the ageing BBB of female mice, but not 
overexpression of adhesion molecules or increased leukocyte transendothelial migration 
(Elahy et al. 2015). However, our results were consistent with studies that have reported an 
increase in adhesion molecule expression in aged endothelial cells from rodents and humans 
(Csiszar et al. 2008). Also, previous studies have described a higher expression of Icam-1, but 
not Vcam-1, in BECs and astrocytes of aged male mice when exposed to inflammatory 
cytokines (Xu et al. 2010). Nevertheless, further research is needed in this field, and additional 
experiments measuring leukocyte adhesion in the female cerebrovascular in vivo might shed 
some light on the age-induced crossing of immune cells into the CNS in absence of pathology.  
Most of the studies discussed above have reported the same mechanistical differences 
observed in our study (e.g. age-induced downregulation of DNMT3A or upregulation of ICAM-
1/VCAM-1/CCL5 in inflammation) independent on the sex. However, some sex differences 
might be playing a role in this system, since expression of DNMTs has shown certain 
differences depending on males or females. Indeed, previous studies have suggested that 
DNMT3A expression might be regulated by sex steroid hormones (Kolodkin and Auger 2011), 
including oestrogen/progesterone-mediated downregulation of DNMT3A in women as 
observed during the menstrual cycle (Yamagata et al. 2009), or upregulation of Dnmt3a in aged 
female mouse brain after injection of estradiol (Liu et al. 2010). If oestrogen induces 
upregulation of Dnmt3a in the mouse, we may speculate that changes in oestrogen levels as 
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observed during reproductive senescence might have an effect on Dnmt3a regulation which in 
turn, and according to our results, will modulate the expression of adhesion molecules such as 
Icam-1. 
In summary, the present study suggests a potential role of DNMT3A in the ageing BBB, 
both by its targeting relationship with miR-144-3p and its independent regulation of pro-
inflammatory mediators such as ICAM-1, VCAM-1 and CCL5. However, some extra analyses 
are needed to determine whether DNMT3A is also related with changes in BBB paracellular 
permeability. Also, most of the experiments where performed in a very simplified in vitro 
human BBB model; therefore, additional experiments in vivo would aid to understand the role 
of DNMT3A in the complex environment of the BBB and whether its deregulation in ageing 
affects barrier function in more ways.   
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Chapter 5. General discussion and conclusions 
5.1 Summary of Results 
This body of work tested the hypothesis that ultrastructural changes at the female BBB 
are related to alterations in gene expression of protein-coding mRNAs and miRNAs that 
regulate BBB integrity and function. Results from the structural analysis (3D reconstruction 
only), sequencing and functional results are summarised in Table 3 and Table 4, respectively. 
Table 3. Summary of ultrastructural changes in the ageing female BBB of cortex and hippocampus (3D 
reconstruction). 
 Young vs Aged Female Mice Cortex  
vs  
Hippocampus Structural Features Cortex Hippocampus 
BM thickness High in aged capillaries High in aged capillaries No difference 
BEC mitochondria 
 
(Number and volume) 
No difference No difference No difference 
BEC Pseudopods 
 
(Number and volume) 
High number and 
volume in aged 
capillaries 
No difference 
High number and 
volume in aged cortical 
capillaries 
Pericyte mitochondria 
 
(Number and volume) 
High volume in aged 
capillaries 
 
No difference in 
number 
 
High volume in aged 
capillaries 
 
No difference in 
number 
 
No difference 
Pericyte coverage over 
BECs 
High in aged capillaries No difference No difference 
Astrocyte coverage over 
BM 
No difference No difference No difference 
Tight junction tortuosity High in aged capillaries No difference 
High in aged cortical 
capillaries 
Tight junction 
complexity 
No difference No difference 
Lower in aged cortical 
capillaries 
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Table 4. Summary of gene expression alterations in the female cortical BBB during ageing.  
Age-deregulated mRNAs (MACE-Sequencing Analysis) 
 Number of 
genes (p<0.05) 
Associated pathways  
(p<0.05) 
Upregulated mRNAs 211 
Inflammatory response; immune system process; 
response to stress; leukocyte migration; cell 
activation; leukocyte cell-cell adhesion 
Downregulated 
mRNAs 
94 
Cellular response to hormone stimulus; 
intracellular signal transduction; circulatory 
system process; response to stress; homeostatic 
process 
Deregulated miRNAs (Small RNA Analysis) 
 Number of miRNAs  
(p<0.05) 
Associated pathways for predicted targets 
(p<0.05) 
Upregulated miRNAs 4 Intracellular signal transduction; endothelial cell 
migration; cellular response to stress; programmed 
cell death 
Downregulated 
miRNAs 
5 
Functional in vitro analysis – Leukocyte adhesion to hCMEC/D3 cell monolayers 
 
Leukocyte 
adhesion  
(Jurkat cells/ 
field) (p<0.05) 
Adhesion molecule 
expression 
(p<0.05) 
Chemokine 
expression 
(p<0.05) 
Pre-miR-144-3p 
transfection 
No difference 
VCAM-1 (higher) 
ICAM-1 (no difference) 
CCL5  
(no difference) 
Anti-miR-144-3p 
transfection 
No difference 
VCAM-1 (no difference) 
ICAM-1 (lower) 
CCL5  
(no difference) 
siDNMT3A transfection Higher 
VCAM-1 (higher) 
ICAM-1 (higher) 
CCL5 
 (higher) 
Ex vivo analysis – Expression of adhesion molecules in brain tissue 
 Vcam-1 (p<0.05) Icam-1 (p<0.05) 
Young mouse brain 
tissue 
No difference 
Low staining intensity and area 
in brain microvessels 
Aged mouse brain tissue No difference 
High staining intensity and area 
in brain microvessels 
 
In the present study, a series of age-related changes in the female mouse BBB have 
been identified at ultrastructural and molecular levels. Ultrastructural analyses showed that the 
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female mouse BBB was modified depending on the age of the individual and the brain region 
analysed, thus, cortical capillaries appeared to present more changes than hippocampal 
capillaries in aged animals. Based on these results, sequencing analysis was performed on brain 
microvessels isolated from cortex only. MACE-Seq analysis showed a significant 
overexpression of genes participating in pathways related to immune and inflammatory 
response, cell activation and leukocyte migration. On the other hand, most of the 
downregulated genes were related to metabolic and signalling pathways. Small RNA analysis 
showed a total of 9 age-deregulated miRNAs. Amongst them, miR-144-3p and its predicted 
mRNA target, Dnmt3a, were reported to be inversely correlated in ageing, and due to their 
potential contribution to ageing BBB and neuroinflammation, they were selected for further 
functional analysis. MiR-144-3p expression was confirmed to participate in the modulation of 
DNMT3A expression in hCMEC/D3 cells, which were also used to estimate the potential 
effects of miR-144-3p/DNMT3A deregulation in cellular function. MiR-144-3p overexpression 
did not show any significant changes in paracellular permeability. Similarly, no alterations in 
leukocyte adhesion were observed after miR-144-3p deregulation. By contrast, silencing of 
DNMT3A was shown to increase leukocyte adhesion as well as expression levels of adhesion 
molecules ICAM-1 and VCAM-1 and the chemokine CCL5. These results do not fully address 
the original hypothesis directly correlating ultrastructural and molecular changes in ageing. 
However, they do suggest age-induced ultrastructural changes at the BBB that are more 
prominent in cortex than hippocampus, in addition to gene expression deregulation that leads 
to a low-grade increase in neuroinflammation. Although no direct link is established between 
structural and molecular age-induced changes in this thesis, the amount of data generated is an 
interesting source of material for future studies to better understand the female mouse BBB in 
the context of ageing.  
 
5.2 BBB alterations during ageing in the context of reproductive senescence 
The specific characteristics of the cerebral vasculature are known to change during 
ageing. These alterations directly correlate with significant BBB breakdown, cognitive decline 
or neuroinflammation in several species including human and mouse (Bowman et al. 2018; 
Fulop et al. 2018; Montagne et al. 2015; Sweeney, Sagare, and Zlokovic 2018). In females, the 
process of ageing is associated with reproductive senescence, characterized among other events 
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by a decrease in sex steroid hormone levels (Maffucci and Gore 2006; Mobbs et al. 1984). 
Oestrogen and progesterone are the main steroid hormones in females, thus have been shown 
to decrease in ageing. In the present study, oestrogen and progesterone plasma levels were 
measured to assess potential differences in ageing. A common way to present data from 
oestrogen and progesterone levels is by the ratio progesterone to estradiol (P/E2) (Bäckström 
and Mattsson 1975; Baird et al. 1991; Hekimoglu et al. 2010). However, in the case of mice, 
another method may be determination of acyclicity by cytology and assessment of vaginal 
epithelium (Byers et al. 2012). In the present study, reproductive senescence was confirmed by 
cytology. In addition, progesterone and oestrogen levels were measured by ELISA assay in 
plasma of young and aged female mice. P/E2 ratio was not changed between young and aged 
mice, which is not consistent with previous reports that have shown an age-related increased 
in P/E2 ratio (Nelson et al. 1981). The unchanged ratio might be due to the use of ELISA over 
other more sensitive techniques that have higher specificity regarding samples with low 
concentration sample (e.g. mass spectrometry) (Nilsson et al. 2015). 
Oestrogen and progesterone have been reported to play neuroprotective roles in 
neuroinflammation, oxidative stress and ischemic injury in human and mouse (Galea et al. 
2002; Garay et al. 2007; Gavin et al. 2009), due to the brain being a hormone-responsive organ 
(Miller and Duckles 2008). In addition, oestrogen has shown neurovascular and BBB 
protection in physiological conditions by promoting mitochondrial efficiency, reducing 
oxidative stress, attenuating expression of pro-inflammatory cytokines and adhesion molecules 
and limiting leukocyte migration across the brain vasculature (Corcoran et al. 2010; Santizo 
and Pelligrino 1999; Stirone et al. 2005). Similarly, progesterone exerts protection against 
neuroinflammation after brain injury and promotes regeneration in young and aged female rats 
(Jiang et al. 2009, 2016). Also, progesterone appears to prevent oedema via downregulation of 
cytokines after ischemia, and by blocking in vivo interactions between immune cells and BECs 
in the BBB (He et al. 2004; Pascual et al. 2013). In addition, progesterone has also been 
reported to prevent inflammatory response and BBB disruption by attenuation of MMP activity 
and TJ degradation in rats (Ishrat et al. 2010). Therefore, age-related changes in hormone levels 
might influence BBB function in women and female rodents. Whereas progesterone appears to 
maintain ischaemia-protection functions in aged female rats (Tanaka et al. 2018), oestrogen 
decline has been reported to promote loss of BBB integrity and altered transport within the 
brain in female mice (Kastin et al. 2001; Wilson et al. 2008) as well as hinder amyloid-β 
clearance in the human cortex (Li et al. 2000). Anti-inflammatory effects of oestrogen, 
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reducing adhesion molecule expression and promoting BBB integrity, also get compromised 
during ageing (Maggioli et al. 2016; Sunday et al. 2007). Based on these findings, hormone 
replacement therapies where thought to mainly counteract the loss of oestrogen-derived 
protection (Zandi et al. 2002). Paradoxically, several studies highlighted the detrimental effects 
of hormone replacement therapy regarding cardiovascular function, enhanced inflammatory 
parameters or cancer (Campagnoli et al. 2005; Ridker et al. 1999). Additionally, oestrogen 
therapy has been shown to increase the risk of developing stroke in post-menopausal women 
(Wassertheil-Smoller et al. 2003), and to worsen inflammatory-induced neural impairment in 
aged female rats (Marriott et al. 2002). Oestrogen differentially affects brain vasculature and 
BBB depending on age, preventing leakage in young rodents but increasing it in aged animals 
(Bake and Sohrabji 2004; Chi et al. 2006). Potential explanations for this age-dependent role 
of oestrogen include types of therapies (e.g. transdermal versus oral administration) and the 
points at which therapy is started (Selvamani and Sohrabji 2010), or age-mediated regulation 
of oestrogen receptors, ER-α and -β (Wilson et al. 2002). Interestingly, studies in middle-aged 
female rats have shown how depending on the starting point of the treatment, oestrogen-
induced expression of ER-α changes, thereby promoting expression of ER-α preferably in 
hippocampus right after ovariectomy, whereas it would shift to cortical ER-α when the 
treatment started several months after ovariectomy (Bohacek and Daniel 2009). Altered 
receptor expression might be linked to the shifted effect of oestrogen. Progesterone and 
synthetic progesterone-like steroids (e.g. progestins) are also used in therapy and commonly 
known as progestogens. Different types of progestogens have been shown to promote different 
effects, including increased risk of breast cancer or stroke when in combination with oestrogen 
therapy in post-menopausal women (Campagnoli et al. 2005; Wassertheil-Smoller et al. 2003). 
By contrast, natural progesterone has been reported to maintain protective and anti-
inflammatory effects after ischemic stroke in aged male and female rodents but not in 
ovariectomised females (Gibson et al. 2011), which suggests that other ovarian factors also 
contribute to the final response to progesterone treatment. These findings suggest that the type 
of progestogen used in therapy does have an impact in the risk of vascular damage (Santen et 
al. 2010). Interestingly, recent clinical guidelines from the International Menopause Society 
have proposed more positive outcomes regarding hormone therapy. In fact, they have reported 
that transdermal estradiol, in opposition to oral oestrogen therapy, is not related with higher 
risk of cardio- or neurovascular complications in elderly women, which suggests that hepatic 
metabolism of oestrogen during the oral therapy somehow induces its detrimental effects (De 
Villiers et al. 2013). Also, the use of micronized progesterone, a synthetic progestogen with 
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identical structure to that of endogenous progesterone, has been shown not to increase the risk 
of vascular-related pathologies (e.g. thromboembolism or stroke) when alone or in combination 
with transdermal estradiol in post-menopausal women (Mueck 2012; Simon 2012). In any case, 
the synergistic effects between ageing and sex steroid hormone roles need further research in 
order to better understand cellular and molecular mechanisms behind it and how they fit into 
vasculopathies such as stroke in the female brain.  
 
5.3 Implications of ageing to the BBB ultrastructure  
5.3.1 BM thickness is increased in aged brain capillaries 
Vascular BM has been previously shown to undergo several molecular, morphological 
and physiological alterations during ageing, mostly focused on protein composition but also 
lower diffusion and filtration rates as well as loss of vascular elasticity and tone (Candiello et 
al. 2010; Perlmutter and Helena Chang Chui 1990; Zarow et al. 1997). The ultrastructural 
analysis performed in this thesis showed a significant thickening of the vascular BM in cortical 
and hippocampal capillaries of aged female mice. Our results are consistent with other studies 
that have observed a progressive age-induced increase in cerebrovascular BM thickness of 
capillaries from both cortex and hippocampus of male and female humans and rodents (Alba 
et al. 2004; Farkas et al. 2006; Gerrits et al. 2010; Hawkes et al. 2013). Some studies have 
associated this age-induced thickening of microvascular BM with changes in the proportion of 
extracellular matrix proteins such as collagen IV or laminins (Ceafalan et al. 2019). Similarly, 
other studies have reported increasing collagen accumulation in brain microvessels not only 
during healthy ageing but also in neurodegenerative diseases such as AD or PD (Farkas et al. 
2000; Uspenskaia et al. 2004). A more in-depth analysis would be needed to assess which 
components of the extracellular matrix are changed in the aged brain capillaries. Also, our 
results were not specific enough to discern between endothelial or astrocytic BM. However, 
available data suggest that the thickening happens mostly in the astrocytic BM and, therefore, 
astrocytes may play an important role in such alteration (Wyss-Coray et al. 2000). Also, in our 
study, astrocytic coverage was increased in the 2D analysis but unchanged in the 3D analysis, 
suggesting possible complex changes in cellular function that would affect the thickening of 
the astrocytic BM. Nevertheless, while the causes of BM thickening and the cell types 
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responsible for it are not fully understood, some of its consequences have already been 
discussed. Increased BM thickness is linked to higher wall stiffness that leads to reduction in 
vascular elasticity and contractile force, which ultimately may have an effect on 
cerebrovascular blood flow (Desjardins et al. 2014). Therefore, progressive BM thickening and 
reduced blood flow might influence the regulation of exchange mechanisms between blood 
and brain, and may be associated with decreased nutrient supply and elimination of waste 
products (Farkas et al. 2006). Accordingly, age-induced increase in BM thickness appears to 
play a role in impaired perivascular drainage of interstitial fluid, contributing to accumulation 
of solutes and participating in the onset of actual pathological conditions including cerebral 
amyloid angiopathy and AD (Hawkes et al. 2011). Altogether, these results suggest that BM 
thickening is a universal feature in the ageing cerebrovasculature, and it may contribute to and 
exacerbate several neurodegenerative disorders that have a vascular component.  
5.3.2 BECs alterations as a mark of cerebrovascular ageing and inflammation 
Alongside microvascular changes, endothelial cells experience molecular and structural 
modifications during healthy ageing (Brandes et al. 2005). Some studies have reported age-
induced dysfunction of endothelial cells, including those of the BBB, which show a 
predisposition towards increased sensitivity to oxidative stress and higher expression of 
proinflammatory markers (Enciu et al. 2013; Rodríguez-Mañas et al. 2009). Therefore, some 
related endothelial characteristics were measured at the ultrastructural level in our analysis, 
including mitochondrial component. Mitochondria play important roles in pathways related to 
cellular energy and redox homeostasis, signalling, calcium buffering and programmed cell 
death, and their structure appear to impact on their function (Kluge, Fetterman, and Vita 2013; 
Picard et al. 2011). Our ultrastructural analysis included assessment of BEC mitochondrial size 
and number in cortical and hippocampal capillaries. No significant differences in mitochondrial 
volume or number per cell were observed in aged BECs compared to young BECs in either 
cortex or hippocampus in the 3D analysis, although the 2D analysis did show a decrease in 
both volume and number. Therefore, results from the 3D reconstruction, but not from the 2D 
analysis, are in contrast to previous observations of decreased size and number as well as 
decreased fusion and fission activity and/or impaired biogenesis of endothelial mitochondria 
in aged mice, primates and cultured ageing human endothelial cells (Burns et al. 1979; Hicks 
et al. 1983; Jendrach et al. 2005). However, other studies performed in male rats have showed 
no progressing differences in BEC mitochondrial area per section with ageing (Burns et al. 
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1981). Similarly, studies performed in elderly women and men did not show significant 
changes in BEC mitochondrial population (P. Stewart et al. 1987). These differentially 
observed changes add complexity to the understanding of neurovascular mitochondrial 
regulation in the context of ageing, since they do not appear to be similar between sexes or 
strains. Interestingly, changes in mitochondrial shape and fusion/fission balance have been 
linked to mitophagy in ageing (Sun et al. 2015). Indeed, mitochondria might undergo more 
fission events and face senescence (Scheckhuber et al. 2011) or show more fusion over fission 
and promote cell survival (Gomes et al. 2011). The differences in our 2D and 3D studies, might 
point out that potential changes in fusion/fission leads to aberrantly shaped mitochondria, 
which may appear as decrease in volume and number in 2D images but not when 3D 
reconstruction is taken into account. The balance that controls mitochondrial shape appears to 
have a higher impact in age-related modifications on mitochondrial function, although further 
research is needed to understand the ultimate effect on neurovascular and BBB function and 
whether sex-differences are at play in that scenario. 
BEC luminal surface has been shown to become irregular in some experiments 
involving accelerated senescent mice, where they show cellular protrusions from the cytoplasm 
into the lumen (E. Y. Lee et al. 2000). In the present study, similar surface projections were 
observed to be more prominent in the ageing brain capillaries, therefore, the size and number 
of these endothelial projections were also assessed in our analysis. Pseudopod were higher in 
number and volume in aged cortical BECs, when these were compared to either young cortical 
BECs or aged hippocampal BECs. Interestingly, structures similar to these pseudopods have 
been reported to appear on endothelial surface under inflammatory conditions in several organs 
including the brain (Lossinsky et al. 1991; Walski et al. 2002). In fact, similar features have 
recently been described in cultured human microvessel endothelial cells (e.g. HUVEC or 
human bone marrow endothelial cells) when stimulated with chemokines (Whittall et al. 2013). 
Additionally, expression of adhesion molecules or chemokine presentation have been reported 
to occur in specific projections on the endothelial cell surface that are complementary to the 
pseudopods observed in our study (Øynebråten et al. 2015). Together, these findings suggest 
that the observed increase in the number and volume of pseudopods in the ageing female BBB 
may increase the interaction of BECs with immune cells under pro-inflammatory conditions. 
Thus, our results might indicate that aged BECs are exposed to a more pro-inflammatory 
environment in the cortex but not in the hippocampus of female mice. A higher pro-
inflammatory state in the female BBB during ageing is supported by previous studies that found 
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a greater upregulation of genes related to immune activation and inflammation in the aged 
female brain compared to the aged male brain in mice and humans (Berchtold et al. 2008; C. 
K. Lee et al. 2000).  
Furthermore, both mitochondrial and proinflammatory modifications observed in our 
study have previously been associated with the role of oestrogen in endothelial function. 
Indeed, some studies have reported a protective role of oestrogen on mitochondrial efficiency 
via reduction of ROS and preservation of mitochondrial membrane potential in cerebral 
microvessels and BECs in vitro (Guo et al. 2010). In the case of inflammation, available data 
have shown how oestrogen promotes vascular function and protection against inflammation by 
increasing eNOS expression and activation (Gavin et al. 2009). In addition, oestrogen has also 
been reported to reduce adhesion molecule expression and leukocyte recruitment on the 
cerebral vasculature and to protect the BBB during inflammation (Maggioli et al. 2016; Mori 
et al. 2004). Oestrogen signalling is mediated by oestrogen receptors (ER-α and -β), from which 
ER-α appears to modulate the brain anti-inflammatory activity of the hormone, by inhibiting 
microglia activation (Vegeto et al. 2003) or inflammatory gene expression in brain 
macrophages via control of NF-kB pathway (Ghisletti et al. 2005). ER-α is expressed in BECs 
and its levels are higher in female rats chronically exposed to oestrogen (endogenous, normal 
cycling females, or exogenous, oestrogen replacement), which explains oestrogen effects in 
cerebrovascular function (Stirone, Duckles, and Krause 2003). Additionally, experiments on 
cultured human BECs have shown that ER-α also mediates oestrogen protective role in 
endothelial mitochondria (Razmara et al. 2008). Oestrogen receptors have shown differential 
expression during ageing in specific regions of the rat brain including the cortex (Wilson et al. 
2002). Age-related decrease in ER-α might contribute to BBB dysfunction in the elderly, as 
suggested by recent in vitro experiments on ER-α-free HUVEC cell line (Kuruca et al. 2017). 
Thus, changes not only in oestrogen levels, but also in the expression of its receptors might be 
contributing to the age-related changes described in BECs in our data. Interestingly, regional 
differences in this hormone/receptor system could also contribute to the differences observed 
between cortex and hippocampus in our study. Indeed, the developmental and postnatal rat 
brain has shown regional patterns in ER-α expression, whose levels are stable in hippocampus 
throughout time, whereas they tend to change more in brain cortical regions depending on the 
age (Pérez, Chen, and Mufson 2003). In addition, differential expression of ER-α linked to the 
shift on oestrogen effects in the BBB integrity of middle-aged female rats (Bohacek and Daniel 
2009), shows regional variance, suggesting potential differences between cortex and 
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hippocampus that may have a higher impact on brain vascular function during ageing and prior 
to hormone replacement treatments.  
Therefore, even though our results regarding oestrogen levels do not show a significant 
change in aged female microvessels, (which as discussed above, might be due to technical 
limitations) a similar mechanism might be behind the ultrastructural changes in BEC that we 
have observed. Taken together, these observations suggest that a combined age-related 
deregulation in oestrogen concentrations and ER expression might be linked to inflammatory 
processes at the ageing female cerebrovasculature and may have a higher impact in cortical 
vessels compared to hippocampal vessels. Also, mitochondrial dysfunction appears to occur at 
molecular and physiological levels rather than at the ultrastructural level, although further 
analysis on cell energy metabolism, mitochondrial function and/or oxidative stress regulation 
would be required to clarify this matter. 
5.3.3 Ageing as a modulator of pericyte mitochondria and coverage of brain capillaries 
Earlier studies have reported age-induced increase in the size of mitochondrial pericytes 
in both the cortex and hippocampus of male mice (Hicks et al. 1983), while more recent reports 
have shown an increase of pericytic mitochondrial size in aged Notch3 mutant transgenic mice, 
therefore in the context of microvascular pathology such as CADASIL (cerebral autosomal 
dominant arteriopathy with subcortical infarcts and leukoencephalopathy), the most common 
form of hereditary stroke disorder (Gu et al. 2012). In any case, such observations are consistent 
with the age-related increase in the volume of pericytic mitochondria observed in female 
cortical and hippocampal capillaries in our study. Mitochondrial structure and shape have been 
described to vary depending on processes of fission and fusion which required precise 
regulation (Fritz, Weinbach, and Westermann 2003). Fission and fusion regulation has been 
described as an essential mechanism in the modulation of respiratory function, mitochondrial 
DNA integrity or cell death (Aerts et al. 2008; Leadsham and Gourlay 2010), and might be 
altered in ageing (Leduc-Gaudet et al. 2015). Indeed, changes in mitochondrial shape appear 
to correlate with changes in mitochondrial DNA and/or structure, which is reported to occur 
during ageing in several tissues (Ciena et al. 2011). Therefore, age-related deregulation of 
mitochondrial structural dynamics might modulate mitochondrial function in oxidative stress 
and cell death during progression of normal ageing and neurodegenerative diseases (Ansari 
and Scheff 2010; Mistry et al. 2013; Morozov et al. 2017). Increased mitochondrial volume 
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and elongated shape have been previously described in aged oocytes, which also showed 
decreased energy-producing capability, suggesting a possible connection between both 
processes (Hao et al. 2009; Simsek-Duran et al. 2013). Moreover, abnormal mitochondrial 
shapes have also been linked to age-induced alterations in mitophagy (mitochondrial 
autophagy) mechanisms, which are directly related to cell survival and senescence (Sun et al. 
2015). Interestingly, fission/fusion balance may change in the context of mitophagy, and 
mitochondria may undergo fission events that lead to progressive senescence and cell death 
(Scheckhuber et al. 2011), or, by contrast, they may show reduced fission and display elongated 
and network-like morphology, which has the potential to both maintain cell viability and 
postpone mitochondrial dysfunction in ageing (Gomes et al. 2011). These observations, 
together with our ultrastructural data, suggest potential age-related modifications in 
mitochondrial function at the BBB, including pericytes, that translate into structural changes 
and might have a higher effect on cell viability. Pericytes have been reported to modulate cell 
communication, TJ formation, BBB integrity and blood flow (Dalkara et al. 2011; Dohgu et al. 
2005; Peppiatt et al. 2006), thus, changes in mitochondrial function and cell energy in pericytes 
may have an effect on BBB integrity via modulation of barrier permeability and disturbances 
in brain microcirculation. Additional studies on pericyte viability and mitochondrial activity 
might help to confirm and to better understand whether these structural alterations are indeed 
related to changes in mitochondrial and cellular function.  
In addition, pericyte coverage over brain capillaries was shown to be significantly 
increased in aged cortical capillaries whereas no changes in coverage were observed in the 
hippocampus. Our results in female mouse brain capillaries are in contrast with several studies 
performed in male mice and post-mortem human tissues from men and women that previously 
reported a decrease in pericyte coverage in the ageing brain, including cortex and hippocampus 
(Bell et al. 2010; P. Stewart et al. 1987). Age-related loss of pericyte coverage and contact with 
BECs has been previously linked to higher neurovascular dysfunction (Duncombe et al. 2017). 
Therefore, the opposite situation as observed in our study would suggest a better outcome 
regarding BBB integrity and blood flow regulation (Kamouchi et al. 2004; Zechariah et al. 
2013). However, the biological meaning of this increased pericytic coverage is unclear, further 
experiments measuring permeability or microvascular flow in vivo would give some 
understanding of the mechanisms behind it.  
5. General discussion and conclusions 
 
143 
 
5.3.4 TJ tortuosity and complexity as potential markers of BBB integrity in cortical and 
hippocampal capillaries 
TJ proteins have been reported to undergo age-mediated modifications (Elahy et al. 
2015; Goodall et al. 2018; Mooradian et al. 2003), having an impact at both functional and 
structural levels of the BBB. Although we did not assess age-related changes in TJ proteins in 
our analysis, these had been extensively reported (Bake et al. 2009; Elahy et al. 2015), and we 
did observe significant age-related differences on TJ structure. Indeed, TJ tortuosity was higher 
in aged cortical capillaries when compared to young cortical capillaries, whereas no significant 
differences were observed between young and aged TJs in hippocampal capillaries. In addition, 
TJ length/complexity did not change with age, but aged cortical capillaries showed more 
complex TJs, as defined by the length of endothelial cell contact, than aged hippocampal 
capillaries. However, although significant, the region-dependent change in TJ complexity was 
very small, thus whether it has any biological meaning is unclear. Little information is known 
about age-related changes in TJ tortuosity and length/complexity, but shorter and less tortuous 
TJs have been previously linked to TJ protein alterations in levels and subcellular localisation 
and to BBB disruption after ischemic stroke in granulin mutant male mice (Jackman et al. 
2013). Similarly, although in the context of Aβ and AD, decreased TJ length has been linked 
to TJ protein disruption and BBB dysfunction (Park et al. 2017). Liebner and colleagues also 
showed that changes in TJ morphology may correlate with altered TJ protein expression and 
distribution in microvessels of human glioblastoma (Liebner, Kniesel, et al. 2000). These 
observations suggest that less TJ tortuosity leads to higher BBB dysfunction and that functional 
and molecular changes at TJs may translate into rearrangement of their structure in BECs. 
Whether the increase in TJ tortuosity that we observed in cortical capillaries compared to 
hippocampal capillaries is related with better BBB integrity would need further analysis, 
including assessment of expression patterns of TJ proteins. Interestingly, a series of estradiol 
treatment experiments in ovariectomised middle-aged female rats have reported age-mediated 
and region-dependent loss of specific TJ proteins, showing altered paracellular permeability in 
hippocampus but not in cortex (Bake et al. 2009; Sandoval and Witt 2011). These findings 
point to TJ regulation mechanisms that depend on the brain region and might be modulated by 
sex steroid hormones. Thus, a combination of sex- and region-dependent differences could be 
the explanation behind the structural changes in TJs observed in our study, although additional 
experiments, such as TJ protein expression analysis, for instance, would lead to more 
conclusive results. 
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5.4 Implications of ageing in brain microvasculature gene expression profile 
In addition to ultrastructural changes, the BBB is also altered at the molecular and gene 
expression levels during ageing (Osgood et al. 2017; Silverberg, Messier, et al. 2010; 
Stamatovic et al. 2019). Recent studies have also linked a role for transcriptional regulation 
and differential expression of miRNAs to several processes in the ageing BBB (Inukai et al. 
2012). Specifically, miRNAs have been shown to participate in cerebrovascular modulation 
and BBB dysfunction in vascular cognitive impairment, neuroinflammation and 
neurodegeneration (W. Liu et al. 2016; Toyama, Spin, and Tsao 2016). Thus, the potential role 
of miRNAs in the onset of healthy ageing is of interest to understand the underlying molecular 
mechanisms. Our sequencing results found that most of the upregulated genes in the female 
ageing BBB were associated with inflammatory and leukocyte adhesion pathways. These 
results are consistent with previous studies that reported a higher inflammatory state of the 
ageing brain in mice and humans (Donato et al. 2007; C. K. Lee et al. 2000; Mejias et al. 2018). 
Additionally, our results are also in line with gene expression analysis performed by Berchtold 
and colleagues that showed how differential expression patterns in the ageing human brain are 
sexually dimorphic with a greater immune activation in elderly women in comparison to age-
matched men (Berchtold et al. 2008). Regarding miRNAs, a total of 9 miRNAs were 
differentially expressed in the female brain microvasculature during ageing, and among the 
predicted targets, several genes were related to response to stress and cell death pathways. 
Similarly, these results are consistent with available data that described processes of oxidative 
stress, endothelial inflammation and cell death during age-induced cerebrovascular dysfunction 
(Modrick et al. 2009; Park et al. 2007; Rodríguez-Mañas et al. 2009). 
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5.5 BBB alterations in ageing appear to be associated with miR-144-3p/DNMT3A 
deregulation 
5.5.1 MiR-144-3p/DNMT3A deregulation induces changes in adhesion molecules but 
only DNMT3A downregulation promotes higher leukocyte adhesion to BECs  
Among the several deregulated miRNAs identified in the aged microvessels, miR-144-
3p was selected for further analysis. Previous studies have reported upregulation of miR-144 
in the aged cortex of non-human primates and patients with AD (Persengiev et al. 2011). MiR-
144-3p has been reported to promote neuroinflammation via microglia activation in 
intracerebral haemorrhage in mice (Yu et al. 2017), and to supress anti-inflammatory proteins 
such as Nrf2 in male rat brain after ischaemia (Chu et al. 2019; Liu et al. 2014). Although no 
evidence is available regarding the role of miR-144-3p in BBB, it has been implicated in 
modulating TJ protein regulation in the blood-tumour barrier of human glioma, increasing 
permeability (Cai et al. 2015). These findings suggest a potential role of miR-144-3p in the 
age-related inflammation occurring in the female brain and BBB. In addition, target prediction 
analysis determined age-deregulated Dnmt3a as a predicted target of miR-144-3p, which is 
consistent with recent studies that have also predicted a reciprocal relationship between miR-
144-3p and DNMT3A in women (Xu et al. 2020). In the present study, Dntm3a mRNA and 
protein levels were found to be significantly downregulated in the ageing female 
cerebrovasculature. Dnmt3a is one of the DNA methyltransferases in mammals, which together 
with Dnmt1 and Dnmt3b modulate DNA methylation. DNA methylation patterns have been 
shown to be significantly changed in several tissues of different species, including the brain 
(Bollati et al. 2009; Christensen et al. 2009; Heyn et al. 2012). Although not in ageing, 
deregulated DNA methylation has been related to changes in TJ proteins in mice (Stamatovic 
et al. 2019), and the overexpression of genes related to amyloid pathology in cultured murine 
BECs exposed to Aβ (Chen et al. 2009). Accordingly, DNMT expression is altered with ageing, 
which includes age-dependent downregulation of DNMT3A expression in neurons of the 
ageing human brain (Siegmund et al. 2007). These findings suggest that age-related changes 
occurring at gene expression level in the female mouse BBB might be related to Dnmt3a 
expression modulation. 
Our analysis of a reciprocal relationship between miR-144-3p expression and Dnmt3a 
levels were confirmed in a human cell line (hCMEC/D3). As our sequencing results indicated 
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that inflammation and leukocyte migration pathways were increased in the aged female BBB, 
both leukocyte adhesion and paracellular permeability were assessed in the context of miR-
144-3p/DNMT3A deregulation. No significant differences in paracellular permeability were 
observed after upregulating expression of miR-144-3p, thus experiments altering expression of 
DNMT3A were not performed. However, additional experiments to determine whether 
DNMT3A deregulation affects paracellular permeability, independently of miR-144-3p, would 
aid to understand the underlying mechanism of DNMT3A role in the ageing BBB. By contrast, 
deregulation of DNMT3A, although not miR-144-3p, was shown to alter leukocyte adhesion to 
hCMEC/D3 cells. Indeed, DNMT3A downregulation induces a significant increase of 
leukocyte adhesion, which suggests that at normal levels DNMT3A exerts an anti-inflammatory 
effect. Little information is available regarding the role of DNMT3A in leukocyte adhesion and 
BBB disruption. However, previous studies have reported that downregulation of another 
Dnmt, Dnmt3b, is linked to higher MMP activity in cultured murine BECs, leading to increased 
BBB permeability (Kalani, Kamat, and Tyagi 2015). Additionally, Dnmt3a loss leads to 
activation of inflammatory responses in mouse mast cells in vivo and in vitro, including higher 
reaction to stimuli and increased cytokine production (Leoni et al. 2017). Similarly, Dnmt3a 
loss in female transgenic mice has been related to inflammation and increased levels or pro-
inflammatory cytokines, especially TNF-α, and upregulation of pro-inflammatory signalling 
genes such as NF-kB (Jacquelin et al. 2018). The potential anti-inflammatory effect of 
DNMT3A is supported in our results by the observation that its deregulation is concomitant 
with upregulation of ICAM-1 and VCAM-1 adhesion molecules and the chemokine 
CCL5(RANTES) in hCMEC/D3 cells. Interestingly, VCAM-1, but not ICAM-1 or CCL5, is 
upregulated when miR-144-3p is upregulated, even though miR-144-3p deregulation did not 
show any effect on leukocyte adhesion. The miR-144-3p effect on VCAM-1 expression might 
be due to the indirect downregulation of DNMT3A mediated by miR-144-3p. It is well 
established that  ICAM-1 and VCAM-1 are upregulated in human BECs under inflammatory 
conditions including exposure to pro-inflammatory cytokines (Stins et al. 1997), promoting 
adhesion and transmigration of leukocytes across the cerebrovasculature in the human brain 
(Nagai and Granger 2018; Supanc et al. 2011). Chemokines such as CCL5 also contribute to 
leukocyte migration across the BBB in the context of inflammation, as reported in human BECs 
in vitro and in female EAE model mice in vivo (Quandt and Dorovini-Zis 2004; Dos Santos et 
al. 2005; Subileau et al. 2009). Despite the fact that little information is available regarding 
ICAM-1/VCAM-1/DNMT3A, and although is not exposed in the context of BBB but in a LPS-
stimulated macrophage line, Dnmt3a inactivation in mice has been recently associated with 
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overexpression of Ccl5 among other chemokines and cytokines (Sano et al. 2018). Taken 
together, these findings suggest that DNMT3A plays an anti-inflammatory role in the BBB, 
and, since DNMT3A participates in de novo methylation, we can speculate that age-related 
depletion of DNMT3A expression levels might induce DNA methylation changes that, directly 
or indirectly, lead to overexpression of pro-inflammatory mediators (e.g. ICAM-1, VCAM-1 
and CCL5) thereby contributing to leukocyte adhesion to the endothelial cells of the BBB. 
5.5.2 Dnmt3a and Icam-1 protein expression are significantly deregulated in the ageing 
female cerebrovasculature 
To determine whether the changes in expression of ICAM-1 and VCAM-1 observed in 
the in vitro experiments are also occurring in the ageing female mouse BBB, protein levels 
were assessed ex vivo by immunohistochemistry in the female brain cortex. Despite being 
significant, CCL5 overexpression in the context of DNMT3A deregulation was small, therefore, 
we decided to focus on the adhesion molecules for this last set of experiments. Ex vivo analysis 
found that Dnmt3a was significantly decreased in the female cerebrovasculature with age. By 
contrast, although no changes were found at mRNA level, Icam-1 protein was shown to be 
significantly decreased in the brain vessels of aged female mice, while Vcam-1 was unchanged. 
These observations suggest a potential difference in Dnmt3a-mediated regulation of Icam-1 
and Vcam-1, since downregulation of Dnmt3a is concomitant with overexpression of Icam-1, 
but not Vcam-1 in the female cerebrovasculature. In fact, Dnmt3a has been reported to 
participate in several processes including tumour suppression, hematopoietic cell 
differentiation, neurogenesis and inflammation (Jacquelin et al. 2018; Yang, Rau, and Goodell 
2015), therefore, within the complex network of modulated genes, many other factors might 
be participating in the Dnmt3a-mediated regulation of adhesion molecules, resulting in a 
differential regulatory mechanism depending on Icam-1 or Vcam-1. This theory of a 
differential regulatory effect mediated by Dnmt3a might be supported in our study by a higher 
increase in ICAM-1 expression compared to VCAM-1 when DNMT3A is silenced in 
hCMEC/D3 in vitro. However, additional experiments assessing the differences in DNA 
methylation in aged brain microvessels versus young brain microvessels would aid 
understanding whether Icam-1 and Vcam-1 expression is directly affected by Dnmt3a and if 
so, whether they are differentially demethylated.   
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The age-mediated upregulation of Icam-1 observed in the ageing female mouse brain 
microvessels is in contrast with previous studies which have reported that the process of ageing 
in the brain is associated with inflammation and loss of TJ proteins but not with leukocyte 
transmigration in female mice (Elahy et al. 2015). However, our results are in agreement with 
previous studies that reported a higher expression of Icam-1, but not Vcam-1, in BECs of aged 
male mice when exposed to inflammatory cytokines (Xu et al. 2010). These findings suggest a 
differential deregulation between Icam-1 and Vcam-1 in ageing, which might be due to Dnmt3a 
age-dependent deregulation and might influence leukocyte adhesion. 
 
5.6 Limitations of the current studies and future work 
Combining TEM techniques with 3D reconstruction gives a high-throughput profiling 
of capillary structural features. Due to its high resolution, this same technique has been used 
before to assess perivascular astrocytic coverage under pathological conditions (Mathiisen et 
al. 2010). The main caveat of this approach is that the process is very time consuming and 
therefore limits the number of vessels that can be analysed and restricts the analysis to certain 
brain cellular and/subcellular components. Therefore, even though some of the structural 
features assessed appear to have a trend towards change, generalization is not possible in some 
of these cases. Alternatively, other methods of serial 3D reconstructions include large-scale 
processing of previously stained brain sections in a quicker and more efficient way (Berlanga 
et al. 2011; Nizari et al. 2019). However, such approaches do not provide the higher resolution 
to discern ultrastructural features. To obtain a much more extensive profiling of structural 
changes in the ageing BBB with same accomplished resolution, a higher number of vessels 
should be analysed, although the amount of work that this requires should be considered.  
The present study has reported regional ultrastructural differences between aged cortex 
and hippocampus, including a more inflammatory state or higher TJ tortuosity in cortical 
capillaries compared to hippocampal capillaries. Additional experiments including assessment 
of in vivo barrier permeability in cortex and hippocampus, or isolation of hippocampal 
microvessels to perform RNA sequencing as we did for cortical microvessel, would be useful 
to determine if the ultrastructural region-dependent differences that we observed have a real 
impact on BBB function. Also, further comparison of BBB changes between these and other 
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brain regions would help understanding the role of the structural changes observed in this study 
on BBB function and whether sex specificity is contributing to the regional differences. 
Regarding our RNA sequencing analysis, the main limitation we encountered was the 
low RNA yield obtained in our first trials for single BEC isolation. Previous studies have 
reported higher yields of isolated microvessels, but they were isolating whole brain regions 
(e.g. cortex or hippocampus) and pooling them together, thus having enough starting material 
(Yousef et al. 2018). In contrast, we aimed to extract RNA from specific microvascular cells 
and therefore the amount of starting material was much lower. Additionally, other groups have 
managed to successfully isolate single cells from brain tissue with acceptable RNA yields using 
magnetic beads (Vanlandewijck et al. 2018). Unfortunately, this same approach did not work 
in our hands, which together with the restrictions in number of animals available made us select 
a more classical protocol for microvessel fragments isolation. As stated by Yousif and 
colleagues, one major handicap of this kind of isolation is the less purified final sample, which 
becomes a problem for experiments aiming to identify and locate specific genes or proteins in 
certain BBB components (Yousif et al. 2007). Which is even more complex when cell 
proportions change between groups, as observed for SMA-α and PDGFR-β in our data. 
Therefore, it is essential to take this into consideration when analysing sequencing results. 
Nevertheless, we considered all these limitations and managed to select an age-deregulated 
mRNA/miRNA pair expressed in BECs. However, studying in the same way the different cell 
types at the brain microvasculature would give a better insight of how the female BBB changes 
in ageing.  
The predicted targeting relationship between miR-144-3p and DNMT3A has been 
partially confirmed by transfection of hCMEC/D3 in which both mRNA and miRNA changed 
in opposite directions. However, additional confirmation could be performed using 3’-UTR-
luciferase assay and luciferase reporter vectors (Lee et al. 2007). Briefly, the protocol consists 
on transfecting these vectors, containing the potential target site that is also present in the 
mRNA of interest, into the cells and measuring luciferase activity. Luciferase activity will be 
reduced if the miRNA is actually binding to the target sequence, which suggests a targeting 
relationship (Hirata et al. 2012; Zhang et al. 2010). As mentioned above, DNMT3A 
deregulation, was shown to promote a proinflammatory phenotype in hCMEC/D3 cells, 
inducing an increase in leukocyte adhesion. Although we did not pursue paracellular 
permeability alteration after observing no significant change for miR-144-3p, leukocyte 
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adhesion experiments have shown that DNMT3A might be the one excessing a higher effect on 
BBB integrity. Therefore, assessing paracellular permeability in hCMEC/D3 in the context of 
DNMT3A deregulation would aid to better understand its role in age-mediated BBB 
dysfunction.  
Also, in order to link DNMT3A deregulation back to female BBB dysfunction and sex 
differences in ageing, some extra experiments involving exposure to sex steroid hormones 
could be done. Indeed, previous studies have proved the anti-inflammatory effects of oestrogen 
in the brain and BBB protection (Duckles and Krause 2011; Ghisletti et al. 2005; Vegeto et al. 
2003), as well as the inflammatory detrimental age-related effects in cerebrovascular function 
related to oestrogen loss during and after reproductive senescence (Deer and Stallone 2016; 
Henderson and Lobo 2012; Sunday et al. 2007). Similarly, results obtained by Berchtold and 
colleagues suggest that upregulation of inflammatory genes in the female brain are not solely 
driven by age itself, but may be related to oestrogen withdrawal in menopause (Berchtold et al. 
2008). Thus, a logical next step would be to repeat the same set up in vitro, but including 
several concentrations of oestrogen in the culture in order to assess a possible hormonal effect 
in miR-DNMT3A deregulation.  
Our results showed that DNMT3A silencing is concomitant with upregulation of both 
ICAM-1 and VCAM-1 in human BECs. However, no changes in mRNA or protein levels were 
observed for Vcam-1 in the brain of ageing female mice, while Icam-1 was significantly 
upregulated at protein level only. Additional experiments could assess changes in DNA 
methylation between aged and young cortical capillaries, to determine whether Icam-1 and 
Vcam-1 are differentially modulated at the methylation level. Similarly, possible post-
translational modifications in Icam-1 protein could be assessed, in order to understand changes 
at the protein level while mRNA levels remain unchanged. Lastly, a final limitation of the study 
is that the described effect of DNMT3A deregulation on leukocyte adhesion to brain 
microvascular endothelial cells has only been assessed by in vitro techniques. In light of the 
existing controversy regarding leukocyte adhesion in the healthy ageing brain (Elahy et al. 
2015; Miguel-Hidalgo et al. 2007), in vivo experiments would be useful to assess whether the 
same conditions are translated into the complex and much richer environment of the brain.  
In any case, we have ended up selecting a couple of the several candidates that were 
shown to be deregulated in ageing. The sequencing dataset obtained from this project will work 
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as a starting point to assess different mechanisms happening at the female ageing BBB in the 
future.  
 
5.7 Conclusions 
The novel observations generated from this PhD project are that: 
1. Healthy ageing induces structural changes in the female BBB that are more 
prominent in cortical capillaries than in hippocampal capillaries. Among the 
structural age-related modifications, we found higher number and volume of BEC 
surface pseudopods, larger volume of pericyte mitochondria and increased coverage 
of pericytic projections over brain endothelium in aged capillaries compared to 
vessels from young female mice. 
 
2. MiR-144-3p, previously described to be upregulated in the ageing brain in neurons, 
is also upregulated at the level of brain microvasculature during ageing.  
 
3. MiR-144-3p appears to negatively regulate Dnmt3a. Moreover, both are changed 
in opposite directions during ageing. Dnmt3a protein levels are also significantly 
downregulated in the mouse cerebrovasculature. 
 
4. In vitro induced deregulation of miR-144-3p does not affect paracellular 
permeability of brain endothelial cells.  
 
5. In vitro induced deregulation of DNMT3A, but not miR-144-3p, promotes 
alterations in leukocyte adhesion to brain endothelial monolayer. Indeed, when 
DNMT3A is downregulated, leukocyte adhesion is significantly increased. 
 
6. ICAM-1, VCAM-1 and CCL5 expression levels are deregulated in hCMEC/D3 cells 
after miR-144-3p/DNMT3A deregulation. In vitro experiments showed that only 
VCAM-1 is increased when miR-144-3p is upregulated. DNMT3A silencing 
promotes significant upregulation of both adhesion molecules and CCL5 in vitro, 
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whereas only Icam-1 protein expression appears to increase in the ageing 
cerebrovasculature from female mouse tissue.  
 
Figure 44. Age-related ultrastructural and gene expression changes in the female mouse BBB: A summary.  
In the present study, brain cortical capillaries were shown to be more affected than hippocampal capillaries during 
normal ageing. The ultrastructural analysis showed a significant increase in BM thickness, higher number and 
volume of BEC pseudopods, increased pericyte mitochondrial volume and coverage, and higher TJ tortuosity. 
MACE-Seq results showed most of the upregulated genes to be related to inflammatory pathways. MiR-144-3p 
and Dnmt3a were shown to have an inverse correlation in the ageing female mouse BBB and in human BECs 
(hCMEC/D3). However, Dnmt3a appears to have a most important effect in inducing the pro-inflammatory effect 
on BECs, independently of miR-144-3p. Indeed, DNMT3A downregulation increases Jurkat T cell adhesion to 
hCMEC/D3 monolayers and promotes upregulation of ICAM-1, VCAM-1 and CCL5, at the mRNA level. By 
contrast, only Icam-1 was proved to be downregulated at the protein level in the aged female mouse microvessels. 
P: pericyte, A: astrocyte. (Diagram by Eduardo Frías Anaya). 
In conclusion, healthy ageing appears to affect the structure of female brain 
microvasculature in a differential way depending on the region, with more prominent 
alterations in cortical capillaries (Figure 44). Such structural differences may be associated 
with increased vessel stiffness, higher number and volume of BEC surface projections, changed 
pericyte coverage and mitochondrial dynamics and altered TJ tortuosity. At the molecular 
level, the female BBB in the cortex is mostly inflammatory active during ageing, with several 
deregulated mRNAs and miRNAs among which miR-144-3p appears to mediate expression of 
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DNMT3A, which in addition appears to promote leukocyte adhesion onto brain endothelium 
when downregulated. The implications of this work suggest a low-grade but increasing 
cerebrovascular inflammation during ageing that may have further consequences on female 
BBB and brain function. Collectively, these alterations may also contribute to the specific sex 
differences observed regarding incidence and progression of cerebrovascular diseases between 
males and females, as well as the development of certain age-induced neurodegenerative 
disorders and vasculopathies that appear to be more prevalent in post-menopausal women. 
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Appendix 
Table 5. List of differentially expressed genes (mRNAs) between young and aged female mouse microvessels 
as analysed by MACE-Seq analysis.  
Negative values mean downregulation in young microvessels with respect to aged microvessels 
(increased in ageing), whereas positive values mean upregulation in young microvessels with 
respect to aged microvessels (decreased in ageing).  
Gene symbol log2FoldChange (Young vs Aged) P-value 
Spc24 -4,988975934 0,00077756 
Fpr2 -4,877932973 0,002410934 
Ms4a3 -4,140862536 0,018412749 
4930519F09Rik -4,140862536 0,020965862 
C030034I22Rik -4,140862536 0,021435008 
Fgf21 -4,140862536 0,03610812 
Pilrb1 -4,041588956 0,03119602 
BC043934 -3,934371332 0,032061357 
Gm13536 -3,823500359 0,002716675 
Itga2 -3,819196535 0,045052234 
Epha1 -3,697939689 0,004624725 
Izumo1 -3,486586084 0,013743093 
Clec4d -3,326097067 0,0214937 
Ubash3a -3,238865483 0,023325952 
Lancl3 -3,238865483 0,029491735 
Ms4a4b -3,175748544 0,007557917 
Ifitm6 -3,163730509 0,033618673 
Ifi204 -3,145493985 0,035622085 
Aspg -3,145493985 0,038887063 
Adgrf4 -3,111431719 0,010086853 
Gm8276 -3,111431719 0,018736733 
Ccnb2 -3,044487731 0,014710657 
Iglc3 -3,003241492 0,004401039 
Glipr1 -2,988253069 7,73E-06 
Prg2 -2,974089042 0,000638213 
Il20rb -2,97389245 0,014860775 
Gssos2 -2,97389245 0,01919566 
Saa2 -2,939002781 0,008114792 
Mki67 -2,939002781 0,009533309 
Ppbp -2,870079405 0,007863125 
AI662270 -2,86149211 0,001985824 
Gm44805 -2,823500359 0,007869773 
Tfap2a -2,821845665 0,020986294 
Arhgap27os1 -2,762256513 0,021194954 
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Oas1b -2,697939689 0,011163393 
Asf1b -2,697939689 0,011586757 
2310040G07Rik -2,697939689 0,013414965 
Cd3d -2,697939689 0,014113233 
Pycr1 -2,697939689 0,021659002 
Guca1a -2,652357513 0,040423026 
Ctsk -2,630995701 0,018706188 
Galnt4 -2,630995701 0,018974841 
Map4k1 -2,560400419 0,036949694 
Hist1h1e -2,560018711 0,001968586 
Cdk1 -2,559708847 0,016934246 
Ltb4r1 -2,558986015 0,007655356 
Plac8 -2,524625807 6,06E-07 
Cd2 -2,500644784 0,012061216 
Pgm3 -2,384917511 0,005896279 
Spn -2,375262831 0,001420609 
AC164087.2 -2,352494811 0,029397125 
Ccl5 -2,316911797 1,64E-08 
Ly9 -2,308140126 0,031597873 
Cks2 -2,308140126 0,037292434 
Poli -2,23792212 0,025237668 
Gm35040 -2,237741437 0,003806356 
Hist1h2ad -2,236992389 0,04590354 
Tmem255a -2,185589915 0,04194061 
Tlr13 -2,175748544 0,022993016 
Retnlg -2,167164849 0,033753732 
Fam227b -2,155656726 0,009107279 
Ptprcap -2,155656726 0,019608343 
Ube2c -2,112700133 0,021643192 
Acp5 -2,08112824 0,001461106 
Nphp4 -2,044780331 0,028512995 
Clec7a -2,031335923 0,005470133 
Fam81b -2,022494638 0,020064873 
Cd300e -2,01548289 0,038508941 
Cst7 -2,003241492 0,016070484 
Hist1h2ao -1,996965189 0,000614799 
Acot10 -1,992448126 0,028118404 
Ear2 -1,988146805 0,016407645 
Fcgr4 -1,950353136 0,001231504 
Gm43362 -1,926270576 0,024435185 
Hist1h2ap -1,921466597 0,000362065 
Atad2 -1,908182905 0,011286865 
Serpina3n -1,900850642 0,024263718 
Tmem132e -1,88992222 0,048310184 
Top2a -1,881405165 0,041242394 
Gm26510 -1,870079405 0,021019074 
Gm14450 -1,866243793 0,01260157 
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H2-Q5 -1,862264637 0,02631063 
Itgax -1,8232872 0,025432917 
Haus6 -1,823167041 0,049115603 
Tmem71 -1,822455447 0,010631605 
Ccr2 -1,822341102 0,049757788 
Mmp9 -1,799828185 0,002634193 
Mrps36-ps1 -1,757037877 0,009159888 
Itgal -1,752579543 0,013401165 
Sp6 -1,740361625 0,017755987 
Slco5a1 -1,723084013 0,033519504 
Gm13056 -1,723084013 0,041215304 
Dsn1 -1,71212408 0,048787151 
Gm45113 -1,71212408 0,04919017 
Ccl8 -1,711608924 0,012858937 
Alas2 -1,702297161 1,54E-06 
Rac2 -1,702050237 0,000148153 
Lrriq1 -1,670751808 0,044844313 
AI854703 -1,664276207 0,021862224 
Cybb -1,659404611 0,000670079 
Milr1 -1,636857644 0,043683944 
Tirap -1,630415956 0,013954666 
Lgals3 -1,619547544 2,83E-05 
1700086O06Rik -1,616298424 0,014750471 
Gm28153 -1,611273778 0,003675271 
Gm15397 -1,607199537 0,042967967 
Olfr78 -1,560018711 0,03939871 
Snx33 -1,544543611 0,011649498 
Cplx3 -1,544543611 0,02753474 
Myo1g -1,527162908 0,016593065 
Hbb-bt -1,523868436 0,000528235 
Phf11d -1,518079599 0,001550341 
Slc6a12 -1,510975476 0,047286661 
Pygl -1,500808606 0,01958119 
Dph5 -1,500754 0,03134274 
Cenpa -1,495843858 0,008552917 
Ttc5 -1,493900454 0,025259639 
Hbb-bs -1,486395583 0,002862353 
Clec4a1 -1,481796701 0,03594314 
Gfap -1,477869327 3,73E-05 
Tarsl2 -1,472315775 0,028492959 
Zfp612 -1,472315775 0,033758194 
Gm9333 -1,47034782 0,014870198 
Hba-a1 -1,462109794 0,001334747 
Mettl13 -1,449458622 0,022179062 
Hba-a2 -1,440744231 0,001308799 
Ighg2c -1,435684045 0,032016019 
Tbccd1 -1,425174323 0,0288716 
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Ptprc -1,424240755 0,005341541 
Arhgef19 -1,414987097 0,028502239 
Topors -1,413663177 0,010328667 
E230029C05Rik -1,403337358 0,002275186 
Dock5 -1,400223425 0,033241307 
Pdcd7 -1,386892666 0,040307623 
Gm9946 -1,383798807 0,003999827 
Tram2 -1,382335917 0,026587593 
Gm37893 -1,382335917 0,043551849 
Lyrm7 -1,380827966 0,016756963 
Lyz1 -1,37522709 0,019489138 
S100a4 -1,373698123 6,57E-05 
Tsacc -1,367456435 0,048756632 
Fgr -1,359718843 0,049350378 
A630001G21Rik -1,348678097 0,014621371 
Zfp688 -1,337476516 0,03120206 
Plbd1 -1,329167728 0,032395936 
Dapp1 -1,328077012 0,009334873 
Tmem45a -1,318857542 0,017454673 
Runx1 -1,315630586 0,046978043 
Fam118a -1,313136345 0,000154631 
Proca1 -1,308140126 0,041847081 
Lyz2 -1,299630648 5,20E-06 
Prkaa2 -1,29682898 0,028149581 
Oasl1 -1,288557877 0,024160072 
C3 -1,284145685 0,003312639 
Crnkl1 -1,281000257 0,009219948 
Calhm2 -1,272651907 0,004790181 
Spsb1 -1,259681835 0,014417298 
Nexn -1,258390178 0,010756861 
Ppp1r32 -1,258390178 0,011943296 
1700018A04Rik -1,255324291 0,004674165 
Gm10125 -1,237843599 0,008290379 
1110002L01Rik -1,237843599 0,047663351 
Ankfn1 -1,220467334 0,00878274 
Clcn2 -1,212768002 0,029856942 
Usp39 -1,211993291 0,032630614 
Fzd8 -1,211993291 0,048418578 
5430405H02Rik -1,210817108 0,04349332 
Pus7 -1,196151504 0,021434225 
C4b -1,188979596 0,003635471 
Wdr46 -1,181187479 0,028124293 
Elp4 -1,17898405 0,005919335 
Dok3 -1,174833082 0,019175011 
Amy1 -1,167396261 0,010016094 
Tapt1 -1,163730509 0,036818897 
Extl1 -1,153777815 0,01396532 
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Mmgt2 -1,144798319 0,029604659 
Hace1 -1,141631021 0,043887952 
Dpf1 -1,139315576 0,02347733 
Ifi30 -1,135270441 0,023141309 
Fmod -1,134348643 0,011291303 
1700001L19Rik -1,128242291 0,018078939 
Lsp1 -1,108541735 0,003446112 
Ccdc85b -1,10287651 0,013993436 
Oma1 -1,09704637 0,018008585 
Ifi203 -1,090353908 0,027000323 
Dcaf15 -1,090353908 0,036597698 
Gm6030 -1,088214682 0,020011755 
Isg20 -1,08274722 0,001818727 
Pla1a -1,078377012 0,019256084 
Elovl4 -1,078377012 0,024607258 
Gm24447 -1,074221329 0,03416316 
Rdh14 -1,063791288 0,028585945 
Tbc1d23 -1,058076264 0,00990261 
Trim12c -1,058076264 0,021675791 
Ccnc -1,052767879 0,027742309 
Foxp4 -1,052278986 0,026867029 
Igf2bp3 -1,051478535 0,042305305 
Zfp275 -1,050721125 0,042029612 
Gxylt1 -1,049822888 0,043176185 
Syde1 -1,047969345 0,005504716 
Bet1 -1,045290898 0,014526372 
Brd1 -1,040946131 0,021030379 
Incenp -1,040402354 0,034006133 
Vav2 -1,039862467 0,031806062 
Adamts2 -1,026451774 0,049374897 
Ccl6 -1,016866467 0,004520333 
Stx2 -1,015371325 0,04045781 
Nos1 -1,012270403 0,000989768 
Plekhh2 -1,005627474 0,0464297 
Coa7 -1,005627474 0,048776447 
Dnmt3a 1,000071005 0,030159302 
Adh1 1,004595794 0,025677712 
Bambi 1,028514975 0,029726779 
Ednrb 1,042248037 0,042792592 
Gem 1,051629924 0,047741874 
5730480H06Rik 1,055161215 0,045395654 
Rbm4b 1,068693501 0,045879129 
Uevld 1,070157517 0,040951108 
Phyhipl 1,070831771 0,00123077 
Hes5 1,084105476 0,014415573 
Csrnp1 1,087956155 0,004279508 
Il18 1,103226805 0,001221479 
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Slc10a1 1,112843318 0,040763673 
Tatdn3 1,12109399 0,035938253 
Rab30 1,1247506 0,038422031 
6330403L08Rik 1,14692595 0,049286867 
Col8a2 1,151122905 0,035196858 
Dcun1d3 1,172405991 0,001952102 
Gm20532 1,177187357 0,019724056 
Pot1a 1,197043043 0,010125899 
F5 1,221629929 0,028249414 
Tubd1 1,242121892 0,023865064 
Ppp4r1 1,251133133 0,000266671 
2610306M01Rik 1,273221866 0,016926541 
Rslcan18 1,280149972 0,011192001 
Cd33 1,282980794 0,00899663 
Cmc4 1,288133521 0,005458346 
Gm17208 1,300577916 0,010575167 
Cox15 1,306577677 0,0064727 
Gan 1,308086004 0,010335639 
Slc29a4 1,316758463 0,01327616 
1500026H17Rik 1,318501154 0,018530176 
Zfp426 1,320354341 0,039254838 
Ccdc112 1,322950084 0,010730855 
3110002H16Rik 1,347080537 0,025952442 
Mblac2 1,347093961 0,008750624 
Gm24305 1,34714667 0,02322239 
Gtf2ird2 1,372194498 0,012793825 
Apoc1 1,380799321 0,033486173 
Rhoh 1,386502743 0,0318404 
B4galnt4 1,390341548 0,004935684 
Rinl 1,4097856 0,046271885 
Tada2b 1,45419797 0,018362363 
Chst10 1,45419797 0,02281032 
Rasl11a 1,468358241 0,008216168 
Cort 1,498795777 0,028087469 
Baiap2l1 1,512265733 0,005527313 
Xkr8 1,512391038 0,047174844 
B230312C02Rik 1,521272026 0,019790324 
Jmjd4 1,521272026 0,024360023 
Adora2b 1,550720095 0,028222221 
Wdr86 1,550720095 0,036802548 
Slc4a5 1,569372767 0,048819494 
Tmem267 1,583213991 0,005508968 
Gm15432 1,592515895 0,046969837 
Mapk7 1,610252316 0,005400341 
Zfp2 1,682487571 0,003908275 
Gm33178 1,761907459 0,047183432 
Pigo 1,762169552 0,004012306 
Appendix 
 
216 
 
1700029J07Rik 1,861443132 0,000877661 
Cideb 1,877325234 0,0331538 
Kl 1,926060726 0,044202038 
Gm20521 1,955210813 0,016869259 
Slc24a5 1,955210813 0,025611775 
Clic6 1,980665329 0,028650906 
Sec31b 2,025728289 0,048043023 
Steap1 2,04262252 0,027590966 
Fsd1l 2,083758278 0,005492359 
Gm23238 2,203001067 0,004486706 
Col9a3 2,233344973 0,031209581 
Stk32c 2,248010315 0,020343858 
AC162376.3 2,285301419 0,027411354 
Gm5555 2,285301419 0,030712401 
A630014C17Rik 2,285301419 0,033815304 
Sgca 2,346869959 0,007174756 
AC122273.2 2,346869959 0,021070594 
Cblc 2,500338537 0,033257846 
Gm16194 2,500338537 0,036629322 
Ppp1r42 2,500338537 0,049031974 
Gm13111 2,6199151 0,006523234 
Chdh 2,637757769 0,028470264 
Cldn2 2,668746538 0,00222697 
Rbp7 2,701649864 0,019387343 
Gm27032 2,932090015 0,028770829 
Gm45606 3,009794301 0,027271098 
AC153144.3 3,083990092 0,018839692 
4731419I09Rik 3,083990092 0,026080383 
Gm2464 3,5730884 0,047351008 
Gm9768 3,672889007 0,034587461 
Hgfac 3,672889007 0,035560992 
Gm25890 3,672889007 0,045378423 
Nppc 3,853352169 0,025599156 
Gm7935 3,93602643 0,029266817 
Stc1 4,013730716 0,016369389 
 
